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Abstract 
Nanoelectrospray ionisation (nanoESI) coupled with quadrupole time-of-flight (QTOF) mass 
spectrometry (MS) has developed to the point that noncovalent complexes of biomolecules can be 
analysed. In this work, current MS technology was used to analyse protein assemblies of tobacco 
rubisco and rubisco activase and their interactions with nucleotides and sugar phosphates. The 
first nanoESI mass spectra of rubisco and rubisco activase are presented. Rubisco activase was 
determined to have a higher relative binding affinity for ADP over AMP-PNP (and by inference, 
ATP) and the addition of ATP-Mg revealed a possible second nucleotide binding site. This is the 
first clear evidence of a second nucleotide binding site on rubisco activase and binding at the first 
site potentiated binding at the second site. Further, an interaction between rubisco activase and 
RuBP, but not CABP was observed. While this observation should be treated with caution, the 
binding of RuBP to rubisco activase suggests direct involvement of rubisco activase in removing 
RuBP from the inactive rubisco-RuBP complex. The inability to observe a rubisco activase-CABP 
complex suggests a specific interaction of rubisco activase with RuBP. The addition of rubisco 
activase to the inactive rubisco-RuBP complex led to removal of RuBP from rubisco, though no 
direct complex between rubisco and rubisco activase was observed by ESI-MS. In addition, the 
oligomeric assembly of an archaeal rubisco from Methanococcoides burtonii was investigated. In 
the presence of substrates, RuBP or CABP, or divalent metal cofactors, M. burtonii rubisco 
assembled from dimers into decamers. The nanoESI mass spectra confirmed results observed 
using native polyacrylamide gel electrophoresis. These results suggest a re-examination of the 
classification of the rubisco superfamily since the M. burtonii rubisco has catalytic and structural 
similarities with other archaeal rubiscos, but closer sequence homology to bacterial type II 
rubiscos.  
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NanoESI-MS was also used to investigate protein subassemblies of the DNA polymerase III of the E. 
coli replisome. This molecular machine is responsible for the replication of chromosomal DNA 
prior to cell division. The interaction between the 2 sliding clamp and the polymerase  subunit 
was the focus of this investigation, in particular, characterisation of the two 2-binding sites on the 
 subunit, as well as preliminary work to determine conditions toward the assembly of larger 
subassemblies of the replisome. Complexes of the core ( ) subassembly with the 2 sliding 
clamp, and core with the truncated  subunit, c16, were observed. Determination of the conditions 
for observation of these complexes has set the scene for more detailed analysis of the order of 
assembly of the replication machinery and for an understanding of the protein binding partners 
involved in key interactions. Based on the observations made in this work, evidence has recently 
been obtained using nanoESI-MS to show that the  proofreading subunit interacts directly with 
the 2 sliding clamp. 
Finally, travelling wave ion mobility mass spectrometry (TWIMS) is a relatively new type of IMS. In 
IMS, ions are separated not only on the basis of mass/charge, but also by their size and shape. 
Since this a newly commercially available technology, it was of interest to determine the resolving 
power of the Synapt™ HDMS™ instrument for protein conformers. A mixture of 2 and transferrin, 
proteins of similar mass but different shape, was resolved using TWIMS. TWIMS was also used to 
confirm that changes in charge state distribution can correspond to protein unfolding, where the 
unfolded form of DnaB-N was separated from the folded conformation. Differences in collisional 
cross section were determined from TWIMS data of complexes of calmodulin in positive or 
negative ion mode. In these studies, mass spectrometry provided information that is not readily 
available from other techniques. 
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General Introduction 
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Processes that occur in cells require the interactions of proteins, and in many cases interactions 
with nucleic acids and small molecule effectors (e.g. lipids, metal ions, nucleotides). In order to 
understand fully the molecular players that are involved, the dynamics and sites of the 
interactions to atomic detail, a suite of complementary biochemical and biophysical techniques is 
required. In recent years, advances in electrospray ionisation mass spectrometry (ESI-MS) have 
meant that this technique can be applied to the analysis of multi-component noncovalent 
assemblies of biomolecules and to probe conformational changes. 
In this work ESI-MS was used to investigate aspects of the assembly of oligomeric proteins and 
protein binding partners of biomolecular machines and their interactions with small molecules. 
Furthermore the introduction of the travelling wave ion mobility cell coupled with a quadrupole 
time-of-flight (QTOF) mass spectrometer enabled investigation of its ability to separate protein 
conformers. The introduction below sets the scene outlining the background of biological mass 
spectrometry, followed by discussion of the importance of biological molecular machines and 
techniques that have been used to study these systems. Finally, the role of protein conformation 
within molecular machines and methods to study changes in protein conformation is briefly 
described. 
 
1.1 Development of biological mass spectrometry 
Mass spectrometry (MS) is a technique that is used to determine the mass-to-charge (m/z) ratio of 
ions and can be applied in MS/MS (tandem mass spectrometry) experiments to interrogate the 
chemical structure of molecules or fragments of molecules based on their mass. It involves 
vaporisation of the sample and ionisation of the resulting gaseous molecules, which are then 
separated according to their m/z. Early ionisation methods for MS were chemical ionisation (CI) 
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and electron ionisation (EI), but these methods are unsuitable for use with large, fragile 
biomolecules because the energy required for ionisation results in substantial fragmentation.1,2  
The concept of electrospray ionisation (ESI) was first introduced by Dole and coworkers in the 
1960s.3 They proposed a new technique to transfer an ionised macromolecule from solution to the 
gas phase without degradation.4 To test this, a sample of polystyrene (molecular weight 51,000 
Da) in a volatile solvent was sprayed from an electrostatically charged hypodermic needle into an 
evaporation chamber containing nitrogen gas. Evaporation of the solvent resulted in the 
generation of “macroions” in the gas phase. The macroion current was detected by a Faraday 
cage, providing the first demonstration of electrospray ionisation.4 
Further development of this “soft” ionisation technique was carried out by Fenn and coworkers in 
the 1980s.5,6 By coupling ESI with a quadrupole mass filter, they demonstrated the first analysis of 
large intact molecules in 19887 with multiply charged ions generated from solutions of 
polyethylene glycol (PEG) of various molecular mass ranging from 200 to 17,500 Da.7 In 1989 ESI-
MS was used to measure the molecular mass of several proteins, including insulin (5,730 Da), 
lysozyme (14,300 Da), -amylase (54,700 Da) and conalbumin (76,000 Da).8 Since then, MS has 
become well established in biology, particularly in the field of proteomics9-11 where ESI-MS and 
ESI-MS/MS provide information about the primary sequence of proteins and their molecular mass. 
The process of ESI involves the spraying of a dilute sample solution from an electrostatically 
charged needle tip into a bath gas at atmospheric temperature, producing charged droplets. When 
a positive voltage is applied to the capillary needle, the molecular ions contain multiple charges 
[M+nH]n+; if a negative voltage is applied, [M–nH]n- ions are formed. The solvent evaporates from 
the droplet, reducing the size of the droplet while the charge remains, until Coulombic repulsive 
forces surpass the surface tension of the droplet causing fission into smaller drops. This process 
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continues until ions free of solvent remain. This has been explained by the ion evaporation model 
in which an ion is expelled from the solvent12 or the charge residue model in which charges on the 
surface of the droplet remain on the ion as the last of the solvent evaporates4 (Figure 1.1).  
 
 
Figure 1.1. Schematic representation of the charge-residue model. Adapted from Gaskell 1997. 13 
 
It is still unclear which of these (or other) models describes what is actually happening during 
electrospray ionisation. It has been suggested that either mechanism can occur in different 
situations. 14-17 Generally, smaller ions are thought to be generated by the ion evaporation model 
while generation of larger ions, such as those of proteins and nucleic acids is thought to be best 
described by the charge residue model.18,19 
The ions are then passed towards the mass analyser in a high vacuum system. Mass analysers that 
are often coupled with ESI sources include ion trap,20-23 quadrupole,6,24-26 time-of-flight27 or 
quadrupole time-of-flight (QTOF) analysers28-30. The different types of mass analysers and mass 
spectrometry in general have been reviewed elsewhere.13,27,31-33 
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1.2 Advantages of MS for studying biomolecules 
While techniques for analysis of biomolecules and biomolecular complexes such as nuclear 
magnetic resonance (NMR) spectroscopy and X-ray crystallography can enable structure 
determination to near-atomic resolution, not all samples are amenable to these techniques.34 X-
ray crystallography is a method that involves analysis of an X-ray diffraction pattern caused by 
interaction of the X-rays with a crystallised sample. Based on the way the X-rays diffract upon 
striking the crystal, inter-atomic distances and angles of the atomic components of the crystal are 
measured and the arrangement of atoms within the biomolecule can be determined.35 In some 
cases, however, it can be difficult to grow crystals. This is particularly a problem in proteins with 
large unstructured areas, or those which have several conformational forms in equilibrium. Some 
biomolecules form crystals not suitable for X-ray diffraction.36 NMR involves subjecting a protein 
sample to a strong magnetic field. The protein is isotopically labelled with 13C or 15N, which have 
nuclear spin. Atomic nuclei with nuclear spin are affected by radiofrequency pulses that are 
applied to the sample. This changes the balance between different energy levels of the nuclei, as 
some absorb energy and move to a higher energy level. When the nuclei return to a lower level, 
the energy given off can be detected. The presence of electrons close to the nucleus will shield it 
from an external magnetic field, so the position of atoms within a molecule will affect nuclei 
energy levels and three-dimensional structure can be assigned.34 NMR is applicable to relatively 
small proteins, and often involves long experimental time frames. Both X-ray crystallography and 
NMR require substantial amounts of sample.34,37  
There are a number of advantages of using ESI-MS for studying noncovalent complexes. The 
multiple charging that occurs reduces the m/z observed for high mass biomolecules allowing mass 
analysis. Further, once instrument and solution conditions for a particular sample have been 
optimised, only relatively small amounts of sample material need to be used. The development of 
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nanospray ESI (nanoESI) has further reduced the amount of material required without 
compromising signal intensity (typically 1-2 L, compared to 100-200 L for conventional ESI 
samples).38 NanoESI involves the use of gold-coated capillaries that are pulled to a tip with a 
diameter of ~1 m. Samples are directly loaded into the needle, so there is no need for solvent 
pumps or inlet valves.38 NanoESI results in the generation of smaller droplets, which aids the 
desolvation process. In this way it has been proposed to be superior for preservation of 
noncovalent interactions since milder conditions are required for desolvation.9 A fully automated, 
chip-based nanoESI system has also been developed (NanoMate with ESI chip, by Advion), which 
provides the advantages of conventional nanoESI with additional benefits of automated high-
throughput analyses with no carryover.39 
A review by Loo in 1997 discussed the “S” advantages of ESI-MS for analysis of noncovalent 
complexes.40 The first advantages are speed and sensitivity. Compared to techniques such as NMR 
and X-ray crystallography, MS data can be acquired in a very short amount of time. It is also 
capable of detection down to the low picomole-femtomole range.41,42 Another capability of MS is 
specificity. Specific interactions are responsible for the formation of protein complexes and ESI-MS 
is able to distinguish relative binding affinities between different binding partners. The final “S” 
advantage is stoichiometry. Through direct measurement of the molecular mass of the complex, 
the stoichiometry can be easily determined. For example, Watt et al. studied the oligomeric forms 
of the E. coli DnaB helicase and a series of mutants using ESI-MS and observed hexameric and 
heptameric forms of the protein.43 
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1.3 ESI-MS of noncovalent biological complexes 
Further to its use in proteomics, ESI-MS has also become a complementary technique to the more 
established structural biology tools. The gentle nature of ESI allows the investigation of higher 
order structures of proteins and protein complexes.  Ganem et al. first applied ESI-MS to study 
specific noncovalent complexes in 1991 to examine the interaction between the cytoplasmic 
receptor FKBP and each of two immunosuppressive agents, FK506 and rapamycin.44 This work was 
followed by analysis of a complex of hen egg white lysozyme with its substrate, a hexasaccharide 
of N-acetylglucosamine.45 That same year, Katta and Chait showed that ESI-MS can provide 
information on the conformation of a protein.46 They examined the charge state distributions 
(ions) that were observed for myoglobin when exposed to different solution conditions. When the 
solution was at pH 3.35, the mass spectrum showed a charge state distribution in which the ions 
were of relatively low m/z (i.e., high number of charges). Under these conditions, myoglobin is 
expected to be denatured and the haem dissociates. At pH 3.9, where both native and denatured 
forms of myoglobin are present, two distinct charge state distributions were observed. In addition, 
ions corresponding to the intact haem-globin complex were observed.46 Following from these 
initial studies, the use of ESI-MS to investigate noncovalent protein-protein interactions has 
continued to grow. The application of ESI-MS for analysis of other noncovalent complexes such as 
protein-nucleic acid, protein-drug and DNA-drug complexes, has also become increasingly 
widespread. Numerous reviews have been published summarising the work in this field.9,37,40,47-53  
 
1.3.1 Protein-DNA complexes 
Many cellular processes, such as replication, translation and transcription involve interactions 
between proteins and DNA. Characterisation of these interactions can provide information about 
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the binding stoichiometry and affinity of the proteins with DNA, identification of protein-DNA 
contact points, structural changes upon binding and the biological consequences of protein-DNA 
complex formation. A review by Beck et al. gives examples of studies up to 2001 that used ESI-MS 
to investigate protein-DNA complexes.50 A more recent review by Fabris focused on the role of MS 
for studying nucleic acids in the post-genomics age, in particular the ability of MS to study 
interactions of nucleic acids with biomolecules and ligands and its importance in new drug 
discovery.54 An early study of protein-DNA interactions using ESI-MS was carried out by Cheng and 
coworkers.55 They investigated the gene V protein from bacteriophage f1 which is known to 
stabilise single-stranded DNA (ssDNA) during phage replication, and its complexes with 
oligonucleotides of different lengths (13-18 bases). Their results showed a 2:1 protein to 
oligonucleotide stoichiometry for protein complexes with oligonucleotides shorter than 15 bases, 
while a 4:1 stoichiometry was observed for complexes with oligonucleotides containing 16 or 
more bases. These results were in agreement with binding stoichiometries obtained by solution 
phase studies.56,57 
ESI-MS has been used by Kapur et al. to study the binding interactions between Tus protein of E. 
coli and its DNA recognition sequence, TerB.58 Tus protein halts replication by binding tightly to 
specific DNA sequences (Ter) on the E. coli chromosome. The ESI mass spectra showed a 1:1 
complex of Tus:Ter was present, consistent with the X-ray crystal structure.59 No complex was 
detected when Tus was treated with nonspecific sequences of DNA, indicating that ESI-MS 
detected only the specific Tus-Ter complex. The relative order of binding affinities for Ter DNA 
with mutant Tus proteins determined by Kapur et al. was also in agreement with solution studies 
(Biacore).58,60 
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Kamadurai et al.61 used ESI-MS to detect conformational changes of a protein upon DNA binding. 
Bacteriophage  integrase catalyses site-specific DNA recombination. The ESI mass spectrum of 
the catalytic domain of the protein exhibited three charge state distributions corresponding to 
unfolded, folded and dimeric protein. Upon addition of a substrate DNA sequence, the charge 
state distribution changed to show only the protein-DNA complex and the folded protein. The lack 
of unfolded protein indicated that the protein was stabilised upon DNA binding.61 The 
relationships among the ESI process, the observed charge state distribution, the protein sequence 
and size, as well as protein conformation is discussed in greater detail in Chapter 5. 
 
1.3.2 Protein-metal complexes 
Protein-metal interactions play an important role in biological systems. Metalloproteins are 
important for numerous metabolic processes, such as respiration and photosynthesis. Proteins can 
interact with a number of metal ions; however, the most common binding interactions occur with 
Mg2+ and Ca2+ as well as with  transition metal ions such as Fe2+, Fe3+, Zn2+ and Mn2+. This is a 
consequence of their abundances and their ability to form coordinate bonds with functional 
groups on amino acids.62,63 The functions of these metal ions are varied. For example, 
carboxypeptidase A hydrolyses C-terminal amino acids from polypeptides. It contains a zinc ion 
that acts as an electrophilic catalyst to promote hydrolysis.64 The zinc ion stabilises the negative 
charge on the oxygen and doing so, forms a transition state.65 Metal ions can also act as redox 
agents, such as iron in cytochromes. Cytochromes are a group of membrane-bound proteins that 
often include a haem-bound iron that is able to be oxidised or reduced and thus is often involved 
in electron transfer processes.66 Many enzymes require metal ions to assist in catalysis. For 
instance, ATPases and other enzymes couple the hydrolysis of ATP to other more 
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thermodynamically unfavourable processes. These enzymes often require the presence of Mg2+ 
bound to the ATP to function efficiently. The Mg2+ coordinates to both the -phosphoryl and -
phosphoryl group of ATP. This binding withdraws electrons from the phosphoryl anhydride bond 
of the terminal group, assisting in hydrolysis.67 
The protein calmodulin regulates Ca2+-signalling pathways in eukaryotic cells. Calmodulin 
undergoes a substantial conformational change upon binding of Ca2+ ions. This conformational 
change is important biologically as it is in this state that calmodulin binds its substrates. The X-ray 
crystal structure of calmodulin shows that large hydrophobic regions of the protein are exposed 
upon Ca2+ binding.68,69 
Since ESI-MS can be used to determine accurate molecular masses, it is able to distinguish 
whether metal ions are bound to proteins. Loo and coworkers were able to confirm the presence 
of four Ca2+ ions binding to calmodulin using this method.70 In some cases where the masses of the 
metals are sufficiently different, the metal ions that are present can be distinguished. Feng et al. 
examined the metal binding of the protein matrilysin using ESI-MS and found that it contains two 
Zn2+ and two Ca2+ binding sites.71 In cases where there are two metal ions of similar mass (e.g. Zn2+ 
at 65.39 g.mol-1 and Cu2+ at 63.55 g.mol-1), this task is more difficult. 
 
1.3.3 Multimeric protein complexes 
Biological processes are often carried out by multimeric assemblies of protein complexes rather 
than by a single protein.37 These complexes can be either homocomplexes (contain multiple copies 
of one protein) or heterocomplexes (contain different proteins). The formation of protein 
complexes often acts to inhibit or activate one or more of the proteins within the complex, and 
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the same complex is often capable of performing a variety of functions, depending on the 
situation. As well as coordinating functional activities, oligomerisation is also thought to help 
prevent proteolysis and thermal denaturation of the proteins.9  
In recent years, ESI-MS has been demonstrated as a suitable method for investigating multimeric 
protein complexes as these interactions can be retained during the transfer from solution to the 
gas phase.40,72 By measuring the molecular mass of the complex, the number of subunits in the 
quaternary structure can be determined. The coupling of time-of-flight (TOF) mass analysers with 
ESI has allowed the analysis of increasingly larger protein complexes, since the m/z range for a TOF 
spectrometer is in principle unlimited.33 The development of nanoESI has also aided the analysis of 
these complexes. The smaller orifice from which ions are sprayed in nanoESI results in the 
production of smaller droplets. This means lower voltages and lower desolvation temperatures are 
required and these milder conditions favour the preservation of noncovalent interactions.38  Ayed 
et al. showed the first demonstration of high mass protein-protein interactions by ESI-MS.73 These 
researchers investigated the citrate synthase from E. coli, and the effect of binding of the allosteric 
inhibitor, NADH, on the equilibrium between its oligomeric forms. The binding of NADH shifted the 
equilibrium to the hexameric form of the protein, as it binds selectively to the hexamer. 
Complexes with m/z values close to 10,000 were detected in these experiments. 
Fitzgerald et al. also used ESI-MS to investigate the oligomeric structure of the protein, 4-
oxalocrotonate tautomerase (4OT).41 MS data showed that 4OT forms a hexameric structure under 
native conditions. They also examined four single point-mutants of 4OT, which only formed 
monomeric protein. These results indicated specific residues of 4OT that may be important in 
maintaining its hexameric structure.41 This demonstrates the utility of ESI-MS to not only elucidate 
the oligomeric nature of the complex, but residues involved in stabilising the oligomeric assembly. 
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ESI-MS has also been used to identify protein assembly intermediates in heterogeneous 
complexes.74 The self-assembly of proteins into highly ordered amyloid fibrils is the cause of a 
number of diseases, such as Alzheimer’s. The early stages of assembly of amyloid fibrils formed 
from human -2-microglobin were monitored using ESI-MS. This method is advantageous for this 
type of study due to its ability to identify oligomeric species within a complex mixture of self-
assembling molecules and to monitor their behaviour in real time.74 
It is also possible to investigate the spatial arrangement of subunits in multi-protein complexes 
using “proteomics” applications of ESI-MS. A complex is cross-linked under conditions that yield 
mainly pairwise linked proteins; the products are separated by gel electrophoresis, and the 
components of the separated bands are identified using MS.75 Detection of cross-linked peptides 
from two separate proteins indicates that these proteins were spatially close within the complex. 
This procedure was used to propose a topological model for the Nup84p subcomplex of the 
nuclear core complex in yeast.75 
 
1.4 Other ESI-MS techniques for analysing protein complexes. 
1.4.1 Collision-induced dissociation (CID) 
In addition to providing information about the subunit composition of multimeric protein 
complexes, ESI-MS can be used to investigate specific subunit interactions and topology through 
controlled dissociation of the protein assembly.76 This process is known as collision-induced 
dissociation (CID). Using a QTOF instrument, an ion of interest is selected in the quadrupole. The 
ion is then subject to increased potential across the collision cell where it encounters inert gas 
molecules (e.g. argon). The kinetic energy is converted to internal energy causing dissociation of 
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the complex to its components which are detected in the TOF analyser.28 Figure 1.2 shows an 
example of a CID experiment carried out on the human haemoglobin complex. 
 
Figure 1.2. Example spectra of a CID experiment on the human haemoglobin complex. A. Native ESI mass 
spectrum of tetrameric haemoglobin. B. MS/MS of the 18+ ion of the tetramer. Adapted from 
Chernushevich et al. 2001.
28
 
 
Haemoglobin forms a tetramer consisting of two -chains and two -chains, with one haem group 
per subunit. The ESI mass spectrum in Figure 1.2A shows the intact tetrameric complex. During 
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CID, the tetramers fragment into monomers and trimers, shown in spectrum B. Monomer subunits 
are observed both with and without haem, and the trimers are found in all possible combinations: 
(2  +  + nh) and ( + 2  + nh), where n is the number of haem rings ranging from zero to four.28 
Rostom et al. used this technique to examine the interactions between transthyretin (TTR) and 
retinol-binding protein (RBP).77 Formation of the TTR-RBP complex prevents the loss of retinol 
from the body through glomerular filtration. The ESI mass spectrum revealed the presence of the 
TTR tetramer, the tetramer with one RBP bound and the tetramer with two RBP bound. By 
inducing the dissociation of these complexes in the gas phase, it was shown that each RBP 
molecule interacts with three TTR monomers, providing information on the overall architecture of 
the assembly.77 This method has also been successfully used to determine subunit interactions 
within the ribosome,78 and the chaperone GroEL complex,76,79 
 
1.4.2 Subunit exchange 
ESI-MS can be used to study protein subunit exchange of multimeric complexes in order to 
understand the physical properties and dynamics of oligomeric assemblies. This technique allows 
monitoring of exchange in real-time and direct measurement of the relative populations during 
exchange. Sobott et al. used ESI-MS to monitor the subunit exchange of small heat shock proteins 
(sHSPs) PsHSP18.1 from pea and TaHSP16.9 from wheat. This was possible because the 
exchanging subunits from the different plants have different masses. The protein assemblies were 
both dodecameric, and analysis of the kinetics of exchange showed that it proceeded via 
sequential incorporation of dimeric subcomplexes.80 Subunit exchange can also be measured by 
enriching a protein in [15N] or [13C]. This approach was used to investigate subunit exchange of 
transthyretin.81 A solution containing homotetramers of natural isotopic abundance was incubated 
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with labelled homotetramers and monitored over time using MS. Subunit exchange of wild-type 
transthyretin was found to occur via both monomers and dimers, while a mutant form of 
transthyretin (L55P) associated with systemic amyloid disease was shown to occur predominantly 
via dimer exchange.81 
 
1.4.3 Hydrogen/deuterium exchange (HDX) 
Hydrogen/deuterium exchange (HDX) is a method for studying protein folding and unfolding.82 
Labile protons in the protein molecule are exchanged for deuterium atoms of the solvent.83 The 
labile protons are exchangeable protons on the side chains such as those on histidine, arginine, 
lysine and the hydroxyl groups of serine and threonine as well as the amide protons. Exchange is 
often quenched by acidification prior to analysis to slow “back exchange” on amide protons. 
Amide protons that are protected from exchange with deuterons are those that are buried in the 
protein or involved in hydrogen bonds.84,85 
MS is a useful method to follow HDX as the incorporation of a deuteron atom for a proton results 
in an increase in mass. Monitoring HDX rates can yield structural information as hydrogen bonding 
and limited solvent accessibility will slow HDX rates. In this way, the extent and rate of unfolding, 
and also the extent and site of interactions between binding partners (in combination with 
proteomics methods) can be determined. This method has been used to investigate the 
equilibrium folding behaviour of lysozyme.86 At lowered pH and increased temperature, the native 
protein is in equilibrium with its denatured forms and exchange is assumed to only occur in the 
unfolded protein. If interconversion between the native and denatured forms is fast compared to 
the exchange rate of amides in the denatured state, then at any given amide site the proton 
occupancy is uniform over the whole protein population, resulting in one peak present in mass 
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spectrum (second-order exchange, EX2). However, if interconversion is slow compared to amide 
exchange, then two distinct populations will be present in the mass spectrum, corresponding to 
half the protein population containing exclusively hydrogen molecules, and the other half 
exclusively deuterium molecules (first-order exchange EX1). The results of the lysozyme 
experiment were indicative of the EX2 exchange mechanism.86 
 
1.5 High mass range ESI-MS 
Standard quadrupole mass analysers have a limited m/z range (usually m/z 2,000-4,000), 
restricting the application of ESI-MS to smaller complexes.87 The coupling of ESI with TOF or QTOF 
mass analysers increased the possible m/z detection range significantly.33 Other modifications 
have been reported that increase the transmission of high m/z ions that are generated when 
analysing larger noncovalent complexes. A number of studies have demonstrated that improved 
transmission of high m/z ions can be achieved by increasing the pressure in the first vacuum stages 
by reducing the pump speed or adding a collision gas.30,88-91 During the ESI process, the analyte 
experiences collisions with background gas, becoming activated and losing solvent molecules as a 
result. The pressures in different stages of the mass spectrometer determine the average collision 
frequency with the background gas atoms, and together with the accelerating electric field, 
influence the kinetic energy of the ions. This kinetic energy determines the extent of activation the 
analyte will experience.30 When the sample ions travel from the ion source at atmospheric 
temperature, through to the transfer optics region under vacuum, they have considerable kinetic 
energy.  Increasing the background pressure by addition of a collision gas in the initial vacuum 
stages results in a “collisional cooling” effect, where the excess translational energy of the ions is 
17 
 
absorbed by a bath gas and the path of the ions becomes more focused, resulting in improved 
transmission of ions at high m/z.28,90,91 A diagram demonstrating this effect is shown in Figure 1.3.  
 
 
Figure 1.3. Schematic diagram of the collisional cooling effect of ions travelling through the transfer optics 
region of a mass spectrometer at higher pressure. The circles represent ions and arrows represent kinetic 
energy. The oscillating line represents their path through the region. 
 
Rostom and Robinson used this technique and were able to maintain the fourteen noncovalently 
bound subunits of chaperonin GroEL intact in the gas phase by careful manipulation of the 
pressure gradients within an ESI QTOF mass spectrometer.88  
As described earlier, CID experiments are a useful way to determine the stabilities of 
macromolecular complexes. The limited m/z range for quadrupole analysers does not allow the 
selection of high m/z ions that are common for large protein complexes for CID. To overcome this, 
Robinson and coworkers used a modified QTOF mass spectrometer (Figure 1.4) to analyse large 
macromolecular assemblies.30  
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Figure 1.4. Schematic diagram of the modified QTOF mass spectrometer. The significant modifications 
include reduction of the frequency of the quadrupole so it can select ions up to m/z 32,000 and insertion of 
a valve allowing argon to enter the transfer optics region of the ion path. Adapted from the Waters website 
http://waters.com/. 
 
By lowering the frequency of the quadrupole analyser to 300 kHz, they were able to extend the 
accessible m/z range from 4,000 to around 32,000. A collisional cooling effect (as described 
earlier) was achieved by addition of a leak valve for admitting argon to allow increased pressure. 
These modifications enabled determination of the pathway of assembly and disassembly of 
individual subunits and subcomplexes of transthyretin and retinol-binding protein, and their 
ligands, thyroxine and retinol.30,77 
These examples highlight the opportunity that is now present to investigate the assembly and 
dynamics of noncovalent protein-protein interactions of biomolecular machines using ESI-MS. 
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1.6 Biomolecular machines 
Molecular machine is a broad term used to describe an assembly of macromolecules that uses the 
interaction of individual molecules to produce a specific action.92 It has become evident that 
molecular machines, made up of large noncovalent assemblies of proteins, and sometimes nucleic 
acids and other molecules, are involved in complicated cellular processes. An important aspect of 
structural biology involves characterisation of the functional parts of a biomolecular machine, in 
particular, the relevant subunit assembly and conformational changes that occur during energy 
conversion and function. 
The F0F1 ATP synthase is an example of a biologically important molecular machine that has been 
studied in detail. This is a membrane enzyme that plays a key role in biological energy metabolism 
by catalysing ATP synthesis.93,94 ATP (adenosine-5'-triphosphate) is often referred to as the 
“universal energy currency” of cells. This is because the energy released from ATP hydrolysis is 
used, for example, as mechanical energy in muscle contraction, electrical energy in nerve 
conduction, or osmotic energy in transporting substances across membranes.94 Hydrolysis of ATP 
results in production of ADP (adenosine-5'-diphosphate) and inorganic phosphate. To continue the 
cell energy cycle, ATP must be continuously regenerated from these compounds, and this is 
carried out by the F0F1 ATP synthase.
94 The F0F1 ATP synthase is comprised of two components: the 
membrane-bound F0 motor and the globular F1 motor,
95 shown in Figure 1.5. 
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Figure 1.5. Structure of the F0 and F1 components of ATP synthase. Reproduced from von Ballmoos et al. 
2009. 94 
 
The F0 motor is embedded in the membrane, and acts as an ion channel. A flow of ions through the 
membrane causes the subunits of the motor to rotate. The F1 motor is water soluble and catalyses 
ATP synthesis or hydrolysis, in a mechanism that involves conformational changes in the subunits 
of F1 upon binding of ADP/ATP.
94 The F0 and F1 motors are connected by two subunits. Rotation of 
the F0 motor causes these interconnecting subunits to rotate, and it is this action that drives the 
conformational changes and resulting ATP synthesis by the F1 motor.
92 A number of interactions 
are required, including several protein domains, as well as interactions within the mitochondrial 
membrane and nucleotides and phosphate molecules, making this cooperative action quite 
complex. This example demonstrates the complexity involved in the function of a molecular 
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machine and the number of processes and conformational changes that need to be determined to 
fully understand its mechanism of action. 
Another extensively studied biomolecular machine is the proteasome. The proteasome is present 
in eukaryotic cells and is an important component of the proteolytic pathway. It is responsible for 
the degradation of cellular proteins through proteolysis, and in this way the concentration of 
particular proteins or misfolded proteins can be regulated. In eukaryotes, the 26S proteasome is 
essential to the ubiquitin pathway of protein degradation. In this process, proteins are initially 
tagged for degradation by conjugation with ubiquitin. This tag allows the proteasome complex to 
recognise which proteins are to be degraded. The 26S proteasome consists of a 20S core complex 
(700 kDa) and two 19S regulatory subunits.96 The 20S core is made up of four stacked heptameric 
rings, forming a barrel shape with a central cavity. The two inner rings are made up of  subunits, 
and it is these subunits which contain the proteolytic active sites. The two outer rings are made up 
of  subunits and interact with the 19S regulatory subunits.96 Two 19S subunits bind at either end 
of the barrel, acting as “caps” and regulating the entry of proteins into the 20S core.97 The 19S 
subunits recognise ubiquinated proteins that are to be degraded. They are also thought to have a 
role in unfolding and translocation of the ubiquitinated proteins into the 20S core97. The 19S 
complex consists of multiple subunits. Most of the subunits have been identified and some specific 
functions have been assigned; however, the functional organization of the complex has yet to be 
elucidated.97 It is known that some subunits bind to the subunits of the 20S complex, and some 
of these subunits contain ATPase activity. Other subunits interact with the ubiquitin bound to 
proteins that are tagged for degradation.97  
The assembly of an active proteasome complex is a complicated process due to the large number 
of subunits and interactions involved. The Robinson group has investigated the in vitro assembly 
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pathway of the bacterial 20S proteasome using ESI-MS.98 The - and -subunits of the 
Rhodococcus erythropolis 20S complex were combined and the assembly progress was followed in 
real-time by MS. In this way, the time-dependent mass changes could be directly monitored. The 
researchers observed the formation of an -heterodimer, an early assembly intermediate, as 
well as “half-proteasomes” (heptameric -ring attached to heptameric -ring) and the gradual 
appearance of the full 20S proteasome, shown below schematically in Figure 1.6.  
 
Figure 1.6. Schematic diagram of the two possible assembly pathways of the 20S proteasome. In pathway a 
assembly is initiated by the formation of the seven- -subunit ring. In pathway b it is initiated by formation 
of an /  heterodimer. Both pathways then proceed to formation of a half-proteasome followed by 
dimerisation to give the active full proteasome. MS experiments confirmed that assembly occurs through 
the /  heterodimer pathway (pathway b). Reproduced from Sharon et al. 2007. 98 
 
ESI-MS has also been used to investigate the structure and dynamics of the ribosome. Ribosomes 
are a complex of RNA and proteins that functions to translate the genetic code from nucleic acid 
to protein.99 The ribosome interacts with messenger RNA (mRNA) and using the mRNA as a 
template assembles the amino acids into a polypeptide chain. The amino acids are bound to 
transfer RNA molecules (tRNA), which identify the appropriate mRNA codon so that the correct 
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protein sequence is formed.100 The prokaryotic ribosome is the 70S ribosome, which consists of 
the small 30S subunit and the large 50S subunit.101 Each subunit is made up of several RNA 
nucleotides and a number of proteins. The Robinson group used ESI-MS to study several aspects of 
the ribosome structure and function.  
 
Figure 1.7. Mass spectra of the 70S and the 50S subunits of the ribosome. The top spectrum shows well 
resolved charge states for the 30S and 70S subunits. The 50S subunit was separated by chromatography and 
the spectrum for the isolated 50S subunit is shown on the bottom. Reproduced from Ilag et al. 2005. 102 
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They successfully obtained a mass spectrum of the intact Thermus thermophilus 70S ribosome, a 
complex of around 2.3 MDa, as shown in Figure 1.7. This demonstrates the high mass range 
possible for detecting large biomolecular machines. A series of CID experiments was also 
performed to dissociate the intact ribosome and understand interactions between components of 
the ribosome as well as properties of the individual proteins.78,102 
These studies demonstrate some applications of ESI-MS for the study of biomolecular machines, in 
particular for revealing details of the assembly pathway and transient intermediate complexes 
formed during the assembly of large macromolecular complexes. 
 
1.7 Protein Conformation 
The shape or conformation of a protein is essential to its biological function and can have an effect 
on a variety of cellular processes, such as ligand binding, enzymatic activity and molecular 
recognition dynamics. The highly organised activity of a molecular machine may be regulated by 
ordered conformational changes in one or more of its proteins powered by nucleoside 
triphosphate hydrolysis (or other sources of energy).103 An understanding of protein conformation 
is thus important to the study of the assembly and mechanisms of molecular machines.  
 
1.7.1 Levels of protein structure 
Protein molecules are comprised of a combination of 20 naturally occurring amino acids joined 
through peptide bonds. The linear sequence of these amino acids is known as the protein primary 
structure. The chemical properties of the amino acids are determined by their side chains and 
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these can interact with each other through various noncovalent interactions, such as hydrogen 
bonding, electrostatic interactions, van der Waal forces and dipole moments.  
The secondary structure is formed by hydrogen bonding between amide and carbonyl groups of 
the polypeptide backbone. Forms of secondary structure include the -helix, which is stabilised 
only by intrastrand hydrogen bonding, or a -sheet, which can be stabilised by intramolecular but 
also intermolecular bonding between parallel or antiparallel -sheets.  
Protein tertiary structure is the three-dimensional structure of the complete polypeptide chain 
and is formed through specific interactions between separate secondary structural units. The 
interaction between several polypeptide chains is referred to as the quaternary structure. Often, a 
protein can form more than one stable conformation, and the conversion between conformations 
can be important to its biological function. For example, haemoglobin (Hb) binds oxygen 
cooperatively and has two different conformations corresponding to its oxygenated and 
deoxygenated forms.104-106  
The quaternary structure of the deoxygenated form of Hb is “tense”, with a low affinity for 
oxygen. Binding of oxygen induces a conformational change, resulting in the oxygenated Hb, which 
is in a more relaxed structure with a higher affinity for further oxygen binding. Hb can then 
transport the oxygen to other cells in the body, and upon oxygen release will return to its tense, 
deoxygenated conformation.104-106 This example shows how changes in protein conformation can 
act as a molecular switch in biological processes. The transition between conformational states 
triggers protein function or regulation. 
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1.7.2 Protein conformation revealed by ESI-MS 
In positive ion ESI-MS, the charge state distribution of a protein arises from protonation of the side 
chains of exposed basic amino acids and the N-terminus.18,107 Within an electrospray droplet a 
protein in a more folded conformation will have fewer basic residues exposed to the surface of the 
droplet during the ionisation process and hence will pick up fewer charges than an unfolded form 
of the same protein.91 Therefore, changes in the charge state distribution observed in ESI mass 
spectra of proteins are thought to relate to changes in protein conformation (or unfolding ↔ 
folding).108-112 Sometimes in protein mass spectra there is not a single distribution of ions, but 
rather a bimodal or higher order distribution. The presence of different or overlapping charge 
“envelopes” is thought to relate to the existence of protein molecules in different conformational 
states.110 Konermann and Douglas used ESI-MS to investigate the acid-induced unfolding of 
cytochrome c and apomyoglobin.110  
The resulting mass spectra of cytochrome c showed two distinct charge state distributions (CSD), 
as shown in Figure 1.8, corresponding to a highly cooperative (two state) unfolding mechanism. 
The CSD around m/z 800 corresponds to unfolded protein. As a greater number of basic residues 
were exposed to the surface of the electrosprayed droplet, a greater number of protons were 
picked up. The apomyoglobin showed a gradual shift in the observed CSD, indicative of multiple 
conformations and a non-cooperative folding mechanism.110 In these experiments, ESI-MS was 
able to probe differences in the cooperativity of protein unfolding transitions. 
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Figure 1.8. ESI mass spectra of cytochrome c at decreasing pH demonstrating two distinct charge state 
distributions corresponding to the folded (~1,600 m/z) and unfolded (~800 m/z) conformations of the 
protein. Reproduced from Konermann et al. 1998. 
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Also in early work in this area, Loo et al. used ESI-MS to investigate solvent effects on protein 
conformation.113 Lysozyme, a protein with four disulfide bonds contributing to its tertiary 
structure, was treated with a reducing agent, and the differences in the mass spectra before and 
after reduction were compared. It was found that treatment with the reducing agent resulted in 
an increase in the number of positive charges associated with the protein in the mass spectrum. 
This is consistent with unfolding of the lysozyme as a result of reduction of its disulfide linkages.  
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These examples of the application of ESI-MS as a tool for investigating differences in protein 
conformation are complicated, since changing the solvent conditions affects not only the extent of 
protein folding, but can also influence the ESI process. This can result in alterations of the 
observed CSD that are not necessarily a result of conformational change alone. A more detailed 
discussion of the effect of protein conformation on the CSDs observed in ESI mass spectra is 
presented in Chapter 5. 
 
1.7.3 Ion mobility mass spectrometry (IMMS) 
Ion mobility spectrometry (IMS) is a technique to separate ions in the gas phase based on their 
mobility through a drift tube of buffer gas under the influence of a weak electric field.114-116 The 
time it takes to traverse the drift tube correlates to the collisional cross section of the molecule, 
but is also influenced by its mass and associated charge117. Ion mobility spectrometry coupled with 
mass spectrometry (IMMS) provides additional structural information about biomolecules not 
revealed by MS alone. Initial instruments were limited in that mobilities and m/z ratios were 
measured independently.118 This was overcome by the development of an injected-ion mobility 
TOF mass spectrometer designed to record ion mobilities and m/z ratios of multiple ions 
simultaneously.118 This meant that CSDs (possibly corresponding to different conformations) 
formed during ESI were separated according to differences in their mobilities in the drift cell and 
then dispersed by their m/z ratios in the TOF analyser.118 This technique can be used to investigate 
changes in protein conformation, as a protein in a folded form has a smaller cross-section than an 
unfolded protein of the same mass. The folded protein will have higher mobility through the cell 
and hence a shorter drift time, compared to the unfolded protein.117 Ion mobility mass 
spectrometry is discussed in greater detail in Chapter 5. 
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1.8 Scope of the thesis 
This thesis presents ESI-MS studies of proteins/protein complexes that are part of the molecular 
machinery of cells. In particular, the applications of high mass range mass spectrometry and ion 
mobility mass spectrometry for large, noncovalent protein complexes are highlighted.  
In Chapter 3, ESI-MS was used to investigate the structure, stoichiometry and mechanism of 
interaction between rubisco and rubisco activase. Experiments focusing on the nucleotide binding 
properties of rubisco activase, including identifying a second nucleotide binding site, were 
conducted in order to gain a better understanding of the role of ATPase activity during rubisco 
activation. In addition, the interaction between rubisco and rubisco activase was explored by 
preparation of an inactivated rubisco-RuBP complex. The effect of substrate and metal cofactors 
on the oligomeric assembly of rubisco from the anoxic archaeabacterium, Methanococcoides 
burtonii, was also investigated. 
In Chapter 4 the interactions between the 2 sliding clamp and  polymerase subunit of E. coli 
DNA polymerase III, a component of the replisome, were investigated. In particular, two possible 
2-binding sites on the  subunit were the focus of this work. The longer term goal of this work is 
to build up larger assemblies of the replisome to enable studies of its assembly pathway and 
protein-protein interactions.  
Finally, the applications of a new ion mobility mass spectrometer that makes use of travelling 
wave ion mobility separation (TWIMS) for investigating protein complexes and conformation was 
investigated in Chapter 5. Specific examples highlighting the ability of the TWIMS instrument to 
resolve protein conformers are presented.  
30 
 
 
 
Chapter 2 
 
Materials and Methods 
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2.1 Materials 
All reagents and solvents used were of the highest grade commercially available. MilliQ water 
from Millipore (Molsheim, France) was used in all experiments. 
 
General reagents and materials 
Bovine serum albumin (BSA), magnesium acetate (Mg(OAc)2), calcium acetate (Ca(OAc)2), cobalt 
chloride (CoCl2.6H2O), ethylenediaminetetraacetic acid (free acid, EDTA), trifluoperazine 
(dihydrochloride, TFP), guanidine hydrochloride, adenosine 5'-triphosphate (magnesium salt, ATP), 
adenosine 5'-diphosphate (free acid, ADP), adenosine 5'-( , -imido)triphosphate (free acid, AMP-
PNP), adenosine 5'-( -thio)triphosphate (free acid, ATP S), polyethylene glycol (PEG), N-
[Tris(hydroxymethyl)methyl]glycine (tricine) 4-(2-Hydroxyethyl)-1-piperazinepropanesulfonic acid 
(EPPS), phospho(enol)pyruvic acid (monopotassium salt, PEP), sodium hydrogen carbonate 
(NaHCO3) and creatine phosphate (dibasic tetrahydrate) were purchased from Sigma-Aldrich (St. 
Louis, USA). Ammonia, ammonium acetate (NH4OAc), potassium chloride, acetic acid, formic acid, 
methanol (HPLC grade) and sodium chloride were obtained from Ajax Finechem (Seven Hills, 
Australia). Tris(hydroxymethyl)aminomethane (Tris) was obtained from ICN Biomedicals (now MP 
Biomedicals; Aurora, USA). Nicotinamide adenine dinucleotide (NADH), pyruvate kinase (PK) and 
lactate dehydrogenase (LDH) were purchased from Roche Diagnostics (Castle Hill, Australia). 
Dialysis tubing (10,000 molecular weight cut off (MWCO)) was purchased from Crown Scientific 
(Moorebank, Australia). Slide-A-Lyzer™ dialysis cassettes (10,000 MWCO, 0.1 – 0.5 mL) and Slide-
A-Lyzer™ mini dialysis units (7,000 MWCO, 10 – 100 L) were purchased from Thermo Scientific 
(Illinois, USA). Millipore Biomax centrifugal filters (5,000 MWCO) were obtained from Millipore 
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(Bedford, USA). Reagents for the Bio-Rad DC protein assay and Chelex-100 resin were from Bio-
Rad (Hercules, USA). Custom-made oligonucleotides were obtained from Geneworks (Adelaide, 
Australia). Custom-made peptide sequences were from EZBiolab (Indiana, USA). Coupling enzymes 
for the rubisco/RuBP assay were a kind gift prepared by Dr. Heather Kane (Reseach School of 
Biology, Australian National University). 
 
Rubisco and replication proteins 
The proteins rubisco activase (and mutants; RA1 D311K and RA2 K314V) and rubisco from tobacco, 
rubisco from Methanococcoides burtonii, and the sugar phosphates ribulose-1,5-bisphosphate 
(RuBP) and carboxyarabinitol-1,5-bisphosphate (CABP)  were kindly provided by Assoc. Prof. 
Spencer Whitney (Research School of Biology, Australian National University). The proteins beta 
( ), alpha ( ), tauc16 (16 kDa fragment of the C-terminal domain, c16), core ( ), and DnaB-N (N-
terminal domain residues 24-136 of DnaB) were a kind gift from Prof. Nicholas Dixon (School of 
Chemistry, University of Wollongong). 
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2.2 Methods 
2.2.1 Protein preparation 
 
Rubisco activase 
Recombinant rubisco activase was stored at -80 °C in 40 mM Tris-HCl buffer, pH 8, and 20% (v/v) 
glycerol. Prior to MS analysis, 100 L aliquots was taken from the frozen stock and thawed on ice, 
then diluted to 300 L with 10 mM NH4OAc. The diluted protein was then dialysed against 3 x 2 L 
of 10 mM NH4OAc, pH 7.2, at 4 °C.  
 
Removal of ADP from rubisco activase 
Thawed 100 L aliquots of rubisco activase were diluted to 300 L with 40 mM Tris-HCl buffer, 4 
M in NaCl pH 8, and then dialysed at 4 °C against 3 x 250 mL of 40 mM Tris-HCl buffer 4 M in NaCl, 
pH 7.2, followed by 2 x 2 L of 100 mM NH4OAc, pH 7.2. 
 
Addition of nucleotides to ADP-free rubisco activase 
ADP-free samples of rubisco activase were titrated with increasing amounts of either ADP or AMP-
PNP, and analysed using nanoESI-MS (see Table 2.3 for MS conditions). The concentration of ADP-
free rubisco activase in the samples was approximately 30 M (as judged by Bio-Rad DC protein 
assay; see section 2.2.2). An aliquot of 5 M NH4OAc was added so that the final NH4OAc 
concentration was 500 mM. Appropriate volumes of nucleotides (ADP and AMP-PNP) were added 
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to give final concentrations of 1 M, 5 M, 10 M, 50 M and 100 M. To test the ATPase activity 
of rubisco activase (section 2.2.3), an ADP-free sample was prepared and 5M NH4OAc and ATP-Mg 
added to give final concentrations of 500 mM and 100 M, respectively. Competitive nucleotide 
binding experiments were performed in three different ways. First, an aliquot of ADP was added to 
ADP-free rubisco activase followed by AMP-PNP after 5 - 10 minutes. Second, an aliquot of AMP-
PNP was added to ADP-free rubisco activase followed by ADP. Finally, the ADP-free rubisco 
activase was added to a mixture of ADP and AMP-PNP (so they were added simultaneously). The 
final concentrations of rubisco activase, nucleotide and NH4OAc in all samples were approximately 
30 M, 100 M and 500 mM, respectively. 
 
Interaction of rubisco activase with sugar phosphates 
A 30 L aliquot of rubisco activase stock was diluted with 400 L of 10 mM NH4OAc, pH 7.2. Buffer 
exchange was then carried out using Millipore Biomax centrifugal filters (5,000 MWCO). The 
solution was centrifuged at 10,000 g (at 4 °C) using an Eppendorf 5415C bench top centrifuge 
(Crown Scientific, Moorebank, Australia) until the volume was approximately 20 L. A 400 L 
aliquot of 10 mM NH4OAc, pH 7.2, was added and the process repeated. The next two buffer 
exchanges were performed by adding 400 L aliquots of 500 mM NH4OAc and 2 L of RuBP stock 
(24.6 mM in 3 mM HCl) before protein samples were concentrated to ~20 L. The final 
concentration of rubisco activase for nanoESI-MS analysis was ~20 M. The same procedure was 
followed for CABP, with the exception that 10 L of CABP (5.7 mM in biocine) was added. 
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Tobacco rubisco 
Determination of accurate masses of small and large subunits 
Rubisco isolated from Nicotiana tabacum leaves and purified by a previously reported 
procedure119 was stored at -80 °C in 40 mM Tris-HCl buffer, pH 8 and 20% (v/v) glycerol. A 10 L 
aliquot of rubisco was diluted to 300 L with 6 M guanidine hydrochloride, then dialysed 
exhaustively (at least 10 solution changes) against 0.1% formic acid at 4 °C. To prepare native 
rubisco for nanoESI-MS analysis, a 10 L aliquot of rubisco was diluted to 300 L with 100 mM 
NH4OAc then dialysed against 3 x 2 L 100 mM NH4OAc, pH 7.2, at 4°C. 
 
Preparation of CO2-free, Mg
2+-free rubisco; preparation of rubisco-RuBP and rubisco CABP 
complexes 
All buffer solutions were run through a Chelex-100 column, and bubbled with N2 gas for several 
hours. This was achieved by attaching a fritted glass sparger which introduced a steady flow of N2 
gas into the solution and sealing with parafilm to reduce exposure to air. A 10 L aliquot of rubisco 
was diluted to 300 L with 100 mM NH4OAc and 1 mM EDTA treated as described above. The 
rubisco was then dialysed using a Slide-A-Lyzer™ dialysis cassette at 4 °C against 3 x 400 mL of 100 
mM NH4OAc and 1 mM EDTA, pH 7.2, then 4 x 400 mL 100 mM NH4OAc, pH 7.2. During dialysis, 
buffer solutions continued to be sparged with N2 gas. To prepare a sample of rubisco-RuBP8 
complex, 5 L of RuBP (24.6 mM) was added to a glass vial. The solvent was evaporated using a 
Christ Alpha 1-2 LD freeze-dryer before addition of 100 L of 100 mM NH4OAc. The solvent was 
again evaporated and made up in 50 L of the N2-sparged 100 mM NH4OAc buffer. A cap with a 
septum seal was used to close the vial and N2 gas was blown into the vial to reduce air exposure. 
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When the rubisco had undergone the dialysis procedure outlined above, it was removed from the 
dialysis cassette with a syringe and injected directly to the septum sealed vial containing RuBP, so 
the rubisco would bind with RuBP in the inactive state before any significant exposure to CO2.  
To prepare a sample of rubisco bound with CABP, the appropriate volume of CABP to give a final 
concentration of ~100 M (stock 5.7 mM) was added to a sample of rubisco that had been 
dialysed against 3 x 2 L of 100 mM NH4OAc, pH 7.2, and buffer exchange was carried out using 
Millipore Biomax centrifugal filters (5,000 MWCO). 
 
Attempted preparation of a rubisco-rubisco activase complex 
Attempts to prepare a complex of rubisco with rubisco activase were carried out in several ways. 
First, rubisco activase that still had ADP bound was used. Appropriate volumes of the rubisco-RuBP 
complex and rubisco activase were added to give final concentrations of 5 M rubisco, 200 M 
RuBP and 8 M rubisco activase in 100 mM NH4OAc. Samples were also prepared that contained 
additional ATP-Mg, AMP-PNP or ATP S. In these samples, the final concentrations of the other 
components were the same, and the final concentration of nucleotide was 100 M. ADP-free 
rubisco activase was also used. Samples were prepared with rubisco-RuBP, rubisco activase (with 
no ADP) and either no nucleotide, ATP-Mg, AMP-PNP or ATP S added. The final concentrations of 
each component were the same as described above.  
The different samples of rubisco activase (i.e., with and without ADP) were also added to the 
rubisco-CABP complex in the presence or absence of nucleotides (ATP-Mg, AMP-PNP or ATP S). 
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M. burtonii rubisco 
M. burtonii rubisco (extraction and purification procedure described in Alonso et al. 2010 120) was 
stored at -80 °C and thawed on ice. Prior to MS analysis, 100 L aliquots of rubisco were diluted to 
300 L with 10 mM NH4OAc and dialysed against 3 x 2 L of 10 mM NH4OAc, pH 6.8. 
 
Preparation of M. burtonii rubisco – sugar phosphate complexes 
Appropriate volumes of either RuBP or CABP were added to M. burtonii rubisco (above) give final 
concentrations of rubisco and RuBP/CABP of ~2 M and 100 M, respectively. Samples of rubisco 
with different metal cofactors were prepared by addition of the appropriate metal ion, Mg(OAc)2, 
Ca(OAc)2 or CoCl2 prepared in 100 mM NH4OAc to give a final concentration of metal of 100 M, 
and rubisco ~2 M. The final concentration of NH4OAc for all samples was 100 mM. All samples 
were kept on ice for 30 minutes prior to MS analysis. 
 
Rubisco activase mutants 
Rubisco activase mutants, RA1 (D311K) and RA2 (K314V), stored at -80 °C were thawed on ice. 
Prior to MS analysis, 100 L aliquots of each were diluted to 300 L with 10 mM NH4OAc and 
dialysed against 10 mM NH4OAc, pH 7.2. The method applied to remove bound ADP from RA1 and 
RA2 was the same as described for wild-type rubisco activase (p34). 
To compare the interactions of RA1 and RA2 with different nucleotides, appropriate volumes of 
ATP-Mg, ADP, AMP-PNP or ATP S were added to the mutant samples (ADP removed) to give a final 
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nucleotide concentration of 100 M. The final concentration of RA mutant in each sample was ~30 
M and NH4OAc was 100 mM. 
 
2, the sliding clamp of DNA polymerase III 
The  subunit of E. coli DNA pol III stored at -80 °C was thawed on ice prior to experiments. A 100 
L aliquot was diluted to 300 L with 100 mM NH4OAc and dialysed against 3 x 2 L 100 mM 
NH4OAc, pH 7.2. Prior to MS analysis, 5 M NH4OAc was added to give a final NH4OAc concentration 
of 500 mM. 
To prepare a complex of wild-type 2, a 300 L aliquot of  was dialysed against 200 mM 
NH4OAc, pH 7.2. A 100 L aliquot of  (diluted to 300 L) was also dialysed against 200 mM 
NH4OAc (since  is less stable in 100 mM NH4OAc). Appropriate volumes of dialysed ,  and 5 M 
NH4OAc were added to give final concentrations of ~1 M of each protein, and 500 mM NH4OAc. 
To prepare a complex of mutant 2, a 300 L aliquot of mutant  called here t (920-QADMF-924 
 920-QLDLF-924)  was dialysed against 3 x 2 L of 200 mM NH4OAc, pH 7.2. A 100 L aliquot of  
was diluted to 300 L and dialysed against 3 x 2 L of 200 mM NH4OAc, pH 7.2. Appropriate 
volumes of dialysed mutant  and  were added to give a final concentration of 1 M each, and 
methanol was added to 5% (v/v). A sample of wild-type  and was prepared with methanol in 
the same way as a comparison. 
The  subunit was titrated with increasing amounts of a number of different peptide sequences of 
: wild-type internal; wild-type C-terminal; M3 internal; M9 C-terminal and M12 C-terminal. Stock 
solutions of peptide sequences were prepared by dissolving the appropriate amounts in water to 
give a final concentration of 1 mM. Some sequences that were less soluble were solubilised by 
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addition of small amounts of dilute ammonia solution to the stock. The peptide sequences are 
outlined in Table 2.1. 
Table 2.1. Nonapeptide sequences of the subunit. 
Peptide Sequence Molecular weight (Da) 
WT C-terminal SEQVELEFD 1094.7 
WT internal IGQADMFGV 937.1 
M3 internal IGQLDLFGV 961.1 
M9 C-terminal SEQLDLFFD 1113.2 
M12 C-terminal SEQVELEAD 1019.04 
 
For all samples, the concentration of  was 20 M. Appropriate volumes of the peptides were 
added to give samples with molar ratios of :peptide of 1:0.25, 1:0.5, 1:1 and 1:2. The final 
concentration of NH4OAc in all samples was 100 mM. 
A complex of 2 with ssDNA was prepared by addition of stock solution of dA16 (ssDNA sequence 
with 16 adenine bases, 1.5 mM in water, see section 2.2.6 for preparation detail). Samples were 
prepared in a number of ratios; the concentration of  was 15 M, and the molar ratio of :dA16 
was 1:1, 1:5, 1:10, 1:20 and 1:40. The final concentration of NH4OAc in each sample was 150 mM, 
at pH 7.2. 
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Tauc16 and complexes with  and 2 
The 16 kDa C-terminal fragment of , termed c16,
121 was stored at -80 °C and thawed on ice prior 
to experiments. A 20 L aliquot of c16 was diluted to 300 L with 200 mM NH4OAc and dialysed 
against 3 x 2 L of 200 mM NH4OAc, pH 7.2. 
To investigate the possible interaction between the c16 subunit and the short peptide sequences 
of  (WT internal, WT C-terminal, M3 internal, M9 C-terminal and M12 C-terminal), a ten-fold 
excess of each peptide was added to separate c16 samples. The final concentration of c16 in each 
sample was 5 M, and the final concentration of NH4OAc was 200 mM. 
A complex of c16, mutant  and 2 was prepared by dialysis of each protein separately against 200 
mM NH4OAc, pH 7.2. An appropriate volume of was added to c16 giving a 1:1 molar ratio of 
each. The sample was then left to sit on ice for ten minutes before addition of an aliquot of  
mutant to give a ten-fold excess of  (final concentration 1 M). Methanol was added to the 
sample to 5% (v/v) and left to sit on ice for another ten minutes prior to MS analysis.  
 
Core ( ) complex and complexes with 2 and c16 
The core complex had been prepared by mixing the subunits  in the ratio 1:1:1 and purifying 
by gel filtration and stored at -80 °C. A 100 L aliquot of core was thawed on ice, diluted to 300 L 
with 100 mM NH4OAc and dialysed against 3 x 2 L 100 mM NH4OAc, pH 7.2. 
To prepare a complex of core with 2, an appropriate volume of  was added to a sample of core 
to give a final core concentration of 1 M and a six-fold excess of . 
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Core was titrated with varying amounts of c16. The final concentration of core in all samples was 1 
M. Appropriate aliquots of c16 were added to core to give the following ratios of core: c16, 1:0.5, 
1:1, 1:2, 1:3. The final concentration of NH4OAc for all samples was 100 mM, at pH 7.2. 
 
Transferrin 
Stock solutions of holo-transferrin (Tf) were prepared at a concentration of 1 mg/mL in 100 mM 
NH4OAc, pH 7.2 and kept on ice. Native samples were prepared by diluting the transferrin with 100 
mM NH4OAc, pH 7.2, to produce a solution at 10 M.  
A mixture of Tf and 2 was prepared for IMMS analysis. For this sample, appropriate volumes of 2 
and Tf were mixed to give a final concentration of each of 5 M, with a final NH4OAc 
concentration of 100 mM. 
 
Cyclised/linear DnaB-N 
DnaB-N aliquots (cyclised and linear forms), stored in 50 mM Tris-HCl, pH 7.6, 15% glycerol, 100 
mM NaCl and 5 mM MgCl2 at -80 °C, were thawed on ice, diluted to 300 L and dialysed against 3 
x 2 L of 10 mM NH4OAc, pH 7.6 at 4 °C. Prior to MS analysis, the proteins were diluted to 10 M 
and prepared as specified in the relevant section of the text. 
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Calmodulin 
Samples of apo-calmodulin (apoCaM) were prepared by dissolving an appropriate amount in 300 
L water and dialysing at 4 °C against the following solutions: 4 x 2 L of 10 mM NH4OAc and 2 mM 
EDTA, pH 5.6; 4 x 2 L of 10 mM NH4OAc, pH 5.1; and 1 x 2 L of 10 mM NH4OAc, pH 7.6.
122 The final 
concentration of apoCaM following dialysis was ~100 M. To prepare a sample of calmodulin with 
its full complement of calcium (Ca4CaM), an aliquot of calcium acetate (5 mM in 10 mM NH4OAc, 
pH 7.6) was added to apoCam to give an 8-fold excess of calcium over protein. The mixture was 
left on ice for 15 minutes, giving a final concentration of Ca4CaM of ≥ 10 M. A complex of the 
drug trifluoperazine (TFP) with Ca4CaM was prepared by addition of an aliquot of TFP (5 mM TFP in 
10 mM NH4OAc, pH 7.6) to the protein, giving a final protein concentration of 10 M and a final 
TFP concentration of 50 M. 
 
2.2.2 Protein concentration determination 
The concentrations of proteins were determined in two different ways. The first method involved 
spectrophotometric measurement using a Shimadzu PharmaSpec UV-1700 UV-Visible 
spectrophotometer (Shimadzu, Japan). The molar extinction coefficients, 280, are shown in Table 
2.2. 
Concentrations of rubisco and rubisco activase were determined using a Bio-Rad DC protein assay. 
Standard solutions of BSA (Sigma, Australia), 0-5 mg/mL, were prepared from 10 mg/mL stock BSA 
solution in 100 mM NH4OAc, pH 7.2. A 3 L aliquot was taken of each standard and the protein 
stock solution. Bio-Rad reagent A (37.5 L) was added to each standard or protein sample, 
vortexed and pulse-centrifuged before 300 L of Bio-Rad reagent B was added. 
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Table 2.2. Extinction coefficients ( 280) used to determine protein concentrations. 
Protein Extinction coefficient at 280 nm ( 280), M
-1cm-1 
Beta123 14,650 
Alpha (and mutant)121 95,440 
Tauc16
121 18,350 
DnaB-N (cyc and lin)
124
 9,530 
Transferrin125 111,900 
Calmodulin126 3,300* 
*The wavelength used to measure the concentration of calmodulin was 277 nm 
 
The mixtures were again vortexed and pulse-centrifuged. The mixtures were analysed after 20 
minutes using the UV-visible spectrophotometer set to 750 nm. The BSA standards were prepared 
and measured in duplicate. A standard curve was produced from the average absorbance of the 
BSA standards readings, and the concentrations of proteins were interpolated from the curve. 
 
2.2.3 Activity assays 
 
ATPase assay 
The ATPase assay was based on a method described in Luria and Burrous 1957,127 where the 
production of ADP is measured spectrophotometrically through an enzyme-linked assay as shown 
in the scheme below. The enzyme activity is measured by following the decrease in A340 as NADH is 
oxidised. 
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Scheme 2.1 ATPase assay 
The reaction mixture contained 890 L of buffer (100 mM Tricine-KOH, pH 8.0, 20 mM KCl, 5 mM 
MgCl2, 6% PEG), 20 L of 100 mM PEP, 20 L of 10 mM NADH, 40 L of 50 mM ATP and 90 units 
each of pyruvate kinase and lactate dehydrogenase. The absorbance at 340 nm was measured 
over five minutes to get a background rate. The reaction was started by the addition of rubisco 
activase (10-20 g) and the rate of hydrolysis determined from the rate of NADH oxidation by 
measuring the absorbance at 340 nm at 23 °C. 
 
Rubisco/RuBP assay 
The rubisco/RuBP assay couples the production of 3-phosphoglycerate (the product of the 
reaction catalysed by rubisco) with the oxidation of NADH and measured spectrophotometrically 
(shown in scheme 2.2 below). Since two molecules of 3-phosphoglycerate are produced in the 
reaction between CO2 and RuBP, there are four molecules of NADH oxidised per molecule of RuBP 
consumed. The coupling enzymes (3-phosphoglycerate kinase, glyceraldehyde-3-phosphate 
dehydrogenase, triose phosphate isomerase, glycerol-3-phosphate dehydrogenase, carbonic 
anhydrase and creatine phosphokinase) were prepared separately by dialysis against the buffer 
(50 mM EPPS-NaOH pH 8.0 and 25 mM MgCl2). A “cocktail” was also prepared that contained 200 
M NADH, 10 mM NaHCO3, 10 mM ATP and 5 mM phosphocreatine.  
45 
 
The reaction mixture contained 950 L of the cocktail, 20 L of the coupling enzymes and 10 L of 
rubisco. The mixture was incubated at 23 °C for ~10 minutes to activate the rubisco and a 
background rate was measured. A 25 L aliquot of RuBP was then added to the mixture and the 
absorbance at 340 nm measured over ten minutes at room temperature. 
 
Scheme 2.2 Basis of rubisco/RuBP assay 
 
2.2.4 Circular dichroism (CD) 
CD measurements were made using a Jasco J-810 spectropolarimeter. All spectra were recorded 
using a 0.1 cm quartz cell and the following parameters: λ =250-190 nm; recording speed 100 
nm/min; response 4 sec; spectral band width 1 nm; number of accumulated scans = 4. The 
reference was 100 mM NH4OAc for all samples. All CD spectra presented here were obtained after 
subtraction of the background. In all measurements, the temperature was kept at 20 °C using a 
Ratek thermoregulator water bath. The final concentration of rubisco activase and rubisco 
(dialysed under different conditions) was ~5 M for all CD measurements. 
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2.2.5 Over-expression and purification of the t mutant 
The procedure for the over-expression and purification of t was carried out in the laboratory of 
Prof. Nick Dixon’s group (at UOW) with the assistance of Dr. Slobodan Jergid, as described in 
Chapter 4. Buffers and solutions used during this procedure were as follows: LBT (LB medium,128 
supplemented with thymine) media (prepared as 1 L): 10 g tryptone, 5 g yeast extract, 5 g NaCl, 
2.5 mL of 1 M NaOH and 20 mL (2.5 g/L) thymine. Buffer A: 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2 
mM dithiothreitol (DTT), 20 mM spermidine and 100 mM NaCl. Buffer B: 50 mM Tris-HCl, pH 7.5, 1 
mM EDTA, 2 mM DTT, 200 mM NaCl and 30% glycerol. Buffer C: 50 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, 2 mM DTT, 30 mM NaCl and 30% glycerol. Buffer D: 20 mM sodium phosphate, 1 mM EDTA, 
2 mM DTT and 10% glycerol. 
 
2.2.6 Preparation of DNA 
The single-stranded DNA sequence, dA16 (16 adenine bases), was dissolved in 1 mL of 10 mM 
NH4OAc before undergoing purification using a Waters HPLC (high performance liquid 
chromatography) system. A C18 octadecylsilyl column (8 x 100 mm Waters Delta Pack™ Radial 
Pak™ Cartridge, 15 M, 300 Å) equilibrated with 10 mM NH4OAc was used, at a flow rate of 1 
mL/min. A linear gradient of 0-60% aqueous acetonitrile in 10 mM NH4OAc was used to elute the 
DNA from the column, and detection was carried out by UV absorbance at a wavelength of 260 
nm. The peaks corresponding to the ssDNA were collected and freeze-dried using a Savant Speed 
Vac (Selby-Biolab, Australia), then redissolved in 100 mM NH4OAc, pH 7.2, and stored at -20 °C. 
The concentration of purified dA16 was calculated by measuring the UV absorbance at 260 nm and 
using the Beer-Lambert law. The molar extinction coefficient of dA16 was calculated from the 
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extinction coefficient of the individual bases obtained from the Oligonucleotide Properties 
Calculator website, using the value for adenine of 15,200 M-1.cm-1. 
 
2.2.7 Mass spectrometry 
All mass spectra were acquired on either a Waters extended mass range QTOF Ultima™ 
(Manchester, UK) or a Synapt™ HDMS™ ion mobility mass spectrometer (Manchester, UK), 
depending on the experiment. Prior to analyses of samples, the mass spectrometers were 
externally calibrated using a solution of 1 mg/mL or 10 mg/mL in 70% isopropanol (for high 
molecular weight proteins) cesium iodide. The different protein samples were prepared as 
described in section 2.2.1. The mass spectrometer and instrument conditions used were different 
for different experiments as outlined below. The experimental conditions reported for each set of 
experiments were obtained after the optimisation of the different parameters in order to obtain 
the best possible spectrum. 
 
Rubisco/rubisco activase 
The following experiments concerning rubisco/rubisco activase (Chapter 3) were carried out using 
the QTOF Ultima™ mass spectrometer: native rubisco activase; rubisco activase interaction with 
nucleotides; rubisco activase with RuBP; rubisco subunit accurate mass determination and rubisco 
activase mutant accurate mass determination, under the conditions described in Table 2.3. 
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Table 2.3 ESI-MS conditions used for rubisco/rubisco activase experiments on the QTOF Ultima™ instrument 
MS Parameters  
Capillary (V) 1500 
Cone (V) 300 
RF lens 1 energy (V) 160-200 
Collision Energy (V) 4 
MCP (V) 1700 
Ion optic region pressure (mbar) 2 x 10-1/3 x 10-1 
 
The following experiments concerning rubisco/rubisco activase (Chapter 3) were carried out using 
the Synapt HDMS: characterisation of native rubisco; rubisco-RuBP; rubisco-RuBP with rubisco 
activase (with or without nucleotides); rubisco activase with CABP and rubisco activase mutants 
with nucleotides, under the conditions described in Table 2.4. 
 
Table 2.4. ESI-MS conditions used for rubisco/rubisco activase experiments (Chapter 3) using the Synapt™ 
HDMS™ instrument. 
MS Parameters  
Capillary (V) 1500 
Cone (V) 200 
MCP (V) 1800 
Trap energy (V) 6 
Transfer energy (V) 4 
Backing pressure (mbar) 3.6 
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All experiments using M. burtonii rubisco were carried out on the Synapt™ HDMS™ instrument 
under the conditions outlined in Table 2.5. 
 
Table 2.5. ESI-MS conditions used for M. burtonii rubisco experiments (Chapter 3) using the Synapt™ 
HDMS™ instrument. 
MS Parameters  
Capillary (V) 1500 
Cone (V) 200 
MCP (V) 2000 
Trap energy (V) 1 
Transfer energy (V) 1 
Backing pressure (mbar) 4.0 
 
 
Subunits of the replisome 
The following experiments concerning E. coli replisome proteins (Chapter 4) were carried out using 
the QTOF Ultima™: native 2; wild-type  with 2; 2 with ssDNA; native core and core with 2, 
under the conditions described in Table 2.6. 
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Table 2.6 ESI-MS conditions used for replisome experiments carried out using the QTOF Ultima™ 
instrument. 
MS Parameters  
Capillary (V) 1500 
Cone (V) 150 
RF lens 1 energy (V) 180/200 
Collision energy (V) 4 
MCP (V) 1700 
Ion optic region pressure (mbar) 2.5 x 10-3/1.5 x 10-1 
 
The following experiments concerning E. coli replisome proteins (Chapter 4) were carried out using 
the Synapt™ HDMS™ under the following conditions as outlined in Table 2.7: t; t with 2; t with 
2 and c16; 2 with peptides; c16 with peptides and core with c16. 
 
Table 2.7. ESI-MS conditions used for replisome proteins experiments (Chapter 4) carried out using the 
Synapt™ HDMS™ instrument. 
MS Parameters  experiments Peptides with 2 or c16 Core with c16 
Capillary (V) 1500 1500 1500 
Cone (V) 200 200 150 
MCP (V) 2100 2000 2000 
Transfer energy (V) 1 4 2 
Trap energy (V) 1 2 2 
Backing pressure (mbar) 4.0 2.15 3.2 
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Ion mobility mass spectrometry experiments 
The ion mobilities of different proteins and protein complexes were analysed using the Waters 
Synapt™ HDMS™ ESI mass spectrometer. The samples were prepared as described in section 2.2.1. 
The optimised instrument conditions for these experiments are outlined below in Table 2.8. 
 
Table 2.8. ESI-MS conditions for IMMS experiments carried out using the Synapt™ HDMS™ instrument 
MS Parameters 2/Tf experiment Cyc/Lin DnaB-N 
experiment 
CaM experiment 
Capillary (V) 1500 2600 2600 
Cone (V) 100 35 35 
Source temp (°C) 40 40 40 
Desolvation temp (°C) - 40/240 40 
Trap energy (V) 1 6 6 
Transfer energy (V) 1 4 4 
Bias 20 20 20 
MCP (V) 1800 1800 1800 
Wave velocity 200 450 450 
Wave height  11.6 10 12 
Extraction height 5 5 5 
Backing pressure (mbar) 2.5 x 10-3 2.5 x 10-3 2.5 x 10-3 
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Chapter 3 
 
Rubisco, Rubisco Activase and 
Interactions with Substrates and 
Effectors 
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This chapter is presented in two parts. Part One presents a mass spectrometric investigation of the 
multi-subunit enzyme, rubisco, and the oligomeric protein that activates it, rubisco activase. These 
proteins are key players in photosynthesis in higher plants. 
In Part Two, mass spectrometry was used to investigate the oligomeric assembly of rubisco from a 
cold-adapted archaeabacterium, Methanococcoides burtonii. 
 
Part One: Rubisco in higher plants 
 
3.1 Introduction 
Rubisco (ribulose bisphosphate carboxylase/oxygenase) is the enzyme responsible for catalysis of 
the first step of carbon dioxide assimilation in photosynthesis. It is the most abundant protein on 
Earth,129 but is also one of the least efficient enzymes and is recognised as rate limiting for 
photosynthesis.130 As a consequence, the enzyme rubisco activase is also present in plant cells. 
Owing to the importance of photosynthesis in the ecology of the planet, its significance makes it a 
target for improving agricultural productivity130 and there are many projects that aim to produce 
plants with more efficient genetically-modified rubisco.131,132 
 
3.1.1 Photosynthesis 
Photosynthesis is the process by which light energy is converted to chemical energy by plants. 
Carbon dioxide is assimilated and the products are stored as sugars or other organic compounds. 
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Photosynthesis provides the ultimate source of energy and nourishment, either directly or 
indirectly, for almost all living organisms.133 It is an important component of the carbon cycle 
enabling reentry of carbon to the biosphere.133 Photosynthesis occurs in the chloroplasts of plants 
and proceeds in two separate, but mutually dependent stages: the light-dependent processes 
(light reactions) and the light-independent process (dark reactions or Calvin cycle). Figure 3.1 
shows an overview of the reactants and products involved in photosynthesis. 
 
 
 
Figure 3.1. Overview of photosynthesis. In the light reactions, light is absorbed, starting a series of electron 
transfer steps that, overall, result in the oxidation of H2O to release O2. In the dark reactions (Calvin cycle), 
CO2 is fixed and is incorporated into sugar phosphates to form glucose and other sugars. 
 
In the light reactions, light is absorbed by chlorophyll, and the resulting energy is transferred 
through a series of redox partners and is coupled with the production of adenosine-5’-
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triphosphate (ATP).133 During this process, water is oxidised to release O2 as a by-product and 
NADPH is formed.134 The light reactions are carried out by two photosystems linked in series, 
Photosystem I and Photosystem II.135 Each photosystem is an assembly of accessory pigments and 
electron transport agents (proteins with redox active cofactors).133 These electron transport 
agents are located in close proximity in the membranes of the chloroplasts and have reduction 
potentials such that electrons are transferred sequentially. In this way, the energy from light 
absorption is transferred to Photosystem II, where water is oxidised, and then to Photosystem I, 
where NADP+ is reduced.135 Collectively, the two systems power the movement of protons across 
the chloroplast membrane to drive the generation of ATP.135 
In the Calvin cycle (dark reactions), ATP and NADPH, provided by the light reactions is used in the 
reduction of carbon dioxide to produce carbohydrates. Figure 3.2A shows the substrates and 
products of this cycle. The Calvin cycle can be separated into three distinct phases.136,137 In the first 
phase, carbon dioxide diffuses into the chloroplast where it reacts with ribulose bisphosphate 
(RuBP) to form two molecules of 3-phosphoglycerate, in a reaction catalysed by the enzyme 
ribulose-1,5-bisphosphate carboxylase/oxygenase (rubisco). The intermediates formed in this 
process are shown in Figure 3.2B. In the second phase, 3-phosphoglycerate is phosphorylated by 
ATP and the resulting product is reduced by NADPH to yield glyceraldehyde-3-phosphate.133 In the 
final phase of the cycle, RuBP is regenerated in a series of reactions catalysed by various enzymes, 
to allow the cycle to continue.138 
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Figure 3.2. The Calvin cycle. A. The Calvin cycle has three phases: (1) Carbon dioxide fixation (2) 3-
phosphoglycerate reduction (3) RuBP regeneration B. Structures of the reactants and products of the 
reaction catalysed by rubisco. 
A 
B 
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3.1.2 Rubisco structure 
The structure of rubisco has been determined.130,139 Rubisco of higher plants and cyanobacteria 
forms a hexadecameric quaternary structure. It consists of eight identical large subunits of around 
51-58 kDa, and eight identical small subunits of around 12-18 kDa, making it one of the largest 
enzymes found in nature.130 Figure 3.3 shows an X-ray crystal structure of spinach rubisco. It is 
arranged as four large subunit dimers joined at each end by four small subunits.140  
 
Figure 3.3. Structure of the rubisco hexadecamer shown in ribbons. The large subunits are shown in teal and 
the small subunits are shown in orange. Drawn from data in the Protein Databank (1RCX).
141
 
 
The C-terminal domain of each of the large subunits is arranged as an /  barrel.130 The active site 
involves residues from this region and residues of the N-terminal region of the other large subunit 
in the dimer.140  
In order for rubisco to catalyse the carboxylation of RuBP, it requires activation by an additional 
CO2 molecule to the substrate CO2.
142 This activation involves the carbamylation of a lysine residue 
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in the active site.143 The resulting carbamate is then able to coordinate with a divalent Mg2+ ion 
(shown in Figure 3.4). 
 
 
Figure 3.4. Carbamylation of the lysine 201 residue in the rubisco active site and coordination to Mg2+ ion. 
 
Crystal structures show that the rubisco active site can be in either an open or closed state.144 The 
active site of rubisco in the open state (carbamylated and bound with RuBP) and the closed state 
(uncarbamylated and bound with RuBP) are shown in Figure 3.5 to compare the conformational 
differences. The transition between the open and closed states appears to involve the N-terminus 
of one large subunit rubisco shifting away from the active site, leaving the site accessible to 
solvent.144 
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Figure 3.5.  Comparison of the active site of rubisco in the open (white) and closed (grey) states. RASMOL 
was used to show differences in the -carbon backbone of residues 36-60 and 83-103 of the N-terminal 
domain of one subunit and residues 460-475 (462) and 329-340 of the C-terminal domain of the other 
subunit of a large subunit homodimer, taken from structures of 1RCX and 1RXO.  RuBP of the “closed” 
structure (1RCX) is shown in spacefill. Reproduced from Portis 2003.145 
 
3.1.3 Rubisco function 
Rubisco is only able to catalyse the reaction between the enediol form (Figure 3.2B) of RuBP and 
CO2 when in its active conformation.
146 Carbon dioxide reacts with the enediol to give 2-carboxy-3-
ketoarabinitol-1,5-bisphosphate, which after undergoing hydration is cleaved to give two 
molecules of 3-phosphoglycerate138 (see Figure 3.2B).  
In addition to carboxylation, rubisco can also catalyse an oxygenation side-reaction. This involves 
the reaction of oxygen and water with the enediol form of RuBP to yield 3-phosphoglycerate and 
2-phosphoglycolate.147 The O2 used in oxygenation and the CO2 required for carboxylation 
compete for the rubisco active site, meaning that oxygenation inhibits carboxylation and hence 
reduces rubisco’s activity in photosynthesis.148 This is one of the paradoxes of rubisco activity: that 
an enzyme that is so important in photosynthesis through its reaction with CO2, also uses the 
much more abundant O2 as a substrate. It has been proposed that the carboxylation reaction 
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catalysed by rubisco evolved under atmospheres with high CO2 and low O2 conditions, where the 
oxygenation reaction was insignificant.149,150 This competing reaction only became more significant 
as the O2 levels in the atmosphere increased.
150 The relative specificity of rubisco for CO2 or O2 has 
been shown to be largely dependent on temperature. At higher temperatures, the specificity for 
CO2 decreases and results in a higher ratio of oxygenation to carboxylation.
138 Genetic engineering 
aimed at enhancing the selectivity of rubisco for CO2 over O2 in major agricultural crops is a key 
focus of research.130,151,152 
Rubisco activity is dependent on the balance between the inactive (noncarbamylated) and active 
(carbamylated) forms of the protein. Thus, the factors that influence the carbamylation of rubisco 
ultimately regulate its activity. Another paradox concerning the activity of rubisco is that the 
substrate RuBP inhibits the activation of rubisco by CO2, since it is able to bind the 
noncarbamylated (inactive) form of rubisco more tightly than the active form.153 Binding of RuBP 
to the inactive rubisco induces a conformational change that prevents carbamylation by CO2 and 
binding of Mg2+.153 This has been demonstrated by comparison of the X-ray crystal structures of 
the inactive rubisco-RuBP complex with the activated rubisco-RuBP complex (using Ca2+ ion 
instead of Mg2+ to trap rubisco in the open form).141 The activity of rubisco is also decreased by the 
binding of other sugar phosphates, such as carboxyarabinitol-1-phosphate (CA1P).154 The effect of 
this sugar phosphate is different to the inhibition by RuBP in that it binds preferentially to the 
active form of rubisco,155 inhibiting catalysis by obstructing the active site.154 CA1P has been linked 
with diurnal variations of rubisco activity,155 as it is known to accumulate in the leaves of a number 
of plant species during the night.138 The activity of rubisco that has been inhibited by sugar 
phosphates such as RuBP is restored by the action of the enzyme, rubisco activase.145 
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3.1.4 Rubisco activase 
Rubisco activase is essential to the catalytic function of rubisco of vascular plants and green algae 
during photosynthesis. It regulates rubisco activity by facilitating the conversion of inactive rubisco 
to a form that can be activated. It achieves this by increasing (somehow) the dissociation of 
inhibitory sugar phosphates from inactive rubisco.156-159 The rubisco can then be activated by CO2 
and Mg2+ and go on to catalyse the reaction of RuBP with CO2. Rubisco activase was first 
discovered by Somerville and colleagues160,161 when a mutant form of Arabidopsis thaliana lacking 
this protein was found to be deficient in rubisco activation. The rubisco enzyme from this mutant 
was biochemically identical to wild-type rubisco, indicating the lack of rubisco activation was 
caused by some other factor. Proteins in the chloroplast from the mutant were compared with 
wild-type by two-dimensional polyacrylamide gel electrophoresis and it was found that 
polypeptides absent in the mutant corresponded to two isoforms of a protein that was named 
rubisco activase.162 Using a light-dependent rubisco activation assay, it was demonstrated that 
activation of rubisco relied on the presence of the two rubisco activase sequences lacking in the 
mutant.162 Rubisco activase has since been found in all higher plant species examined163 and in 
some algae.164,165 
As well as rubisco activation activity, rubisco activase also exhibits ATPase activity. ATPases are 
enzymes that hydrolyse ATP to ADP and inorganic phosphate. The energy released on hydrolysis of 
the phosphoanhydride bond is used to drive other less favourable reactions or to provide energy 
for mechanical processes.166 The ATPase activity of rubisco activase is required for rubisco 
activation.127,167-169 This will be discussed in more detail below (section 3.1.6).  
 
62 
 
3.1.5 Rubisco activase structure 
A three-dimensional structure of rubisco activase has yet to be determined. Consequently, the 
details of the mechanism of activation of rubisco and the nature of the putative interaction of 
rubisco with rubisco activase remain unclear. A breakthrough towards understanding the action of 
rubisco activase was its identification as an AAA+ protein. Rubisco activase was observed to 
contain several features that are characteristic of AAA+ proteins, and functions to activate rubisco 
through ATP hydrolysis, which led to this classification.170 AAA+ proteins (ATPases associated with 
various cellular activities) are a class of ATPases associated with the assembly, operation and 
disassembly of protein complexes.170 Their functions can also include the assistance of protein 
folding and unfolding, protein transport and protein degradation.166 Molecular chaperones are a 
class of otherwise unrelated proteins that assist in the correct noncovalent assembly of other 
proteins, but are not involved when the assembled proteins are carrying out their usual biological 
function.171 Since AAA+ proteins are functionally related to molecular chaperones, the 
characterisation of rubisco activase as an AAA+ protein suggested a chaperone-like mode of 
action. It has been proposed previously that rubisco activase behaves more like a molecular 
chaperone than a conventional enzyme. Several biochemical properties typical of molecular 
chaperones were observed for rubisco activase.172  
The defining characteristic of AAA+ proteins is a conserved ATP binding domain of around 200-250 
amino acids. This binding domain consists of several structural and sequence-specific features, as 
shown in Figure 3.6.173  
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Figure 3.6. Typical structure of an AAA+ domain. Crystal structure of the AAA+ domain of NSF103 (N-
ethlymaleimide-sensitive fusion protein, an AAA+ protein involved in complex disassembly during 
membrane fusion) showing the positions of several key structural elements. -Helices are shown in orange, 
and -sheets shown in blue. A non-hydrolysable ATP analogue, AMP-PNP, coordinated by Mg2+ is shown in 
stick representation. Reproduced from Hanson and Whiteheart 2005.173 
 
It can be divided into two subdomains. The N-terminal subdomain contains a -sheet of parallel 
strands arranged in a unique sequence compared with other nucleotide binding domains.173 The C-
terminal subdomain is -helical and is positioned above the N-terminal subdomain.166 Walker A 
and B motifs are a feature of this conserved AAA+ domain, and are essential for ATP binding in 
these proteins.170 The Walker A motif interacts with the Mg2+ cofactor and the phosphate groups 
of the nucleotide.166,174 The binding of a Mg2+ ion is necessary for AAA+ proteins to stabilise 
negative charge accumulation at the nucleotide -phosphate following nucleophilic attack by an 
activated water molecule. The Walker B motif contains two carboxylate side chains that protrude 
into the active site. One is involved with coordination of Mg2+, while the other acts as the catalytic 
base that activates the nucleophilic water.166  
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The AAA+ domain also contains two sensor domains, which are able to detect the presence or 
absence of the nucleotide -phosphate and activate conformational changes accordingly.166  
 
Figure 3.7. Schematic representation of the domains within the AAA+ domain of rubisco activase and a 
comparison of amino acid residues 267-334 from a variety of Solanaceae and non-Solanaceae plants. 
Reproduced from Li et al. 2005.175  
 
The Sensor 1 domain interacts with residues from the Walker B motif and with the nucleotide -
phosphate.173,176 In addition to nucleotide sensing, the Sensor 2 domain has also been shown to be 
involved with protein-substrate recognition.175,177-179 A comparison of the sequence of the Sensor 2 
domains for a variety of Solanaceae and non-Solanaceae plants is shown in Figure 3.7. Arginine 
residues are a common feature of the AAA+ domain. The extended side chain and positive charge 
of the arginine residue means it is able to interact with phosphate groups via hydrogen bonding or 
electrostatic interactions.178 It has been previously reported that conserved arginine residues in 
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other AAA+ proteins are crucial for ATP binding and hydrolysis178 in a way similar to the “arginine 
finger” in GTPase,180 where the arginine interacts with the nucleotide -phosphate bound to an 
adjacent subunit. So while the three-dimensional structure of rubisco activase remains to be 
determined, its classification as a member of the AAA+ protein family has important implications 
for its structure and how it may influence the activation mechanism.  
AAA+ proteins generally form ring-shaped oligomers (usually hexameric), and this structure is 
important for their ATPase activities and modes of action.166,170,173 For example, cytoplasmic 
dynein contains a head domain consisting of a ring arrangement of AAA+ domains that power its 
movement along microtubules.181 Several studies indicate that rubisco activase also forms active 
oligomeric assemblies. Early experiments were consistent with the self-association of rubisco 
activase in the presence of the solvent-excluding reagent polyethylene glycol (PEG).182 In the same 
work the activities of the protein were shown to be enhanced over a range of increasing protein 
concentrations, which implied that self-association stimulated both the rubisco activation and 
ATPase activities of rubisco activase. Intrinsic fluorescence has been used in a number of studies to 
observe the aggregation of rubisco activase under different conditions. An increase in intrinsic 
fluorescence indicates a structural change causing the environment of one or more tryptophan 
residues to become more hydrophobic. This fluorescence increase was attributed to an increase in 
oligomerisation of the protein.183 Both Mg2+ and K+ promote the ATPase activity of rubisco 
activase. When these ions were present in saturating amounts, the ATPase activity and fluorescent 
enhancement also reached a maximum that did not increase as the protein concentration was 
raised above 1 M. Below 1 M, ATPase activity and fluorescent enhancement decreased rapidly. 
This behaviour had previously been observed for actin and it was proposed that this suggested a 
large oligomeric form of rubisco activase in equilibrium with monomer.184 Lower protein 
concentrations also led to a decrease in the ability of rubisco activase to activate rubisco, 
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supporting that a higher order oligomeric form of rubisco activase was required to interact with 
rubisco during activation.184 Wang et al. investigated the effect of ATP-induced protein 
aggregation on rubisco activase activity using intrinsic fluorescence.183 It was found that ATP 
hydrolysis increased with the rubisco activase concentration and this was consistent with an 
increase in the amount of the aggregated form at higher concentration.183 The effect of the 
addition of ATP to rubisco activase has also been examined using 1-anilinonaphthalene-8-sulfonic 
acid (ANS) fluorescence.168 ANS is a fluorescent reporter group that binds to hydrophobic regions 
of proteins and is able to detect conformational changes.185 Comparison of the results from this 
study with that using intrinsic fluorescence showed a few differences. The addition of ATP resulted 
in a much faster response in fluorescence reported by ANS than the rate of change of intrinsic 
fluorescence (Trp). It was suggested that this was because the increase in intrinsic fluorescence 
reflects a change in the rubisco activase conformation induced by binding of ATP and Mg2+, not 
simply the occupancy of the nucleotide binding sites. These results together suggest that the 
change in conformation of rubisco activase induced by the binding of ATP-Mg2+ is required before 
ATP hydrolysis.183 These results are in agreement with the results described earlier where 
increased self-association, ATP hydrolysis and rubisco activation was observed after treatment 
with PEG.182 These studies confirm that the ability of rubisco activase to form large oligomeric 
structures is essential to its function as an ATPase and as an activator of rubisco. 
Experiments carried out to confirm the size or preferred oligomeric form of rubisco activase have 
produced varied results, dependent on the conditions and method used. An early attempt to 
determine the molecular weight of rubisco activase from spinach and tobacco used rate zonal 
sedimentation and gel filtration chromatography. Native rubisco activase gave an apparent 
molecular weight of around 58,000 Da, in agreement with the expected monomer mass. In the 
presence of PEG, the apparent molecular mass increased two- to four-fold.182 While the addition 
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of ATP and Mg2+ increased the intrinsic fluorescence of rubisco activase indicating self-association, 
a significantly smaller increase was observed when either ATP or Mg2+ alone was used. This result 
indicates the aggregation of rubisco activase is stimulated by the presence of ATP and Mg2+.183 Gel 
filtration chromatography was also used in this study to observe the aggregation of rubisco 
activase. The results showed increased aggregation when the protein was present with ATP and 
excess Mg2+, consistent with the intrinsic fluorescence results described above.183 An attempt to 
characterise the size of rubisco activase from spinach using gel filtration was difficult as the 
protein always eluted as an asymmetric peak skewed to a smaller size. This indicated a mixture of 
oligomeric forms was present. An estimate of oligomers consisting of around 8-14 subunits was 
reported, varying depending on the temperature and the presence or absence of ligands.183  
The results described above suggest that the monomeric and oligomeric forms of rubisco activase 
are in dynamic equilibrium, powered by ATP hydrolysis.182,183 In a more recent study, intrinsic 
fluorescence was used to investigate oligomerisation of rubisco activase from tobacco. Arginine 
residues located in the AAA+ domain that are expected to be involved in ATP binding were 
mutated.179 Previous work, which examined rubisco activase from spinach, showed that ATP 
binding induced aggregation to larger oligomeric forms.183 In the tobacco study, the apparent 
molecular masses of wild-type rubisco activase (and the arginine mutants) were similar in the 
presence of ATP or ADP.179 After obtaining these contrasting results, an arginine mutant of spinach 
rubisco activase was examined. Addition of ATP to this mutant showed no increase in intrinsic 
fluorescence to indicate a conformational change due to nucleotide binding, but the apparent 
molecular weight increased as determined by gel filtration chromatography. It was concluded that 
the contrasting results imply that the ATP-induced increase in intrinsic fluorescence may not be a 
result of increased aggregation but may only correspond to reorientations between subunits 
within the oligomeric complex. It was also suggested that larger oligomers form transiently during 
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ATP binding/hydrolysis which may not be detected by these methods.179 Further work is needed to 
elucidate the precise structure and oligomeric form of rubisco activase that is functional during 
ATP hydrolysis and rubisco activation. 
 
3.1.6 ATPase activity 
The role of ATP hydrolysis catalysed by rubisco activase during the activation of rubisco is not fully 
understood. Activation of rubisco is dependent on ATP hydrolysis, but ATP hydrolysis by the 
activase does not require the presence of rubisco.145,169 The ATPase activity of rubisco activase has 
been proposed to supply energy for inducing conformational changes in rubisco that alter the 
binding affinity of rubisco for sugar phosphates.156,182 ATP hydrolysis by rubisco activase has also 
been proposed to induce oligomerisation and it is this form which can activate rubisco. Both 
effects may be important. As discussed above, the interaction of rubisco activase with ATP is likely 
to influence the protein oligomerisation state, and these properties are both linked to the ability 
of rubisco activase to activate rubisco. Comparison of the extent of oligomerisation of rubisco 
activase (as determined by intrinsic fluorescence) with its ATPase activity indicate a relationship 
between the two properties. This has implications for the possible ATPase-mediated mechanism 
of activation. A molecular sequence of events has been put forward whereby ATP binding to 
rubisco activase induces oligomerisation and then ATP hydrolysis occurs.145  
As described earlier, the AAA+ domain is where ATP binding occurs. AAA+ proteins will generally 
assemble into ring-shaped oligomers, such that the ATP binding sites are positioned at the 
interfaces between subunits.173 The ATPase mechanism of AAA+ proteins is thought to involve 
nucleophilic attack of the -phosphate of ATP by an activated water molecule, in a process that is 
stabilised by a Mg2+ ion. The metal binding site of rubisco activase has been investigated 
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previously and it was found that it contains two tightly bound Mg2+ ions which were not removed 
after precipitation with ammonium sulfate in the presence of EDTA.186 A conserved arginine 
residue in the AAA+ domain is thought to be involved in ATP binding, with ATP hydrolysis 
producing a conformational change in the adjacent subunit of the oligomeric complex. ATP 
hydrolysis can then be cycled around the subunits.166 While this is a general mechanism, it has 
been noted that the mode of action of different AAA+ proteins is varied and elucidation of the 
mechanism for rubisco activase remains an intensive topic of research.  
 
3.1.7 Rubisco-rubisco activase interaction 
The activation of rubisco by rubisco activase requires some kind of interaction between the two 
proteins.142,145 The stoichiometry and mechanism of the interaction between rubisco and rubisco 
activase has yet to be elucidated. Given that rubisco activase is an AAA+ protein, it is though that it 
functions by undergoing a conformational change that is associated with ATP binding or 
hydrolysis, and in doing so stimulates a conformational change in the target protein, rubisco.173 
This is the proposed mechanism for other AAA+ ATPases such as the clamp loader complex of 
Escherichia coli during DNA replication.170 While this seems likely for rubisco activase, there is no 
direct evidence to support this. Several studies have indirectly supported a physical association of 
rubisco and rubisco activase. Rubisco activase demonstrates specificity for rubisco from particular 
plant species. For example, the rubisco activase from a Solanaceae species (e.g., tomato, eggplant, 
capsicum chili, etc.) cannot efficiently activate rubisco from a non-Solanaceae species.156 
Comparisons of the rubisco large subunit sequences from Solanaceae and from non-Solanaceae 
species showed that they contain different residues on the surface of the large subunit.187 
Mutagenesis studies showed that a single residue (Pro 89) unique to Solanaceae proteins, located 
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on the N-terminus of the rubisco large subunit was required for activation by rubisco activase.188 
Chemical cross-linking has also been used to show that rubisco activase binds to the large subunit 
of rubisco189 and co-immunoprecipitation of the two proteins has been demonstrated.172 Studies 
involving a chimeric rubisco activase (with spliced regions from tobacco and spinach rubisco 
activase) indicate that the rubisco activase C-terminal domain was the main determinant of 
rubisco species specificity.190 These results confirm that at some point during the process of 
rubisco activation, a rubisco-rubisco activase complex is present. 
Several possible models for the mechanism of activation by rubisco activase have been put 
forward. Salvucci and Ogren142 proposed that the multimeric rubisco activase with bound ATP 
interacts with the inactive rubisco-RuBP complex. Rubisco activase then catalyses the hydrolysis of 
ATP, ultimately causing a conformational change in rubisco so that RuBP is bound less tightly. 
Andrews and coworkers191 proposed a similar mechanism; however, they suggested that ATP 
hydrolysis does not induce the conformational change in rubisco, but rather acts to return rubisco 
activase to a conformation that is able to interact with rubisco. Portis145 agreed with the 
mechanism put forward by Salvucci and Ogren,142 whereby ATP hydrolysis powers a 
conformational change in rubisco activase (present in a large oligomeric form) which changes the 
conformation of rubisco to allow sugar substrates to dissociate (see Figure 3.8).  
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Figure 3.8. Model of rubisco activation mechanism as proposed by Portis. Sugar phosphate inhibitors bind to 
the large subunits of rubisco (shown in white, small subunits shown in blue) to give inactive rubisco with 
closed active sites (white ellipses, open active sites shown as grey ellipses) (bottom left). Rubisco activase 
with ATP (shown in red) binds to the inactive rubisco (top left), and catalyses ATP hydrolysis, causing a 
conformational change in the rubisco-rubisco activase complex that opens the active sites (top right). The 
inhibitors can now dissociate more rapidly and rubisco activase is released from rubisco, restoring rubisco to 
the active state (bottom right). Adapted from Portis 2003.145 
 
Comparison of the open and closed states of rubisco, and mutation of key residues of both rubisco 
and rubisco activase suggested that the residues near 89 and 94 of the large subunit of rubisco 
and 311 and 314 of the activase are likely to participate in the interaction between rubisco and 
rubisco activase.187,188,190 A conserved Glu 93 on rubisco and Arg/Lys 312 in the activase were 
proposed to be involved in the interaction.   
These models do not explain exactly how inhibitors are released from rubisco. It is unclear 
whether rubisco activase actively removes the sugar phosphates from rubisco by binding directly 
to RuBP, or whether rubisco activase causes a conformational change in the structure of rubisco 
that favours dissociation of RuBP. The mechanism by which the complex of rubisco activase-ADP 
binds and forms a complex with ATP is also ambiguous. This may also be enabled by some kind of 
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conformational change that decreases the affinity of rubisco activase for ADP. These questions 
need to be addressed in order to conclusively determine the rubisco activation mechanism. 
 
3.1.8 Scope of this chapter 
The applications of ESI-MS have expanded so that the stoichiometry and specificity of 
biomolecular noncovalent interactions can be analysed. Rubisco activase presents a challenge as 
little is known about its functional forms or the molecular mechanism by which it activates 
rubisco. In Part One of this chapter, ESI-MS was used to probe the oligomeric structures of rubisco 
activase. In an effort to better understand the mechanism of rubisco activase during the activation 
of rubisco, the nucleotide binding properties of rubisco activase were also investigated. NanoESI-
MS of rubisco activase showed that ADP is tightly bound, so prior to investigations on the effects 
of nucleotide binding, a method was developed to remove the ADP while minimising denaturation 
of the protein. A possible second nucleotide binding site on the rubisco activase monomer was 
discovered. Rubisco is a hexadecameric protein of ~560 kDa and therefore presents a challenge for 
nanoESI-MS analysis. Conditions were optimised to observe the intact complex of rubisco. Several 
experimental plans were pursued to detect by nanoESI-MS a complex of inactivated rubisco-RuBP 
with rubisco activase. 
In Part Two, nanoESI-MS was used to determine the subunit stoichiometry of Methanococcoides 
burtonii rubisco. M. burtonii is a psychrophilic (cold-adapted) archaeabacterium. A mass 
spectrometric study in combination with biochemical work (ANU) was carried out to observe the 
assembly of rubisco dimers into decamers upon interaction with substrates, RuBP and CABP, or a 
variety of metal cofactors. 
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 3.2 Results and discussion 
3.2.1 Molecular mass and distribution of oligomeric forms of rubisco 
activase 
Preliminary work for this project was undertaken during the Honours year and included the 
determination of the accurate molecular mass of rubisco activase monomer. The spectrum is 
presented again here for comparison with results obtained during the PhD project. To measure 
the accurate mass of a protein, addition of acid to the sample prior to analysis ensures that the 
protein is fully protonated and consequently can assist in the electrospray process.40 Figure 3.9A 
shows the ESI mass spectrum of rubisco activase dialysed against 10 mM NH4OAc, pH 7.2. Acetic 
acid was added to 13% (v/v) just prior to ESI-MS analysis.  
 
Figure 3.9. Positive ion nanoESI mass spectra of rubisco activase. A. Dialysed against 10 mM NH4OAc, pH 7.2 
and treated with acetic acid prior to analysis. The numbers (e.g. 24+) represent the ions, e.g. [M+24H]24+. B. 
After addition of NH4OAc to 500 mM. 1 indicates monomer, 2 indicates dimer, 3 indicates trimer, 4 indicates 
tetramer, 5 indicates pentamer and 6 indicates hexamer. 
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This spectrum in Figure 3.9A shows several charge state distributions suggesting a combination of 
partially folded protein structures present in the mixture, with maxima corresponding to the 
[M+24H]24+, [M+18H]17+ and [M+13H]13+ ions at m/z 1783, 2377 and 3290, respectively. ESI results 
in multiple charging of proteins and the different charge state distributions represent varying 
accessibilities of different basic amino acid side chains to the surface of electrospray droplets 
during the ionisation process.18,192,193 From this spectrum, the molecular mass of monomeric 
rubisco activase was 42,760.1 ± 0.3 Da. This mass was in reasonable agreement with the 
calculated mass determined from the protein sequence obtained from our collaborators at the 
Australian National University, Canberra, which gave a mass of 42,759.6 Da.  
Since the quaternary structure of rubisco activase has yet to be conclusively determined, nanoESI-
MS of the protein at pH 7.2 was then performed. This preserves the electrostatic and hydrogen-
bonding interactions that keep a noncovalent complex intact. The best ESI mass spectra of rubisco 
activase were obtained after dialysis against 10 mM NH4OAc, pH 7.2, with addition of NH4OAc to 
500 mM prior to analysis. A spectrum is shown in Figure 3.9B. At lower concentrations of NH4OAc, 
the relative abundance of ions corresponding to higher oligomeric forms (m/z range 5500-7500) 
was lower. This spectrum is very different from that obtained from rubisco activase in the 
presence of acid and from the normal charge distribution commonly observed for monomeric 
proteins. The distribution of ions in the spectrum is also very different from what is commonly 
observed for oligomeric proteins that prefer a particular stable stoichiometry. For rubisco activase, 
it is likely that a range of oligomeric forms of the protein are present in solution. Each oligomeric 
form is represented by a distribution of ions, which led to complications in assigning each peak 
since the charge states of different forms can overlap. For example the 20+ ion of a tetramer has 
the same m/z as the 10+ ion of a dimer.  
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Closer inspection of each ion revealed fine structure. Figure 3.10 shows the m/z region 4600-5000 
from Figure 3.9B. The mass for the rubisco activase dimer, based on the mass determined from 
Figure 3.9A, is 85,520 Da.  
 
Figure 3.10. Positive ion nanoESI mass spectrum of the [M+18H]18+ charge state of the rubisco activase 
dimer in 500 mM NH4OAc, pH 7.2. D represents free rubisco activase dimer; A represents binding of ADP 
molecules to the dimer. 
 
These peaks are broad, as has been observed previously for nanoESI mass spectra of protein 
complexes.43,194 This is thought to be the result of inclusion of water molecules and small ions such 
as Na+ in the folded protein structure under the experimental conditions.43 This limits the accuracy 
of the mass determination. The ion of low abundance observed at m/z ~4754 is consistent with 
the [M+18H]18+ ion of a dimer of mass 85,534 Da. There are two ions to higher m/z associated with 
the dimer. The abundant ion at m/z ~4779 corresponds to a mass of 85,961 Da. The ion at m/z 
~4802 corresponds to a mass of 86,388 Da. The mass difference between each ion corresponds to 
427 Da and the mass of ADP is 427.2 Da. Given that rubisco activase is known to be a potent 
ATPase, this suggests that ATP was present when the protein was isolated and purified and was 
hydrolysed to ADP. Similar observations were made for all oligomeric forms. For example, the ions 
in the m/z region 5250-6000 correspond to trimer, trimer + 1ADP, trimer + 2ADP and trimer + 
3ADP. Previous experiments support that one ADP molecule binds to each rubisco activase 
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monomer.195,196 No ATP was added to any buffers during the purification of rubisco activase (S. 
Whitney, personal communication). The ATP (or ADP) must have been present in the E. coli cells 
engineered to produce recombinant rubisco activase.  
The ions corresponding to rubisco activase with bound ADP were analysed to determine the 
correct assignment of ions in the spectrum. The calculated m/z value for the [M+9H]9+ ion of the 
rubisco activase monomer (4752 m/z) is equal to that for the [M+18H]18+ ion of the dimer; the 
[M+9H]9+ ion of the monomer + 1ADP (4800 m/z) is also at the same value of m/z as the 
[M+18H]18+ ion of the dimer + 2ADP. It is more likely that a group of three ions would correspond 
to free dimer, dimer + 1ADP and dimer + 2ADP at the same charge state, rather than monomer at 
half the charge state, dimer + 1ADP and monomer + 1ADP at half the charge state. Taking this into 
consideration, the oligomeric forms of rubisco activase observed in the nanoESI mass spectrum 
shown in Figure 3.9B were assigned. 
Based on the observations from the current work, previous studies aimed at investigating the 
effects of salts and solution conditions on the extent of oligomerisation of rubisco activase may 
have been affected by the presence of free rubisco activase together with ADP-bound protein 
prior to the addition of any other reagents. Rate zonal sedimentation and gel filtration showed 
that PEG increased the molecular mass of rubisco activase by two- to four-fold.182 While no further 
nucleotides or Mg2+ were added to the samples in these experiments, the rubisco activase in this 
study was purified from spinach and tobacco leaves and stored in the presence of ATP, so it is 
likely based on our observations here, that the rubisco activase contained bound ATP/ADP. In 
other work, the addition of either ATP with Mg2+, or ATP S with Mg2+ was observed to almost 
double the size of rubisco activase compared to ATP alone or ADP with Mg2+ 183. It is also possible 
that the conditions required used for gel filtration chromatography may affect the oligomerisation 
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of rubisco activase.184 The effect of Mg2+ and protein concentration on the formation of rubisco 
activase oligomers was investigated using intrinsic fluorescence.184 In that study, spinach rubisco 
activase was overexpressed and purified from E. coli cells. The rubisco activase was likely to have 
been exposed to ATP during the overexpression process. 
 
3.2.2 Rubisco activase-nucleotide interaction 
An understanding of the interactions of ATP and ADP with rubisco activase is necessary since the 
rubisco-activating activity of rubisco activase requires ATP and is inhibited by ADP.127,167 To 
understand the mechanism of rubisco activation, specific nucleotide interactions (such as binding, 
hydrolysis and ATP/ADP exchange) need to be correlated with specific steps of the activation 
process.168 The oligomeric forms and/or the conformation of rubisco activase might be affected by 
the presence or absence of ADP (Figure 3.8), and it has been shown previously that ATP may be 
involved in the aggregation of rubisco activase.145,168,179,183 A previous study examined the 
purification and assay of rubisco activase.127 Following purification, the enzyme was frozen and 
stored in the presence of ATP to preserve rubisco activation activity. To determine the stability of 
the protein in the presence or absence of nucleotides, the ATP in this study was removed by gel 
filtration and the activation activity of rubisco activase was shown to decrease as a result. While 
gel filtration may have successfully removed the weakly bound ATP, the possibility that tightly 
bound ADP remained was not addressed. In that work, no efforts were made to measure directly 
whether any ADP (or ATP) remained bound to the protein. The absence of ATP was inferred by loss 
of rubisco activation activity. The nanoESI mass spectrum shown in Figure 3.10 suggests that ADP 
was likely to have been bound to the protein and that the sample may have been heterogeneous 
with the presence of free and ADP-bound rubisco activase. In order to study the effect of 
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nucleotides on rubisco activase, a new method to remove ADP was developed. ESI-MS was a 
useful method for rapidly assessing whether ADP was successfully removed from the protein. 
 
3.2.2.1 Removal of ADP from rubisco activase 
Removal by lowering pH 
Preliminary experiments aimed at developing a method to remove ADP from rubisco activase 
were carried out during the Honours year. A method was developed that involved dialysis of 
rubisco activase against higher concentrations of NH4OAc, since increased salt concentrations can 
often disrupt noncovalent interactions. Figure 3.11 shows nanoESI mass spectra of rubisco 
activase dialysed against a variety of solutions. Dialysis against a high NH4OAc concentration (4 M) 
alone was not sufficient to fully remove bound ADP (Figure 3.11A), so the pH was lowered. A small 
ion corresponding to rubisco activase + ADP was still present (Figure 3.11B), so the NH4OAc 
concentration was increased to 5 M and this combination was shown to be successful in removing 
the ADP (see Figure 3.11C). While this treatment was successful for removing ADP, the low pH in 
this experiment may have resulted in partial unfolding of the protein, affecting the structure and 
oligomeric forms of rubisco activase (and its function). 
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Figure 3.11. Positive ion nanoESI mass spectra of the [M+12H]12+ charge state of the rubisco activase 
monomer dialysed against different solutions. A. Rubisco activase dialysed against 4 M NH4OAc, pH 7.2 B. 
Rubisco activase dialysed against 4 M NH4OAc, pH 5.5 C. Rubisco activase dialysed against 5 M NH4OAc, pH 
5.5. M represents the free rubisco activase monomer; A represents the binding of ADP molecules to the 
monomer. 
 
In the PhD project, an ATPase activity assay was performed to determine if the low pH treatment 
resulted in loss of function. This assay has been used extensively by others and involves 
spectrophotometric measurement of the rate of NADH oxidation through an enzyme-linked assay 
involving lactate dehydrogenase and pyruvate kinase.127,184 The rubisco activase sample treated 
with 5 M NH4OAc at pH 5.5 showed a ~200-fold loss of ATPase activity, relative to an undialysed 
sample. Circular dichroism (CD) spectra of the samples before and after treatment were also 
acquired. CD measures differences in the absorption of left-handed circularly polarised light versus 
right-handed polarised light which arise due to structural asymmetry. Protein secondary structure 
can be determined in the “far-UV” spectral region (190-250 nm), with -helix and -sheet 
structures giving rise to a characteristic shape and magnitude of a CD spectrum197 (shown below).  
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Figure 3.12. CD spectra associated with various types of protein secondary structure. Solid line represents -
helix, long dashed line represents antiparallel -sheet, dotted line is type I -turn, cross dashed line is 
extended 31-helix and short dashed line is irregular structure. Reproduced from Kelly et al. 2005.
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In this experiment, changes in secondary structure caused by denaturing of the protein can be 
detected by measuring the CD spectrum of rubisco activase under native conditions, and following 
treatment to remove ADP. The results are shown in Figure 3.13. 
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Figure 3.13. CD spectra of rubisco activase dialysed against different solutions. The blue line represents 
rubisco activase dialysed against 10 mM NH4OAc, pH 7.2 with NH4OAc added to 100 mM prior to analysis. 
The pink line represents rubisco activase dialysed against 5 M NH4OAc, pH 5.5 to remove ADP and diluted to 
100 mM NH4OAc prior to analysis. The protein concentration was ~5 M in both samples. 
  
The CD spectrum of rubisco activase in 10 mM NH4OAc, pH 7.2 (blue line) exhibits a spectrum with 
two minima below zero that is characteristic of a mostly -helical secondary structure (see Figure 
3.12). After treatment with 5 M NH4OAc, pH 5.5 to remove ADP (pink line), a flat line at around 
zero was observed, meaning that the rubisco activase had lost secondary structure. This indicates 
that these dialysis conditions resulted in unfolding of the protein. A CD spectrum of rubisco 
activase that had not undergone dialysis against ammonium acetate was also acquired (not 
shown) that resulted in an -helical spectrum. Addition of ADP, ATP or the non-hydrolysable ATP 
analogue, AMP-PNP, to the unfolded sample did not result in a refolded structure (spectra not 
shown), as judged by CD spectroscopy.  
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The results of the ATPase assay and CD experiment indicate that the ADP removal method, while 
successful in removing the tightly bound ADP, had denatured the protein. This nucleotide-free 
rubisco activase was therefore not suitable for investigating its oligomeric assembly, and 
interactions with nucleotides and rubisco. Subsequent experiments were aimed at developing a 
more gentle method of ADP removal. 
 
Removal with 4 M NaCl, pH 7.2 
Since some success was achieved by using a high salt (NH4OAc) concentration, methods were 
tested that involved dialysis against Tris buffer containing different concentrations of sodium 
chloride. Aliquots of rubisco activase were dialysed against either 40 mM Tris-HCl alone or 40 mM 
Tris-HCl with 4 M NaCl (both pH 7.2). ATPase assays and CD spectra were acquired for each sample 
followed by dialysis against 100 mM NH4OAc, pH 7.2, and acquisition of nanoESI mass spectra. The 
nanoESI mass spectra of these samples are shown in Figure 3.14.  
The spectrum in Figure 3.14A shows the monomer region m/z 3100-3500 of rubisco activase 
treated with 40 mM Tris-HCl. The abundant ion at m/z 3287 indicates the free monomer, with a 
low abundance ion at m/z 3320 from the monomer + 1ADP. Figure 3.14B shows the same m/z 
region of the nanoESI mass spectrum of the rubisco activase sample treated with 40 mM Tris-HCl, 
4 M in NaCl. This spectrum shows only the free rubisco activase monomer ion. This indicates that 
treatment with Tris-HCl alone did not fully remove the ADP from rubisco activase, while treatment 
with Tris-NaCl successfully removed all the ADP.  
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Figure 3.14. Positive ion nanoESI mass spectra of rubisco activase ([M+13H]13+ ion) dialysed against different 
solutions to remove bound ADP. A. Rubisco activase monomer dialysed against 40 mM Tris-HCl, pH 7.2, 
followed by 10 mM NH4OAc, pH 7.2. B. Rubisco activase monomer dialysed against 40 mM Tris-HCl + 4 M 
NaCl, pH 7.2, followed by 10 mM NH4OAc, pH 7.2. M represents the free rubisco activase monomer; A 
represents the binding of ADP to the monomer. 
 
Both of the samples showed a characteristic -helical CD spectrum, consistent with folded rubisco 
activase (not shown). The ATPase assay showed that this treatment resulted in a ~7-fold loss of 
ATPase activity. This stands in contrast to the low pH treatment where >99% of the activity was 
lost.  
The high affinity for ADP observed here suggests that experiments carried out in other work to 
investigate the effect of exogenous nucleotide-binding to rubisco activase may have been carried 
out using rubisco activase to which ADP was already bound.127,168,179,183,184 
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3.2.2.2 Affinity of rubisco activase for ATP/ADP 
The ATPase activity (and thus rubisco-activating activity) of rubisco activase has been shown to be 
inhibited by ADP169 which suggests that rubisco activase is inactive in the ADP-bound form. 
Previous experiments that measured the changes in ANS fluorescence upon nucleotide binding 
showed that at pH 7.0, ADP had a higher binding affinity for rubisco activase than ATP.168 This has 
important implications for the roles of ADP and ATP in rubisco activase function. Wang et al.183 
used intrinsic fluorescence to examine structural differences that change the environment around 
tryptophan residues upon binding of ATP or the non-hydrolysable analogue, adenosine 5'-[ -thio]-
triphosphate (ATP S). Inhibition by ADP could be overcome by a higher concentration of ATP S, 
suggesting competitive binding at the nucleotide binding site of rubisco activase.183 The ratio of 
ADP/ATP in the stroma of the chloroplast is thus very important to the activity of rubisco 
activase142. When in environments with little or no exposure to light, ADP/ATP ratios are 1:1 and 
rubisco activase exhibits reduced activity. Upon exposure to light, ADP/ATP ratios are typically 
around 1:2 or 1:3 and the protein demonstrates higher activity.145 The ATPase activity was 
investigated over a range of Mg2+, K+ and protein concentrations.184 It was observed that ADP and 
ATP S were able to bind rubisco activase under low- and high-Mg2+ and K+ conditions. A possible 
ATPase mechanism was put forward taking these data into consideration, whereby ATP is bound in 
exchange for ADP on the rubisco activase monomer. ATP binding stimulates oligomerisation of the 
protein, followed by ATP hydrolysis with release of Pi but not ADP. The bound ADP is then only 
released in exchange for ATP.184  
The development of a method to remove tightly bound ADP from rubisco activase enables 
experiments in which the relative binding affinities of the different nucleotides can be compared 
for the first time. Rubisco activase was titrated with either ADP or AMP-PNP and the resulting 
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nanoESI mass spectra compared. AMP-PNP is a widely used non-hydrolysable substitute for ATP in 
the analysis of ATPases. The structures of ATP, ATP S, AMP-PNP and ADP are shown in Figure 3.15.  
      
Figure 3.15. The chemical structure of various nucleotides. A. ATP. B. ATP S. C. AMP-PNP. D. ADP. 
 
AMP-PNP and ATP are almost identical in structure, except the oxygen linking the - and -
phosphate groups in ATP is replaced by NH in AMP-PNP. It is therefore not possible for an ATPase 
to hydrolyse the -phosphate group of AMP-PNP, but the geometry about this group is similar for 
both nucleotides. Structures have been determined for other ATPases that show that the two 
nucleotides have essentially the same interactions within the active site, but AMP-PNP cannot 
undergo hydrolysis.198 The spectra in Figure 3.16 show the titration of rubisco activase with 
increasing ADP or AMP-PNP from 1-100 M. Since the rubisco activase was shown to be present in 
a higher oligomeric form when the NH4OAc concentration was 500 mM (Figure 3.9B), those 
conditions were used in this experiment. 
A 
B 
C 
D 
86 
 
 
Figure 3.16. Positive ion nanoESI mass spectra of the rubisco activase monomer (approximately 30 M) titrated with increasing ADP (A-E) or AMP-PNP (F-J) in 
500 mM NH4OAc, pH 6.5. A. Rubisco activase + 1 M ADP B. Rubisco activase + 5 M ADP C. Rubisco activase + 10 M ADP D. Rubisco activase + 50 M ADP E. 
Rubisco activase + 100 M ADP F. Rubisco activase + 1 M AMP-PNP G. Rubisco activase + 5 M AMP-PNP H. Rubisco activase + 10 M AMP-PNP I. Rubisco 
activase + 50 M AMP-PNP J. Rubisco activase + 100 M AMP-PNP. M represents the free rubisco activase monomer and A represents the binding of nucleotide 
(ADP or AMP-PNP). 
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The spectra in Figure 3.16 show the m/z region 3400-3800. In Figure 3.16A, the [M+12H]12+ ion of 
the free rubisco activase monomer is present at m/z 3563. The ion at m/z 3599 is from rubisco 
activase monomer with one ADP molecule bound (RA + 1ADP). As the concentration of ADP was 
increased relative to rubisco activase concentration, the abundance of the free monomer ion 
decreased and the RA + 1ADP increased until it was the most abundant ion in the spectrum as 
seen in Figure 3.16. Figures 3.16F-J show the spectra of rubisco activase with increasing AMP-PNP 
concentration. The ion at m/z 3603 corresponds to one AMP-PNP molecule bound to the rubisco 
activase monomer (RA + 1 AMP-PNP). As the concentration of AMP-PNP was increased, the ion 
from the free rubisco activase monomer remains the most abundant ion, with only a small 
increase in the RA + 1AMP-PNP ion abundance. It is apparent upon comparison of the spectra that 
rubisco activase extensively binds ADP, as shown in Figure 3.16E and in agreement with the 
experiments described above, where the monomer is saturated with ADP when the concentration 
was 100 M. In contrast, AMP-PNP shows only weak binding to rubisco activase. This indicates 
that ADP binds more tightly to rubisco activase than does AMP-PNP (and by inference, ATP). This is 
consistent with previous work where changes in ANS fluorescence were used to monitor binding 
of ADP and ATP to rubisco activase.168  
It is interesting to note in Figure 3.16E, where 100 M ADP was present with rubisco activase, a 
low abundance ion is apparent at m/z 3636 that corresponds to two ADP molecules bound to the 
rubisco activase monomer. To investigate this further, another ADP-free rubisco activase sample 
was prepared. This sample was then treated with ATP-Mg to give a final ATP concentration of 100 
M and the resulting spectrum shown in Figure 3.17.  
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Figure 3.17. Positive ion nanoESI mass spectrum of the rubisco activase monomer treated with 100 M ATP-
Mg. M represents the rubisco activase monomer and binding of nucleotides is as indicated.  
 
In this spectrum the [M+12H]12+ ion of the rubisco activase monomer is present. A more abundant 
ion to higher m/z at 3600 is from RA + 1ADP. The presence of bound ADP shows that the ATP was 
hydrolysed by rubisco activase. If there was an ion from RA + 1ATP it would be at m/z 3606. The 
resolution and quality of the spectrum is sufficient to be able to readily distinguish these two 
possibilities. A low abundance ion at m/z 3635 corresponds to the mass of the monomer with two 
ADP molecules bound (854 Da greater than the monomer mass). Another low abundance ion at 
m/z 3642 corresponds to a mass difference 934 Da greater than the monomer. This is consistent 
with the calculated mass of ADP+ATP (934 Da). This is supported by the calculated mass difference 
of 507 Da (mass of one ATP molecule) between this ion and the ion from RA + 1ADP. This result 
indicates that the rubisco activase has been able to hydrolyse the ATP to ADP in the time between 
sample mixing and spectrum acquisition (approximately five minutes). The ability of rubisco 
activase to hydrolyse ATP in the absence of rubisco has been reported previously,169 and is 
confirmed by the ESI-MS data shown here. The observation of peaks with two ADP or with both 
ADP and ATP bound is consistent with more than one nucleotide binding site on the rubisco 
activase monomer. The experiments of Wang et al.183 showed that inhibition of rubisco activase by 
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ADP could be overcome by treatment with ATP S. This was interpreted as competition at the same 
binding site. The possible existence of two nucleotide binding sites suggests a more complex 
involvement of nucleotides. It cannot be ruled out that the ions corresponding to the existence of 
a second nucleotide binding site arise from non-specific interactions. However, the high salt 
reaction conditions (500 mM NH4OAc) should minimise weak non-specific binding interactions 
arising from electrostatic interactions (e.g. the phosphate groups of the nucleotides with arginine 
or other basic residues) providing confidence the second nucleotide binding site is not an 
experimental artifact. 
 
3.2.2.3 Two nucleotide binding sites 
There has been one previous experiment that suggested there are two ATP binding sites on 
rubisco activase.199 Photoaffinity labelling was used to identify the adenine binding domain for ATP 
on rubisco activase.200 It was observed that there were two distinct binding sites that could be 
labelled with azido-substituted analogues of ATP. One of the sites was the previously recognised 
ATP binding domain for rubisco activase (based on homology with other AAA+ ATPases). It was 
thought, however, that the second binding site was interacting with the azido moiety of the probe, 
and was not a specific site for nucleotide binding. The authors concluded that this site was most 
likely a site for interaction with rubisco.200  
A number of conserved arginine residues have been identified in rubisco activase, which are found 
in either the Box VII domain or Sensor 2 domain178 (Figure 3.7). Data obtained from studies on a 
variety of AAA+ members have suggested that despite the conservation of these residues, there is 
considerable divergence in their roles in ATP binding, hydrolysis and coupling of these steps to 
mechanochemical events.178 Li et al.179 examined mutations of these arginine residues in tobacco 
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rubisco activase and found that they are both important for ATP hydrolysis and ATP-induced 
conformational changes. The two arginine residues in the Box VII domain (Arg 241 and Arg 244) 
were suggested to act as two separate “arginine fingers”, and the two residues in the Sensor 2 
domain (Arg 294 and Arg 296) were proposed to have roles in inducing conformational changes in 
response to the presence of ATP and a more subtle role in the maintenance of interactions needed 
to activate rubisco.179 A predicted 3D structure of the rubisco activase AAA+ domains was put 
forward, and is shown below (Figure 3.18). The two “arginine finger” residues are distantly located 
from the ATP binding site, making it impossible for them to interact with ATP from their own 
subunit. This supports the theory that each rubisco activase monomer is able to interact with a 
second ATP molecule and that the role(s) of the arginine residues in AAA+ proteins are diverse and 
require further investigation.179  
 
Figure 3.18. Predicted 3D structure of the AAA+ domains of rubisco activase. The Walker A, Walker B, Sensor 
1, Box VII and Sensor 2 domains are shown in orange, yellow, light green, dark green and blue, respectively. 
ADP is shown in red. Conserved arginine residues are labelled. Adapted from Li et al. 2006.179  
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The possibility that rubisco activase monomer was able to bind ADP and ATP simultaneously, 
suggesting a possible second nucleotide binding site (Figure 3.17) was investigated further in a 
competitive binding experiment. Rubisco activase was treated to remove ADP and separated into 
three reaction mixtures. An aliquot of ADP was added to the first sample and left for ten minutes. 
An aliquot of AMP-PNP was then added and nanoESI mass spectrum acquired following a second 
ten minute incubation. For the second rubisco activase sample, AMP-PNP was added first, 
followed by ADP. ADP and AMP-PNP were added simultaneously to the third reaction mixture 
containing rubisco activase. The resulting spectra are shown in Figure 3.19. 
 
 
Figure 3.19. Positive ion nanoESI mass spectra of competitive binding of different nucleotides to the rubisco 
activase monomer. A. Rubisco activase sample with the addition of ADP followed by AMP-PNP B. Rubisco 
activase sample with the addition of AMP-PNP followed by ADP C. Rubisco activase sample with 
simultaneous addition of ADP and AMP-PNP. M represents the free rubisco activase monomer; binding of 
nucleotides to the monomer is indicated. The final concentration of nucleotide in each sample was 100 M. 
92 
 
Upon examination of the spectra, it is apparent that despite the different order of nucleotide 
addition for the samples, the results are the same. In all three spectra, the ions at m/z 3563, 3599, 
3634 and 3640 correspond to the free RA monomer, RA+1ADP, RA+2ADP and RA+ADP+AMP-PNP, 
respectively. This indicates that the order of addition does not affect the preference of binding, 
and rubisco activase has a clear preference for binding ADP. A greater affinity for ADP is confirmed 
by the high abundance of RA+1ADP. It has been shown previously that a high ATP S concentration 
could overcome inhibition by ADP.183 In contrast, the MS experiments reported here show that the 
ADP binds tightly at the first nucleotide binding site (Figure 3.16A-E). This site does not readily 
bind AMP-PNP (Figure 3.16F-J), but binding of ADP appears to stimulate binding of nucleotides at a 
second binding site (Figure 3.19A) AMP-PNP. 
This experiment was repeated several times and the results were reproducible. There is a 
possibility that the observation of a second nucleotide binding site with nanoESI-MS could be the 
result of non-specific binding. CID experiments have been used previously in ESI-MS studies of 
noncovalent complexes to investigate the stability of the interaction.42,58 A study on the 
interaction between Tus protein and the specific DNA binding sequence Ter examined its 
dissociation under high salt (~800 mM NH4OAc) conditions and at high cone voltage (100 V; “in-
source” CID).58 These conditions were sufficient to compare dissociation behaviour of different Tus 
mutants. In the current work, the two nucleotide binding sites of rubisco activase were observed 
using 500 mM NH4OAc as the solvent, and a cone voltage of 300 V. These conditions should be 
sufficient to exclude any non-specific binding. In support of this, other ATPases have been found to 
contain multiple sites for nucleotide binding. The 90 kDa heat shock protein, Hsp90, is a 
homodimeric chaperone involved in the regulation and signalling systems in eukaryotic cells.201 
The chaperone activity of Hsp90 is dependent on the binding and hydrolysis of ATP.202 
Crystallisation studies revealed the ATP-binding fold in the N-terminal domain,202 but it has 
93 
 
recently been reported that Hsp90 contains a second ATP-binding site on the C-terminal 
domain.203 This C-terminal nucleotide site only becomes accessible to ATP-binding after the N-
terminal site has been occupied.202 Hsp104 from Saccharomyces cerevisiae is another heat shock 
protein with two nucleotide binding sites. Hsp104 is an AAA+ ATPase that is involved in the return 
of aggregated proteins to their folded, active state. Mutation of an arginine residue in the Sensor 2 
region of the second nucleotide binding domain (NBD2) reduced the affinity for both ATP and ADP. 
This indicated the NBD2 is involved in nucleotide binding but not hydrolysis. This mutation also 
resulted in reduced ATP hydrolysis at NBD1. When the NBD2 was mutated to trap it in an ATP-
bound state, the ATP hydrolysis activity at NBD1 was also affected, meaning the catalytic activity 
of NBD1 is dependent on the type of nucleotide bound at NBD2. These results indicate 
communication between the two domains during the ATP hydrolysis cycle. These examples may 
have an implication for the role of the second nucleotide binding site for rubisco activase.  
 
3.2.2.4 Role of magnesium 
As with other AAA+ proteins, the binding and hydrolysis of ATP by rubisco activase has been 
shown to require the presence of Mg2+ ions. In an earlier study of the oligomeric forms of rubisco 
activase using intrinsic fluorescence and gel filtration, it was found that ATP and Mg2+ were both 
required for rubisco activase to self-associate. NanoESI-MS was used to investigate the effect of 
Mg2+ on the formation of oligomeric forms of rubisco activase and its interaction with various 
nucleotides. It was found that there was no difference in either the oligomeric forms observed or 
interaction of different nucleotides in the presence or absence of 10 M Mg2+. It should be noted 
however, that the ATP used in these experiments already contains magnesium. It is possible that 
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this magnesium is sufficient for the ATPase activity of rubisco activase, and if ATP without 
magnesium was added to the sample it may interact differently. 
 
3.2.3 Rubisco activase-sugar phosphate interaction 
The mechanism by which rubisco activase activates rubisco has yet to be elucidated. The question 
of whether rubisco activase achieves this by interacting with the inactive rubisco-RuBP complex, or 
directly binds RuBP to remove it, was initially investigated in the Honours year. An aliquot of RuBP 
was added to a sample of rubisco activase (with ADP still bound) and was found to bind 
extensively with rubisco activase as shown in Figure 3.20. 
Figure 3.20. Positive ion nanoESI mass spectrum of the interaction of rubisco activase with RuBP. 1 indicates 
monomer, 2 indicates dimer, 3 indicates trimer, 4 indicates tetramer, 5 indicates pentamer and 6 indicates 
hexamer. Peaks with no numbers were ambiguous. 
 
In the above spectrum the ions corresponding to higher oligomeric species are of much greater 
abundance than when no RuBP was added (cf. Figure 3.9B), and ions to high m/z (in the range 
7500-9500) were observed, indicating that higher oligomeric forms of rubisco activase may have 
been present. At a glance, the peaks seem much broader than when no RuBP was added (Figure 
95 
 
3.9B). A closer view of the m/z region corresponding to the [M+12H]12+ ion of the rubisco activase 
monomer is shown in Figure 3.21. 
This spectrum demonstrates the extensive binding of RuBP to the rubisco activase monomer. The 
ion of highest abundance at m/z 3565 corresponds to the free rubisco activase monomer (labelled 
as M). The ion at m/z 3590 indicates the binding of one molecule of RuBP to the monomer 
(labelled as M+1R). The adjacent peak at m/z 3600 corresponds to the monomer with one ADP 
molecule bound (labelled as M+1A). An ion corresponding to the binding of one ADP and one RuBP 
molecule to the rubisco activase monomer (labelled as M+1A+1R) is also present at m/z 3626. 
There are also ions at m/z 3652, 3678, 3704, 3730 and 3757 that represent the binding of two, 
three, four, five and six molecules of RuBP to the monomer with bound ADP. 
 
Figure 3.21. Expansion of the 3500-3800 m/z region of the spectrum shown in Figure 3.20. This region 
represents the [M+12H]12+ ion of the rubisco activase monomer and proposed associated complexes. M 
indicates rubisco activase monomer, A indicates binding of ADP and R indicates binding of RuBP. 
 
Closer inspection of the ions at higher oligomeric forms show binding of RuBP, but the ions in the 
spectrum became increasingly difficult to assign since each rubisco activase subunit binds to ADP 
and each subunit+ADP complex was then able to interact with RuBP. RuBP was also added to a 
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sample of rubisco activase that had been dialysed to 
remove ADP and a rubisco-RuBP interaction (although 
not quite as extensive) was still observed with the 
absence of ADP.  
Previous work indicated rubisco activase was unable to 
reactivate rubisco that had been inhibited with CABP, 
despite the similarity in their structures.157 Figure 3.22 
shows a comparison of RuBP and CABP. To test whether the rubisco activase-RuBP interaction 
observed in Figure 3.20 could have biological relevance in the activation mechanism, or is the 
result of non-specific binding either in solution or in the ionisation source of the mass 
spectrometer, the interaction between rubisco activase and CABP was investigated. Aliquots of 
CABP were added to rubisco activase in the presence and absence of ADP and no interaction was 
observed using nanoESI-MS (spectra not shown). Given the similarity in structures of RuBP and 
CABP, this result indicates that rubisco activase exhibits specificity, and supports that the observed 
rubisco activase-RuBP interaction is real and may have significance in the rubisco activation 
mechanism.  
 
3.2.4 Molecular mass of subunits of rubisco 
Rubisco is an enzyme of ~530-560 kDa consisting of eight identical large subunits (molecular mass 
51-58 kDa) and eight identical small subunits (molecular mass 12-18 kDa) (L8S8),
138 arranged as 
four large subunit dimers joined at either end by four small subunits140 (shown above in Figure 
3.3). The masses for these subunits are approximate, since the small subunit is coded by multiple 
A 
B 
Figure 3.22. The chemical structure of 
sugar phosphates in open chain form. 
A. RuBP. B. CABP. 
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copies of the RbcS genes in the nucleus resulting in variations in the peptide sequence, and both 
the small and large subunits undergo post-translational modifications.204,205  
To confirm the mass of the hexadecameric enzyme, the accurate masses of the small and large 
subunits were determined. During preliminary work undertaken in Honours, a sample of rubisco 
was dialysed against 500 mM NH4OAc, pH 7.2, then treated with acetic acid prior to nanoESI-MS 
analysis. A molecular mass of 14,532 ± 0.2 Da was obtained, consistent with the mass of the small 
subunit of rubisco.138 There were no ions in the spectrum corresponding to the large subunit (not 
shown). This is consistent with previous work where mild acetic acid treatment precipitated the 
large subunit.206 Attempts were subsequently made to solubilise the large subunit to enable 
accurate mass determination. A variety of solution conditions were trialled including additions of 
formic acid, isopropanol, acetonitrile, urea and different combinations of these. In all spectra only 
the small subunit was observed.  
In the current PhD project, the mass of the large subunit was determined by treating a sample of 
rubisco with 6 M guanidine hydrochloride followed by dialysis against 0.1% formic acid. When 
rubisco treated in this way was analysed by nanoESI-MS in the presence of 10 mM NH4OAc 
(0.009% formic acid in final solution), ions corresponding to the small subunit and large subunit 
were observed, as shown in Figure 3.23. The ion of highest abundance in the spectrum is [M+6H]6+ 
at m/z 2430, corresponding to the small subunit with a mass 14,532 ± 0.2 Da. A distribution of ions 
with two maxima at m/z 2917 and 3751 corresponding to the [M+18H]18+ and [M+14H]14+ ions of 
the large subunit was also observed, giving a mass of 52,504 ± 1.9 Da. The accurate masses 
obtained from this spectrum are consistent with the approximate masses reported previously.138 
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Figure 3.23. Positive ion nanoESI mass spectrum of rubisco treated with 6 M guanidine hydrochloride and 
dialysed against 0.1% formic acid. Ions corresponding to the small subunit are labelled as SSU and the large 
subunit are LSU. Ions of low abundance to lower m/z of the LSU ions are most likely the result of a small 
amount of proteolysed protein. 
 
From these subunit masses, the accurate mass for the hexadecameric rubisco was calculated as 
536,288 Da. NanoESI-MS of rubisco dialysed against 100 mM NH4OAc, pH 7.2, was then performed 
to obtain a spectrum of the intact hexadecameric enzyme (shown below in Figure 3.24). This is the 
first ESI mass spectrum of this enzyme.  
 
Figure 3.24. Positive ion nanoESI mass spectrum of intact, hexadecameric rubisco dialysed against 100 mM 
NH4OAc, pH 7.2. The dotted lines show the m/z for the [M+52H]
52+
 to [M+49H]
49+
 ions calculated from the 
masses determined from the large and small subunits. 
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The peaks in this spectrum are quite broad, which leads to considerable error when calculating the 
mass of the protein. There are several reasons for peak broadness in ESI-MS. First, a large 
molecule made up of many atoms will have significant contributions from isotopes. Second, the 
protein structure is thought to retain bound water and possible small cations and anions.43,194 The 
masses obtained by nanoESI-MS are, however, more accurate than other methods such as size 
exclusion chromatography or analytical ultracentrifugation. Taking this into consideration, the 
rubisco has remained intact during ionisation and mass analysis. Using the mass calculated from 
those obtained for the small and large subunits (Figure 3.23), the ions expected for the 
[M+52H]52+, [M+51H]51+, [M+50H]50+ and [M+49H]49+, are 10,314, 10,516, 10,726 and 10,945, 
respectively. These values are shown by the dotted lines on the spectrum. Since the inclusion of 
water and small cations/anions, and contributions from isotopes will increase the observed m/z, 
the calculated m/z (dotted lines) will be expected to be found at the beginning of the observed 
peak for each ion. 
 
3.2.5 Fidelity of dialysed rubisco 
It is possible that treatment of rubisco by dialysis against NH4OAc can cause changes in protein 
conformation and/or loss of activity. To assess the fidelity of the rubisco samples prepared for MS 
analysis, a number of tests were performed. First, a CD spectrum of rubisco dialysed against 500 
mM NH4OAc, pH 7.2, was compared with that of rubisco which underwent no treatment (Figure 
3.25). Changes in secondary structure may be indicative of denaturation of the protein. 
From the CD spectrum, the native rubisco (blue line) gives a spectrum that is characteristic of a 
mostly -helical secondary structure, and rubisco that has undergone dialysis (pink line) is almost 
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identical. From this, it appears that dialysis has not adversely affected the secondary structure of 
rubisco. 
 
Figure 3.25. CD spectra of rubisco following different treatment conditions. The blue line represents rubisco 
that had undergone no dialysis and made up with 100 mM NH4OAc. The pink line represents rubisco that 
was dialysed against 500 mM NH4OAc. 
 
A rubisco/RuBP assay (section 2.2.3) was also performed to determine if any activity had been lost 
following dialysis. The rubisco/RuBP assay involves the coupling of 3-phosphoglycerate production 
(the product of the reaction of CO2 and RuBP that is catalysed by rubisco) to the oxidation of 
NADH and measured spectrophotometrically. The calculated specific activities showed that the 
dialysed rubisco had 4-fold less activity than native rubisco. From these results, it is apparent that 
dialysis against NH4OAc to prepare rubisco for ESI-MS analysis has resulted in a somewhat lower 
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activity. Since some activity remained, experiments were carried out to attempt to observe a 
rubisco-rubisco-activase complex. 
 
3.2.6 Rubisco-rubisco activase complex 
Preliminary attempts were made to prepare a rubisco-rubisco activase complex during the 
Honours year. The two proteins were mixed in 500 mM NH4OAc solution. The resulting nanoESI 
mass spectrum showed peaks corresponding to rubisco and rubisco activase; no complex was 
observed. In the current PhD project, factors that may affect the stability of this complex were 
taken into further consideration. 
The first point to consider is the function of rubisco activase. This protein works to activate 
inactivated (non-carbamylated) rubisco, which is trapped as a non-catalytic sugar phosphate (e.g. 
RuBP) complex. It is possible that some (or all) of the large subunits of rubisco may have CO2 
bound as carbamate to a lysine residue. This might affect the ability of rubisco activase to bind to 
rubisco. Therefore, CO2 bound to rubisco needs to be removed (giving the inactive form), and an 
inactivated rubisco in complex with RuBP prepared. 
Carbon dioxide-free, Mg2+-free rubisco was prepared as described in section 2.2.1, p36. In 
preliminary experiments carried out in an attempt to preserve this complex, samples of rubisco 
were dialysed against high concentrations of NH4OAc (500 mM). While high quality spectra were 
obtained, attempts to observe RuBP bound to inactive rubisco by nanoESI-MS under these 
conditions were not successful. Since high ionic strength might dissociate noncovalent 
interactions, a lower concentration of NH4OAc was used. This rubisco sample and a separate 
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sample that was dialysed against 100 mM NH4OAc, pH 7.2 in the presence of air (containing CO2) 
and the absence of RuBP were compared by nanoESI-MS (Figure 3.26).  
 
Figure 3.26. Positive ion nanoESI mass spectra of rubisco. A. Rubisco control B. CO2-free, Mg
2+ free rubisco 
treated with RuBP. The region of the spectrum showing the [M+51H]51+ ion is expanded. 
 
The peaks in the above spectra are broad (for the reasons discussed above) which can lead to 
difficulty in determining the accurate mass of the large protein complex present. There is a shift in 
the observed m/z when rubisco was treated to remove CO2 and RuBP added. In the absence of 
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RuBP (Figure 3.26A), the nanoESI mass spectrum showed an envelope of ions ranging from 
[M+53H]53+ to [M+48H]48+. The most abundant ion starting from m/z 10,516 is indicative of the 
[M+51H]51+ ion of the rubisco hexadecamer corresponding to a mass of ~536,265 Da. When Mg2+-
free, CO2-free rubisco was treated with RuBP (Figure 3.26B), the ion starting from m/z 10,565 
corresponds to rubisco with eight molecules of RuBP bound since the difference in mass is 
approximately 2480 Da (8 x 310 = 2480). The ability of rubisco to bind RuBP supports that the CO2 
removal has been successful. It is also apparent that there has been a shift in the charge state 
distribution upon RuBP binding. For example, when RuBP was present (Figure 3.26B) the 
[M+50H]50+ ion was the most abundant. A change in the charge state distribution supports a 
conformational change on RuBP binding144 (see section 3.1.2), consistent with the formation of a 
rubisco-(RuBP)8 complex in the closed state. 
 A sample of rubisco activase was prepared (no attempt to remove ADP, section 2.2.1 p34) and 
added to the rubisco-RuBP complex. The resulting nanoESI-mass spectrum is shown in Figure 3.27. 
 
Figure 3.27. Positive ion nanoESI mass spectrum of the rubisco-RuBP complex following addition of rubisco 
activase in 100 mM NH4OAc. The ions corresponding to rubisco activase are labelled as RA and the ions 
corresponding to rubisco labelled as Rubisco. 
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In the spectrum above, ions in the m/z range of 2000-6000 correspond to rubisco activase and 
those > m/z 10,000 correspond to rubisco. While no intact complex of rubisco activase-rubisco-
RuBP was observed, there was evidence to indicate an interaction had occurred. Closer inspection 
of the m/z peaks of the rubisco region shows a slight shift. This is shown in Figure 3.28, where the 
region of the spectrum > m/z 10,000 is shown in more detail. 
 
Figure 3.28. Positive ion nanoESI mass spectra of the m/z > 10,000 region of Figure 3.26 following addition 
of rubisco activase. A. The rubisco-RuBP with addition of rubisco activase. B. The rubisco-RuBP complex as a 
control. 
 
Comparison of the rubisco peaks upon addition of rubisco activase (spectrum A) to those of the 
rubisco-RuBP complex (spectrum B, from Figure 3.26B) suggests that RuBP is no longer bound to 
rubisco. The [M+51H]51+ ion of the rubisco-RuBP complex (spectrum B) is at m/z 10,565, while the 
same ion for rubisco upon addition of rubisco activase is at m/z 10,516, which corresponds to the 
mass of the rubisco hexadecamer alone. Closer inspection of the rubisco activase m/z region of 
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Figure 3.27 also shows some differences when compared to a spectrum of rubisco activase alone 
(Figure 3.29). 
 
Figure 3.29. Positive ion nanoESI mass spectrum of rubisco activase upon addition to rubisco-RuBP. A. 
Rubisco activase following addition to the rubisco-RuBP sample (from Figure 3.27). B. Rubisco activase alone 
as a control (from Figure 3.9B). The oligomeric species that each ion corresponds to is indicated by the 
numbers 1-6. 
 
It is apparent when rubisco activase was added to the rubisco-RuBP sample (spectrum A) that the 
resulting rubisco activase peaks were much broader than when a sample of rubisco activase is 
acquired alone (spectrum B).  This may be indicative of RuBP binding to the rubisco activase, but 
upon closer inspection the peaks are too broad to be able to determine this with certainty. 
Furthermore, RuBP was present in the mixture in excess, so it is not possible to determine the 
origin of any RuBP that might be bound to rubisco activase using this approach.   
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Rubisco activase is a known ATPase, and this activity is important to its ability to activate rubisco. 
In the above experiment, the rubisco activase sample that was added to rubisco-RuBP contained 
bound ADP (~50:50 free rubisco activase: rubisco activase-ADP). In the above experiment, it 
appears that RuBP has been successfully removed from rubisco implying that concurrent ATP 
hydrolysis was not necessary for removal of RuBP. This is consistent with a role of binding and 
hydrolysis of ATP by rubisco activase in oligomerisation of the activase and once in a higher 
oligomeric form, this is sufficient for rubisco activation.  
The presence of ATP (or the non-hydrolysable analogues, AMP-PNP or ATP S) may be important 
for observing the interaction between rubisco and rubisco activase. To investigate this further, 
samples were prepared in which ATP-Mg, AMP-PNP and ATP S were separately added to rubisco 
activase prior to addition of rubisco-RuBP. The nanoESI-mass spectra obtained were similar to that 
in Figure 3.28. The details for the preparation of these samples are described in section 2.2.1, p37. 
It is also proposed that rubisco activase has to be in the ATP-bound form (not ADP-bound form) to 
activate rubisco, since ADP has been shown to inhibit the activities of rubisco activase.207 In order 
to test this, a sample of rubisco activase was treated to remove bound ADP (using the method 
described above). This sample was then added to rubisco-RuBP in the presence or absence of ATP-
Mg, AMP-PNP and ATP S. The nanoESI-mass spectra are shown in Figure 3.30. 
These spectra show the m/z region (10,500-10,700) corresponding to the [M+51H]51+ ion of 
rubisco. Spectrum A shows rubisco that has undergone decarbamylation followed by addition of 
RuBP, to give the inactive rubisco-RuBP complex. The beginning of the peak is around m/z 10,575, 
which is consistent with the calculated m/z of rubisco with eight RuBP molecules bound (m/z 
10,565).  Spectrum B shows the rubisco-RuBP sample upon addition of rubisco activase (with 
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removed ADP) and ATP-Mg. The beginning of the peak is observed at around m/z 10,520, which is 
consistent with the calculated m/z for the rubisco hexadecamer with no RuBP bound (m/z 10,516). 
 
Figure 3.30. Positive ion nanoESI mass spectra showed only the [M+51H]51+ ion demonstrating the apparent 
rubisco activase-induced removal of RuBP from rubisco. A. The rubisco-RuBP complex. B. The rubisco-RuBP 
sample following addition of rubisco activase and ATP-Mg. C. The rubisco-RuBP sample following addition of 
rubisco activase with no nucleotides added. Refer to section 2.2.1, p37 for details of preparation. 
 
Spectrum C is the rubisco-RuBP sample upon addition of rubisco activase (with removed ADP) with 
no addition of nucleotides. The beginning of the peak is again at around m/z 10,520, consistent 
with the rubisco hexadecamer.  When the non-hydrolysable ATP analogues AMP-PNP or ATP S 
were added, the resulting spectra (not shown) were identical to when ATP-Mg was added (as 
shown in spectrum B). The spectra indicate that when rubisco activase is added to the rubisco-
RuBP complex, in the presence or absence of added nucleotides, the RuBP was shown to no longer 
bind to rubisco. This may indicate that the ATPase activity may not be directly essential for rubisco 
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activation. However the rubisco activase sample showed an ion of low abundance corresponding 
to bound ADP (~50 % of the total rubisco activase) indicating the ADP was not fully removed in this 
experiment. This brings some uncertainty to the results described above, since the small amount 
of ADP present in the sample may have an effect on the removal of RuBP.  
Unlike RuBP, the inhibitor CABP is different in that it binds to carbamylated rubisco, not 
decarbamylated rubisco. It is thought that rubisco activase is unable to reactivate the inactive 
rubisco-CABP complex.157 To prepare a complex of rubisco-CABP, the rubisco does not need to be 
treated to remove CO2; instead, it was dialysed against 100 mM NH4OAc, pH 7.2, prior to addition 
of CABP. The nanoESI mass spectrum of the rubisco-CABP complex is shown in Figure 3.31. 
 
Figure 3.31. Positive ion nanoESI mass spectra of rubisco treated with CABP. A. Rubisco control. B. Rubisco 
following addition of CABP. The region of the spectrum showing the [M+51H]51+ charge state is expanded. 
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The most abundant ion for each spectrum corresponds to [M+51H]51+. For rubisco alone (spectrum 
A), this is observed at m/z 10,516, while for the rubisco-CABP spectrum this is at m/z 10,568. This 
is consistent with the binding of eight CABP molecules to rubisco (calculated mass difference of 
2848 Da). As was observed for the rubisco-RuBP complex (Figure 3.26B), a slight shift in the charge 
state distribution is also apparent upon formation of a complex with CABP.  
Next, an aliquot of rubisco activase (with ADP still bound; ~50% of the total rubisco activase) was 
added to a sample of rubisco-CABP to determine if the rubisco activase is able to remove CABP 
from the rubisco, or if a rubisco-rubisco activase complex can be observed. The resulting spectrum 
is shown below in Figure 3.32. 
 
Figure 3.32. Positive ion nanoESI mass spectrum of the rubisco-CABP complex following addition of rubisco 
activase. A. Rubisco-CABP treated with rubisco activase (ADP bound) B. Rubisco-CABP complex. 
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Comparison of the rubisco-CABP sample with added rubisco activase to the spectrum of rubisco-
CABP alone indicates that CABP is still bound to rubisco. This result clearly differs from that 
observed with RuBP. To determine if exogenous nucleotides are required to remove CABP from 
rubisco, aliquots of ATP-Mg, AMP-PNP or ATP S were added to separate rubisco-CABP samples 
(giving a final nucleotide concentration of 100 M) with rubisco activase that had undergone 
treatment to remove bound ADP. The resulting spectra (not shown) were identical to those in 
Figure 3.32. Thus, the addition of nucleotide did not effect the removal of CABP from rubisco.  
This result is expected, as it has been suggested previously that rubisco activase could not remove 
CABP bound to rubisco.157 This also supports the result of the previous experiment where rubisco 
activase was able to remove RuBP from the inactive rubisco-RuBP complex. Since in this case CABP 
was not removed, the results of the previous experiment were unlikely to be a result of 
dissociation of the complex due to instrument conditions used in the mass spectrometer or 
solution conditions used in the preparation of the samples.  
 
3.2.7 Rubisco activase mutants 
Previous work has suggested that certain residues in the Sensor 2 domain of rubisco activase are 
important for rubisco substrate recognition.175 A comparison of the sequence of the Sensor 2 
domains for a variety of Solanaceae and non-Solanaceae plants showed that residue 311 was a 
conserved Asp for Solanaceae plants and Lys for non-Solanaceae plants. Residue 314 was Lys for 
Solanaceae plants and Val for non-Solanaceae plants175 (see Figure 3.7). Several rubisco activase 
mutants were prepared and rubisco activation assays performed with rubisco from either tobacco 
(Solanaceae) or spinach (non-Solanaceae). The D311K mutant of tobacco rubisco activase was 
shown to activate both spinach and tobacco rubisco, while wild-type tobacco rubisco activase was 
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unable to activate spinach rubisco. Tobacco rubisco activase with a L314V mutation showed the 
same preference for activating spinach and tobacco rubisco as wild-type tobacco rubisco activase, 
but tobacco rubisco activase with a double mutation (D311K/L314V) activated spinach rubisco but 
had reduced ability to activate tobacco rubisco.175 It was proposed that these two residues in the 
Sensor 2 domain of rubisco activase appear to work in combination to determine the species 
specificity of activase, and may be important in a direct interaction with rubisco during 
activation.175 ATPase assays of these mutants showed that the L314V mutant had reduced ATPase 
activity.175 
The rubisco activase mutants, D311K and L314V (hereafter referred to as RA1 and RA2, 
respectively) were provided by Assoc. Prof. Spencer Whitney’s group at ANU to compare the 
nucleotide and rubisco interactions of these mutants with wild-type using ESI-MS. The accurate 
masses of each of the mutants were first determined by nanoESI-MS following addition of acetic 
acid. The masses of RA1 and RA2 were 42,772 and 42,746 Da, respectively, which corresponds well 
with the mutations of the amino acid sequence, within experimental error. NanoESI mass spectra 
of the rubisco activase mutants were also obtained under native conditions and they were found 
to be almost identical to the spectrum of wild-type rubisco activase.  
 
3.2.7.1 Interactions of rubisco activase mutants with nucleotides 
The rubisco activase mutant RA2 has been shown to have reduced ATPase activity.175 To compare 
the interaction of this mutant and RA1 with wild-type rubisco activase, a variety of nucleotides 
were added to samples of RA1 and RA2 prior to nanoESI-MS analysis. RA1 and RA2 were dialysed 
to remove ADP and aliquots of ADP, ATP S, AMP-PNP and ATP-Mg were added to a final 
concentration of 100 M. The resulting spectra are shown in Figure 3.33. 
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Figure 3.33. Positive ion nanoESI mass spectra of the monomer of the rubisco activase mutants following the addition of different nucleotides. A. Free RA2 B. 
RA2 + ADP C. RA2 + ATP S D. RA2 + AMP-PNP E. RA2 + ATP-Mg F. Free RA1 G. RA1 + ADP H. RA1 + ATP S I. RA1 + AMP-PNP J. RA1 + ATP-Mg. M represents the 
rubisco activase monomer for each of the mutants and binding of nucleotides is as indicated. The final concentration of nucleotide in each sample was 100 M.
RA2 RA1 
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The first thing to note in these spectra is that the treatment to remove ADP has not been 
completely successful. While it removed most of the bound ADP, a very small peak corresponding 
to rubisco activase with one ADP molecule is still present (see Figure 3.33A and 3.33F). However, it 
is still possible to observe the interaction with other nucleotides. The most notable difference 
between the RA2 mutant and wild-type rubisco activase was when ATP-Mg (Figure 3.33E) and ADP 
(Figure 3.33B) were added. For the RA2 mutant with ATP-Mg, the most abundant peak is the free 
rubisco activase monomer at m/z 3563, with small peaks corresponding to monomer+ADP and 
monomer+ATP at m/z 3598 and 3606, respectively. This is in contrast with wild-type rubisco 
activase (see Figure 3.16), where the monomer+ADP was the most abundant peak, and there was 
a small peak corresponding to monomer+ADP+ATP. This indicates the RA2 mutant has not 
hydrolysed the added ATP to ADP to the same extent as wild-type. A similar spectrum was 
observed when ADP was added suggesting ADP binds less tightly to RA2. The RA2 mutant shows 
free rubisco activase monomer as the most abundant peak, whereas wild-type rubisco activase 
shows monomer+ADP as most abundant. These results are consistent with the RA2 mutant being 
deficient in ATPase activity, and that nucleotides do not bind as tightly to the first binding site. 
Recently, ATPase activity assays of the rubisco activase mutants (RA1 and RA2) have been carried 
out in Assoc. Prof. Spencer Whitney’s laboratory at ANU. The activity of RA1 was similar to wild-
type rubisco activase, but the activity of RA2 was almost half the rate of wild-type. These assay 
results correspond well with the MS results presented here. Note that RA1 binds ADP (Figure 
3.33G) and hydrolyses ATP-Mg (Figure 3.33J). 
The interaction of the rubisco activase mutants with rubisco was then compared. A sample of 
decarbamylated rubisco in a complex with RuBP was prepared as described previously. Samples of 
RA1 and RA2 were then added to the rubisco-RuBP and nanoESI mass spectra obtained. As for the 
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wild-type rubisco activase, no rubisco-rubisco activase complex was observed, but RuBP was no 
longer bound to the rubisco. This is consistent with recent findings in the laboratory of our 
collaborators (Milward and Whitney, unpublished) where RA1 and RA2 activated the inactivated 
rubisco-RuBP complex to the same extent as wild-type rubisco activase.  Since the RA2 mutant has 
reduced ATPase activity, its ability to cause the RuBP to be removed from rubisco is further 
support that the ATPase activity of rubisco activase may not be essential for rubisco activation, or 
at least for removal of RuBP.  
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Part Two: Rubisco in the archaeabacteria 
3.3 Introduction 
3.3.1 The role of rubisco in the archaeabacteria 
The major pathway of CO2 fixation in plants in terrestrial and marine environments is the Calvin-
Benson-Bassham (CBB) or reductive pentose phosphate pathway.132,208  Two enzymes that are 
essential to this pathway are rubisco and phosphoribulokinase (PRK). Rubisco can be classed into 
different forms based on kinetic parameters and structure.209 Rubisco as described in Part One of 
this chapter belongs to the Type I rubiscos, which are found in all higher plants, cyanobacteria and 
most eukaryotic algae.209 Their structure is hexadecameric comprising four large (L) subunit dimers 
arranged around a four-fold axis and eight small subunits that cap both ends of the (L2)4 core. The 
Type II rubiscos are found as a dimer of large subunits (L2) with no small subunits
209 and are 
generally found in some photosynthetic proteobacteria, chemoautotrophic bacteria and 
dinoflagellate algae.132,209 Genome sequencing projects unexpectedly uncovered genes encoding 
rubisco in several organisms of the Archaea.210 This was designated as a new form of rubisco, 
called Type III. Type III rubiscos have been found to exist as either large subunit dimers (as judged 
by gel filtration)208 or as a ring-like structure made up of five large subunit dimers211 (shown in 
Figure 3.34). A tetramer of dimers has also been observed in the Pyrococcus horikoshi protein.212 
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Figure 3.34. X-ray crystal structure of rubisco from Thermococcus kodakaraensis showing L10 organisation. 
Each monomer labelled from A-J is shown in different colours. Possible locations of RuBP and magnesium 
ions are marked in ellipses. Taken from Kitano et al. 2001.211 
 
An interesting discovery about Archaeal organisms was that they do not contain the gene for PRK. 
PRK is required to synthesise RuBP, which is the substrate for the reaction catalysed by rubisco 
(and the CO2 receptor in the CBB pathway).
132,209 A functional CBB pathway has not been identified 
in the Archaea213 and this lack of PRK activity led to the questioning of rubisco function in these 
organisms.209 A study that was aimed at investigating the possible functions for Type III rubisco 
identified genes from various archaeal organisms that encode AMP phosphorylase and ribose-1,5-
bisphosphate isomerase. These enzymes are involved in the production of RuBP from AMP and 
phosphate, thus providing an alternate mechanism for RuBP synthesis. The reaction213 is outlined 
in scheme 3.1.  
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Scheme 3.1. Alternate mechanism for RuBP synthesis from AMP and phosphate, leading to reaction 
catalysed by rubisco. 
 
Although the amino acid sequence and subunit composition of all rubiscos are different, the 
overall fold of the core L2 units is similar
212 and specific residues that are essential for catalysis are 
also conserved.208 As discussed in Part One, section 3.1.2, the rubisco active site requires 
carbamylation of a lysine residue by non-substrate CO2 and stabilisation by a Mg
2+ ion (Figure 3.4). 
RuBP is then able to bind the rubisco active site.  
Organisms classified as archaea have been found living in some of the most extreme environments 
on Earth.214 The extremophilic nature of these organisms has led to studies aimed at 
understanding the physiological adaptations to living under extreme conditions. Of particular 
interest are the enzymes of these organisms, which are able to remain catalytically active under 
extremes of temperature, salinity, pH and other solvent conditions.214 Table 3.1 outlines some of 
the various extremophilic phenotypes of archaea. 
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Table 3.1. Different extremophilic phentoypes of archaea.
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Phenotype Optimum Environment 
Thermophiles Grow optimally at 55-80 °C 
Hyperthermophiles Grow optimally at 80-110 °C 
Psychrophiles Require temperatures <20 °C for growth 
Halophiles Grow optimally in salt concentrations approaching saturation 
Methanogens Strict anaerobes that generate energy through the reduction of C-1 and C-2 
compounds to CH4 
Acidophiles Grow at pH values <4 
Alkaliphiles Grow at pH values >9 
Barophiles Grow optimally at pressures up to 50 Mpa 
 
The genome of the anoxic archaeabacterium Methanococcoides burtonii has recently been 
sequenced. M. burtonii was isolated from Ace Lake in Antarctica120 and thus classified as 
psychrophilic (i.e. cold-adapted). Since M. burtonii is an anaerobic methanogenic archaeon it 
might be assumed that its rubisco would function in a similar way to other Type III rubiscos.215 
Surprisingly, the predicted protein sequence of M. burtonii rubisco shows more sequence identity 
with Type II rubisco.215 This contrasting evidence has led to studies aimed at the further 
classification of M. burtonii rubisco.  
 
3.4 Results and discussion 
The first step in the characterisation of M. burtonii rubisco and its oligomeric forms was the 
determination of the monomeric subunit mass. A sample of rubisco was first dialysed against 10 
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mM NH4OAc. Prior to nanoESI-MS analysis, the rubisco was denatured by addition of 5% (v/v) 
formic acid and the resulting spectrum is shown in Figure 3.35. 
  
Figure 3.35. Positive ion nanoESI mass spectrum of M. burtonii rubisco dialysed against 10 mM NH4OAc and 
with formic acid added to 5% (v/v).  
 
The molecular mass calculated from this spectrum was 52,857 Da which corresponds well with the 
predicted mass of 52,856.5 Da. The most abundant ion in the spectrum is at m/z 3524 
corresponding to the [M+15H]15+ ion of the rubisco “large subunit” monomer.  
The crystal structure of the hyperthermophilic archaeon T. kodakaraensis has previously been 
solved.211 It was shown to assemble as a pentamer of dimers (overall L10 structure, as shown in 
Figure 3.34), while other archaeal species have been shown by gel filtration chromatography to 
occur only as dimers208. To determine the oligomeric assembly of M. burtonii rubisco, a nanoESI 
mass spectrum of a sample at pH 6.8 was acquired (Figure 3.36). 
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Figure 3.36. Positive ion nanoESI mass spectrum of M. burtonii rubisco in 100 mM NH4OAc, pH 6.8. 
 
The nanoESI mass spectrum of rubisco dialysed against 10 mM NH4OAc and analysed in 100 mM 
NH4OAc, pH 6.8 is shown above. The most abundant ion in the spectrum was at m/z 5565 
corresponding to the [M+19H]19+ ion of an assembly with a molecular mass of 105,714 Da, which is 
consistent with the mass of the dimer, L2. A mass corresponding to a dimer was also observed 
using non-denaturing polyacrylamide gel electrophoresis (PAGE) analysis carried out by our 
collaborators (Alonso and Whitney) from the Research School of Biology at ANU (not shown).  
 
3.4.1 Substrate-induced assembly of M. burtonii rubisco 
When M. burtonii rubisco was purified from RuBP-expressing E. coli cells, a higher molecular 
weight complex, possibly L10, was observed on non-denaturing polyacrylamide gels (Alonso and 
Whitney). Type II rubisco from the bacterium Rhodospirillum rubrum has been shown previously to 
require the action of the E. coli chaperonin GroEL (with its co-chaperonin GroES) to assemble into 
its functional dimeric structure.216 To confirm the possible assembly to decamers without the 
presence of chaperones as suggested by the electrophoresis experiment, a sample of M. burtonii 
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rubisco was treated with RuBP and analysed at different times after the addition of RuBP by non-
denaturing PAGE (Alonso and Whitney120). The gradual appearance of larger molecular weight 
products was observed over time, along with a decrease in the amount of L2, as shown in Figure 
3.37A. 
 
Figure 3.37. Non-denaturing PAGE of rubisco complexes. Induced assembly of CO2-Mg
2+ activated rubisco L2 
units into L4, L6 and L10 over time by A. 1 mM RuBP and B. 1 mM CABP. Carried out by Dr. Hernán Alonso at 
ANU, Canberra. Taken from Alonso et al. 2020.120 
 
The gels suggested that oligomerisation of L2 rubisco into tetramers (L4), hexamers (L6) and 
decamers (L10) was triggered by binding of RuBP most likely as a result of conformational changes. 
To confirm this, a sample of M. burtonii rubisco was incubated on ice with 100 M RuBP for 30 
minutes following dialysis against 10 mM NH4OAc, and analysed using nanoESI-MS. The resulting 
spectrum is shown in Figure 3.38. 
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Figure 3.38. Positive ion nanoESI mass spectrum of M. burtonii rubisco treated with 100 M RuBP for 30 
minutes. 
 
Ions corresponding to a range of different oligomeric forms are apparent in the above spectrum. 
This is in stark contrast to the spectrum of M. burtonii rubisco in the absence of RuBP (Figure 
3.36). The ions of highest abundance at m/z 5602 and 10,650 correspond to the [M+19H]19+ ion of 
L2, and the [M+50H]
50+ ion of L10, respectively. Less abundant ions are observed in the m/z range 
7000-10,000 which correspond to L4 and L6. This confirms the PAGE results (Figure 3.37). Upon 
closer inspection of each ion, the binding of RuBP to each of the oligomeric forms was evident. For 
example, Figure 3.39 shows the expanded region, m/z 10,500-11,300, showing the L10 form of 
rubisco. The expected m/z of the [M+50H]50+ ion of L10 alone was calculated as 10,572. If ten RuBP 
molecules were bound to L10 (i.e., one RuBP molecule per subunit) the calculated m/z for this ion is 
10,634. In the spectrum, the peaks are broad, but ions can be assigned from the lower m/z side of 
the peaks. 
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Figure 3.39. Positive ion nanoESI mass spectrum of the L10 m/z region 10,500-11,300 of M. burtonii rubisco 
treated with 100 M RuBP. The dotted lines show the m/z expected if ten RuBP molecules are bound per 
decamer, L10. 
 
Closer inspection of ions corresponding to the other forms (L2, L4, L6) suggest the binding of two, 
four and six RuBP molecules respectively. These results are consistent with the assembly of L10 via 
intermediary L4 and L6 forms. It is possible that some L4 and L6 may have arisen as a result of 
dissociation of L10 in the mass spectrometer, but the observation of these forms also using PAGE 
suggests that this is not likely. 
The behaviour of M. burtonii rubisco upon treatment with the rubisco inhibitor CABP was then 
investigated. CABP has a similar structure to RuBP (see Figure 3.22) and has been found to bind 
tightly to the active sites of rubiscos preventing catalysis.217 Non-denaturing PAGE analysis of 
rubisco treated with CABP and measured over time showed that the assembly of L2 into large 
oligomers was faster than when RuBP was used (see Figure 3.37B). A sample of M. burtonii rubisco 
was incubated on ice with 100 M CABP for 30 minutes following dialysis against 10 mM NH4OAc, 
and analysed using nanoESI-MS. The association of L2 into L10 was also observed (Figure 3.40). 
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Figure 3.40. Positive ion nanoESI mass spectrum of M. burtonii rubisco treated with 100 M CABP for 30 
minutes. 
 
The nanoESI mass spectrum of rubisco incubated with CABP is quite similar to when it was 
incubated with RuBP (compare with Figure 3.38). Ions corresponding to the L2, L4, L6 and L10 forms 
are present, with L2 and L10 being the most abundant. The binding of one CABP molecule per 
subunit was also observed for each form upon closer inspection. The spectra in Figure 3.41 show 
the expanded m/z region 5500-5800 corresponding to the [M+19H]19+ ion of the M. burtonii 
rubisco dimer for rubisco alone and in the presence of either RuBP or CABP. The peak in spectrum 
A has a m/z of 5565 which is consistent with the rubisco dimer alone. The peak in spectrum B is 
broader and shows a shift towards higher m/z to ~5590 which is consistent with the binding of two 
molecules of RuBP to the rubisco dimer. The broadness of this peak is possibly as the result of 
inclusion of salts and water or the presence of several species (e.g. rubisco alone, rubisco + 1RuBP) 
makes unequivocal assignments difficult.  The peak in spectrum C has a m/z of 5597 corresponding 
to the binding of two molecules of CABP to the rubisco dimer.  
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Figure 3.41. Positive ion nanoESI mass spectra of the [M+19H]
19+
 dimer ion of M. burtonii rubisco upon 
binding of 100 M RuBP or CABP. A. Rubisco with no added sugar phosphates. B. Rubisco with RuBP. C. 
Rubisco with CABP. 
 
 
An ion mobility mass spectrum of M. burtonii rubisco treated with 100 M CABP was acquired 
(Figure 3.42) to confirm the presence of the different oligomeric forms. Ion mobility mass 
spectrometry will be explained in more detail in Chapter 5. The driftscope image shows the 
various oligomeric forms L2, L4, L6 and L10 at different drift times confirming their assignments in 
the mass spectra. 
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Figure 3.42. Positive nanoESI-IM mass spectrum using a Synapt™ HDMS™ of M. burtonii rubisco treated with 
100 mM CABP. A. Driftscope image. B. Mass spectrum. 
 
 
The binding of Ca2+ or Co2+ instead of Mg2+ to the conserved active site of Type I and Type II 
rubiscos218 has been shown to inhibit rubisco activity.  Non-denaturing PAGE analysis of rubisco 
with Mg2+, Ca2+ or Co2+, and with and without incubation with CABP showed that the inhibitory 
metal ions alone stimulated the assembly of L2 into L10 (Figure 3.43). 
A 
B 
L10 
L6 
L4 
L2 
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Figure 3.43. Non-denaturing PAGE analysis of the influence of activation with Mg2+, Ca2+ or Co2+, with or 
without CABP on the assembly of L2 M. burtonii rubisco into L10 after 20 minutes at 25 °C. Carried out by Dr. 
Hernán Alonso at ANU, Canberra.120 
 
Samples of M. burtonii rubisco that were dialysed against 10 mM NH4OAc and treated with either 
100 M Mg2+, Ca2+ or Co2+ were also analysed by nanoESI-MS (Figure 3.44). The dominant species 
in all of the spectra is the L2 rubisco form. Less abundant ions from L4 and L10 are also present in all 
spectra. Treatment with Mg2+ results in only a small amount of oligomerisation to L10 (spectrum A). 
The oligomerisation of L2 into L10 was stimulated by Ca
2+ (spectrum C) and to a lesser extent Co2+ 
(spectrum D).  
The changes in oligomeric structure in M. burtonii rubisco induced upon binding RuBP or CABP are 
quite dramatic compared to the subtle conformational changes observed in other rubiscos. As 
described in Part One section 3.1.2, the binding of RuBP or CABP to Type I rubisco induces the 
closure of the mobile loop 6 and the C-terminal tail over the active site.144  
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Figure 3.44. Positive ion nanoESI mass spectra of M. burtonii rubisco incubated with different metal ions for 
30 minutes. A. Rubisco with no metals (from Figure 3.36). B. Rubisco + 100 M Mg2+. C. Rubisco + 100 M 
Ca
2+
. D. Rubisco + 100 M Co
2+
. 
 
The observation of the L10 complex suggests the M. burtonii rubisco may have a structure similar 
to that of T. kodakaraensis which has been solved previously (and was shown to have L10 
organisation).211 Figure 3.45 shows a comparison of the M. burtonii rubisco sequence with other 
rubisco large subunits. The residues in T. kodakaraensis that are involved in decamerisation are 
not conserved in M. burtonii, indicating that the dimer-dimer interface is not the same in the two 
proteins. According to this sequence comparison, M. burtonii rubisco contains a 30 amino acid 
insertion towards the C-terminus that is not observed in any of the other rubiscos (underlined in 
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Figure 3.45). The role of these residues and their possible influence on structure, function or 
oligomerisation has yet to be elucidated.  
 
Figure 3.45. Alignment of the M. burtonii rubisco (Mb) with the Type II Rhodobacter sphaeroides (Rs) and 
Rhodospirillum rubrum (Rr) enzymes, the archaea Archaeoglobus fulgidus (Af), Methanococcus Jannaschii 
(Mj) and Thermococcus kodakaraensis (Tk) rubiscos and the Type I tobacco (Nicotiana tabacum, Nt) rubisco 
large subunit. Completely conserved residues are shaded black. Taken from supplementary data from 
Alonso et al. 2010.
120
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Based on the results observed in this study (PAGE by Alonso and Whitney and mass spectrometry 
herein), a proposed mechanism for the L2 to L10 transition was proposed (Figure 3.46). 
 
Figure 3.46. Schematic of the proposed assembly process of L2 M. burtonii rubisco via possible L4 and L6 
intermediates into a pentameric ring. Taken from Alonso et al. 2010.120 
 
 
3.5 Summary and future directions 
NanoESI-MS was used to investigate the oligomeric forms of rubisco activase and rubisco, and 
their interactions with nucleotides and sugar phosphates. Under conditions optimised to maintain 
noncovalent interactions, a distribution of oligomeric forms of rubisco activase was observed. ADP 
was found to be tightly bound to each rubisco activase subunit, thus a method to remove the ADP 
involving dialysis against Tris buffer, 4 M in NaCl, was developed. Following ADP removal, the 
fidelity of the rubisco activase sample was assessed using activity assays and CD spectroscopy. 
While the activity was reduced, some activity was present indicating it was not completely 
denatured. 
Rubisco activase is a known ATPase, and the role of this activity in its mechanism of action during 
rubisco activation is not fully understood. The interaction of rubisco activase with nucleotides was 
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examined, and it was observed to bind ADP with greater affinity than AMP-PNP (an ATP analogue). 
The addition of ATP-Mg to nucleotide-free rubisco activase resulted in rubisco activase molecules 
with both an ADP and ATP molecule bound to the monomer. This indicated the possibility of a 
second nucleotide binding site, which may have implications for rubisco activase function. This is 
the first demonstration of a second nucleotide binding site. Furthermore, the binding of ADP to 
the first site potentiated binding of AMP-PNP at the second site.  
The interaction of rubisco activase with the rubisco inhibitor, RuBP, was also investigated. RuBP 
was shown to bind extensively to rubisco activase. Another rubisco inhibitor, CABP, was shown to 
not interact with rubisco activase indicating there may specificity for the rubisco activase-RuBP 
interaction which may also have functional implications for the rubisco activation mechanism. In 
order to confirm these observations our collaborators (Kane and Whitney, ANU) recently treated 
nucleotide-free rubisco activase with either [3H]-RuBP or [14C]-CABP. After gel filtration, no 
radioactivity remained bound to rubisco activase in either case. This suggests that the RuBP and 
CABP did not bind or were not tightly bound. The reason for the discrepancy between the 
nanoESI-MS results presented here (Figure 3.21) and the gel filtration experiment requires further 
investigation. It would be surprising if the rubisco activase-RuBP complex was a non-specific 
complex arising from interaction in the ionisation source of the mass spectrometer given the 
solution contained a high salt concentration (500 mM NH4OAc). The stability of the complex 
analysed from different solution conditions by nanoESI-MS may provide insight into its physical 
properties. For example, what is the effect of different NH4OAc concentrations and what is the 
effect of different organic solvents of different polarity (e.g. methanol, ethanol)?  
Since rubisco activase is an AAA+ protein and has conserved arginine residues found in the group 
of proteins, it will be useful in future experiments to prepare mutants at these residues and to 
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investigate the effect on ATP binding and ATPase activity. NanoESI-MS conditions have been 
developed in this work to interrogate nucleotide binding sites on rubisco activase and it will be 
interesting to determine whether systematic replacement of the arginine residues will interfere 
with binding at one or both sites. 
A method was developed to produce a CO2-free, Mg
2+-free inactive rubisco complex with bound 
inhibitor RuBP. Addition of rubisco activase (with and without nucleotides) to the inactive rubisco-
RuBP sample resulted in the removal of RuBP from rubisco, though no complex between rubisco 
and rubisco activase was observed. Interestingly, this occurred even without the addition of 
nucleotides. Experiments have since been carried out at ANU to investigate this further. An 
inactive rubisco-RuBP complex was tested for activity in an activation assay. The very slow rate of 
activation of the rubisco-RuBP complexes in assays without rubisco activase or ATP were the same 
as the assays containing the rubisco activase with ADP removed (and no nucleotide added). In 
contrast, the assays supplemented with ATP showed that rubisco activase could activate rubisco, 
confirming also that rubisco activase treated in this way was still active. These biochemical results 
are consistent with the current literature which supports that ATP is required for the activation 
process. The biochemical experiments do not directly comment on the nanoESI-MS results. This is 
because the nanoESI-MS results are consistent with removal of RuBP from rubisco but do not 
comment at all on the enzymatic activity of rubisco. It is possible that RuBP is removed (consistent 
with the MS data) but that a conformational change of rubisco activase (requiring ATP hydrolysis) 
and effecting a conformational change of rubisco is required for activation of enzymatic activity. 
Nevertheless, the nanoESI-MS results need to be treated with caution as the peaks corresponding 
to ions are broad making interpretation more difficult. Further, the loss of RuBP from rubisco 
observed here, even if real may be an artifact of the condition of the experiments (e.g. “non-
biological” behaviour in NH4OAc). 
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NanoESI-MS, with other complementary techniques, was found to be a valuable tool in the 
characterisation of rubisco from the archaeabacterium, M. burtonii. Addition of the substrates, 
RuBP or CABP, was found to induce assembly of the M. burtonii rubisco dimers into decamers. 
Similarly, the addition of divalent metal cofactors induced assembly to a decameric structure. 
These results have demonstrated that M. burtonii rubisco has catalytic and structural similarities 
with other archaeal rubiscos, although it has a closer sequence homology to bacterial Type II 
rubiscos. This conflict raises questions about how to best classify different enzyme forms in the 
rubisco superfamily. It will be interesting to investigate the effect that RuBP, CABP and metal ions 
may have on the oligomeric form of other Type III rubiscos that have been previously shown to 
favour an L2 structure.  
Determination of a crystal structure of the M. burtonii L10 rubisco will enable identification of 
residues involved in the dimer-dimer interaction and contribute towards elucidation of the 
assembly mechanism of L2 into the L10 complex, as well as to describe how the oligomerisation 
process might be promoted by conformational changes in the active site. 
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Chapter 4 
 
ESI-MS Investigations of Protein-Protein 
Interactions Involving the Polymerase 
Subunit ( ) and the Sliding Clamp ( 2) of 
DNA Polymerase III 
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4.1 Introduction 
4.1.1 E. coli DNA replication 
The genetic material of all organisms is contained in its DNA. Prior to cell division, the DNA in each 
cell must undergo replication. This process is carried out by a multi-component molecular machine 
called the replisome. DNA replication occurs in three stages: initiation, elongation and 
termination. Each stage involves many interactions between different proteins of the replisome 
and at times, DNA.219 Bacterial replication, in particular that of Escherichia coli, has been studied 
extensively and is the best understood. This is partly because the E. coli proteins have been over-
expressed via recombinant strategies and isolated in large quantities.219 The replisome has yet to 
be isolated as an intact complex in the quantities necessary for structural studies, but through the 
reassembly of individual components in vitro, details regarding the structure and mechanism are 
now known.219  
Replication is initiated at a specific sequence on the circular E. coli chromosome, called the origin 
(oriC).220 Two replication forks are produced that progress bidrectionally, with the assembly of a 
separate replisome at each fork. The initiator protein, DnaA, recognises oriC, 221 and this region of 
DNA is unwound in both directions, in a process driven by ATP hydrolysis. 
DnaA bound to DNA interacts with and loads the DnaB helicase from a complex with its loading 
partner, DnaC.222 The DnaB helicase uses the energy from ATP binding and hydrolysis to power the 
unwinding of double-stranded DNA (dsDNA).223 DnaB also does this by moving along the strands, 
extending the region of single-stranded DNA. Two molecules of the DnaB hexamer are loaded 
initially, and move in opposite directions on the strands. From this, two replication forks are 
formed. DnaB can then interact with the DnaG primase.224 DnaG is an RNA polymerase that 
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synthesises RNA primers on ssDNA; these primers recruit the DNA polymerase III holoenzyme (Pol 
III) to continue with the elongation phase of DNA replication.224-226 
During the elongation phase, DNA synthesis occurs at the two replication forks. New DNA can only 
be synthesised in one direction (5'→3'), and the two template single strands are arranged in an 
antiparallel fashion. The leading strand is synthesised continuously in pace with the replication 
fork, and the lagging strand is synthesised discontinuously in short fragments (called Okazaki 
fragments) in the direction opposite to fork movement.220 It is thought that the lagging strand 
forms a loop which allows a directional alignment with the leading strand during replication.227 
Figure 4.1 shows a schematic diagram of the proposed organisation of leading and lagging strand 
synthesis. 
 
Figure 4.1. Schematic diagram of leading and lagging strand synthesis. The leading strand is synthesised 
continuously, while the lagging strand is synthesised in a series of Okazaki fragments. It is thought that the 
lagging strand forms a loop to allow simultaneous synthesis of the two strands in the same direction 
(Reproduced from Pomerantz and O’Donnell 2007
228
). 
 
The lagging strand template that has been unwound by DnaB helicase but has yet to be replicated, 
interacts with ssDNA-binding protein (SSB). This interaction protects the ssDNA and prevents the 
formation of secondary structures (such as hairpin loops).229  
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Termination of DNA replication occurs when the two replication forks (progressing in opposite 
directions) arrive at a specific DNA sequence, called a Ter (termination) site. Each Ter site can 
tightly bind to a Tus protein, and this complex blocks the progression of the replication fork.60,230 
 
4.1.2 DNA polymerase III holoenzyme 
DNA Pol III is responsible for the synthesis of new DNA during the elongation phase of replication. 
It is a large multi-protein complex made up of ten different proteins designated by the Greek 
letters: ' and  .227 A schematic diagram showing a proposed assembly of the 
subunits is shown in Figure 4.2. The interaction of subunits shown here is based on functional 
studies and on X-ray crystallography of subassemblies of Pol III.219 Pol III can be separated into 
three functional subassemblies: the core, the sliding clamp and the clamp loader. The components 
and functions of these subassemblies are described below. 
 
Figure 4.2. Subunit assembly of the DNA polymerase III holoenzyme. This figure shows the known protein-
protein binding partners as at 2005. There is now evidence that the 2 sliding clamp also contacts the 
proofreading  subunit (see section 4.3). Reproduced from Schaeffer et al. 2005.
219
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4.1.2.1 The core polymerase ( ) 
The core is made up of the , , and  subunits, which form a stable 1:1:1 complex in vivo. The  
subunit interacts with the C-terminal domain of 231 and the N-terminal domain of  interacts with 
the  subunit.232 No interaction between  and  has been detected, indicating an overall - -  
arrangement.233 The polymerase activity of core is contained in the 1160-residue  subunit.234 The 
structure of a large fragment (residues 1-917) of  was solved in 2006.235 It is analogous to the 
cupped, right-handed structure of other polymerases, with the fingers, palm and thumb domains 
together comprising the catalytic core of the enzyme235 (Figure 4.3). The N-terminus contains a 
PHP (polymerase and histinidol-phosphatase) domain that has been shown to be involved in 
binding with .236 The C-terminal region is responsible for binding to  and , and predictions 
suggest that it contains an OB (oligonucleotide and oligosaccharide binding) fold. An OB fold was 
revealed in the full-length structure of the  subunit from Thermus aquaticus DNA polymerase 
III.237 
 
Figure 4.3. The crystal structure of the large fragment (1-917) of the E. coli DNA pol III  subunit. The palm, 
thumb and finger domains are labelled and catalytically active aspartic acid residues in the palm domain are 
shown as black spheres (Reproduced from Lamers et al. 2006
235
). 
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The  subunit is the proofreading 3'→5' exonuclease and contributes to the high fidelity of 
replication by excising mismatched residues.238 Furthermore, the interaction between  and  
appears to contribute to polymerase stability and enhanced proofreading activity of .239 The  
subunit is made up of two domains.231 The exonuclease active site is located in the N-terminal 
domain ( 186). This domain is also responsible for binding to , whereas the  binding site is 
contained in the C-terminal domain.240 The two domains are joined by a flexible linker region.241 
The exonuclease active site binds two divalent metal ions, essential for its activity.242 The precise 
function of the  subunit has yet to be elucidated. It forms a tight complex with 232 and a slight 
stimulation in the activity of  has been observed in the presence of .233 The three dimensional 
structure of 186 was determined by X-ray crystallography242 and  in a complex with 186 has 
been determined by multidimensional nuclear magnetic resonance (NMR) spectroscopy232 (Figure 
4.4); the structures of  and 186 in the complex show little differences compared to their 
corresponding free structures.232 
 
Figure 4.4. Ribbon representation of the  subunit in complex with 186 determined by NMR spectroscopy. 
186 is shown in grey and  is shown in colour (the amino and carboxy termini are shown in blue and red, 
respectively). The N- and C-termini of 186 are indicated. Reproduced from Keniry et al. 2006.
232
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4.1.2.2 The sliding clamp ( 2) 
The sliding clamp consists of two  subunits which form a stable, ring-shaped dimer. The clamp 
confers processivity to nucleotide addition by encircling dsDNA and binding the polymerase core, 
thus tethering it to DNA during synthesis.227,243,244 The crystal structure of the 2 clamp has been 
determined and is shown below in Figure 4.5. It forms a head-to-tail dimer with a central cavity 
lined by a series of -helices that is large enough to encircle dsDNA.245 The arrangement of the 
dimer to form a ring produces two structurally distinct faces, with the two C-termini extruding out 
from one face (Figure 4.5B). The high resolution crystal structure shows that water molecules are 
present in the central channel.123 The water lining the cavity enables the DNA to slide through 2 
as transient contacts are made. 
              
Figure 4.5. Crystal structure of the E. coli 2 sliding clamp. A. Front view of 2. B. Side view of 2 
demonstrating the two distinct faces. Generated using Pymol from PDB 1MMI.
123
 Water molecules that 
were present in the structure were omitted. 
 
The 2 clamp interacts with  from the polymerase (III) core as shown by a number of techniques, 
such as gel filtration chromatography and surface plasmon resonance (SPR).244,246 In fact, all DNA 
N-terminal 
face 
A B 
C-terminal 
face 
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polymerases from E. coli have been found to interact with the 2 clamp. These also include Pol I, 
Pol II, Pol IV and Pol V, which are involved in other processes such as DNA recombination and 
repair.247-253 This suggests that binding of the clamp by the different polymerases may be 
competitive and regulated, and the clamp may be utilised in succession by different proteins 
during DNA replication and repair processes.253 The interactions of the 2 clamp with other 
proteins will be discussed in more detail in section 4.1.3. 
 
4.1.2.3 The clamp loader 
The sliding clamp does not assemble itself around dsDNA; it requires the assistance of the clamp 
loader complex. This complex uses the binding and hydrolysis of ATP to open the sliding clamp and 
to close it around DNA.244 A general mechanism for clamp-loading has been determined from 
biochemical studies.254 A ‘minimal’ clamp loader complex consists of the , , and ' subunits 
( 3 ')
228 and has been shown to be sufficient for clamp loading.255 The  subunits have ATPase 
activity and act as the ‘motor’ of the complex.254 The  subunit interacts with the 2 clamp and 
opens it at the dimer interface, and it is proposed to act as a ‘wrench’ that allows the clamp to be 
assembled onto DNA.256 The ' subunit is referred to as the ‘stator’, since it remains stationary 
throughout the clamp loading process, while the other subunits move relative to it. Within the 
clamp loader complex, the ' subunit is thought to block the 2 sliding clamp from access to the  
subunit. Following ATP binding to the  subunits, the complex undergoes a conformational change 
that allows the  subunit to interact with the clamp.255 This complex is arranged in a circular 
fashion255 as shown in Figure 4.6.  
142 
 
 
Figure 4.6. Organisation of the 3  complex. The ATP binding sites are located at the subunit interfaces, as 
shown in the cartoon (right) and taken from the structure of ATP site 1 (left) with ATP (shown in purple) 
modelled against the P-loop (shown in blue). Reproduced from Johnson and O’Donnell, 2005.254 
 
ATP binding occurs at the subunit interfaces formed by Ser-Arg-Cys (SRC) motifs from one subunit 
of  and phosphate binding loops (P-loops) from another .254 At the replication fork, two (or three) 
 subunits replace two (or all) of the  subunits, and the  and  subunits are also present giving 
the overall clamp loader stoichiometry of 2 '  (or 3 ' ).
227 
The  and  subunits are both expressed from the same gene (dnaX). The  subunit is the full-
length product of dnaX whereas  is a truncated form that is missing the C-terminal region of .257 
This region of  interacts with the  subunit of the core and plays an important role with regard to 
the overall organisation of DNA Pol III.257 This was first suggested when an assembly of DNA Pol III' 
(consisting of subunits , ,  and ) was isolated and purified. Gel filtration chromatography 
indicated that a complex consistent with two core assemblies and two  subunits was present.258 
As a dimer, 2 can interact with two  subunits and thus acts to dimerise the core, allowing leading 
and lagging strand synthesis to be coupled at the replication fork.258 Since  and  were known to 
have a 1:1 stoichiometry, an organizational role for  was put forward.258 The  and  subunits are 
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not necessary for the clamp loading process but act as accessory subunits. These form a 1:1 
complex, but only  interacts with the  subunit, indicating that  acts as a link between  and 
other subunits of DNA Pol III.259 The  subunit also connects Pol III to SSB and DnaG primase.  
Therefore, the overall stoichiometry of DNA Pol III in its entirety is ( )2 2 ' ( 2)2 (Figure 4.2). 
With this broad understanding of the different protein-protein interactions within the replisome, a 
model of the dynamics of leading and lagging strand synthesis has been put forward (Figure 4.7). 
The leading strand is unwound by the DnaB helicase and the polymerase core, supported by a 
sliding clamp, continuously synthesises new DNA. Lagging strand dynamics are less 
straightforward, since DNA is synthesised discontinuously and the polymerase core is required to 
jump from one Okazaki fragment to the next as each is completed.260 The clamp loader is thought 
to load 2 clamps onto the RNA primers, where they bind the polymerase core. Upon completion 
of an Okazaki fragment, the sliding clamp is separated from Pol III, allowing the polymerase to 
reassociate with a new clamp on the next fragment.260 
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Figure 4.7. Model for the dynamics of the E. coli replisome at the replication fork. As the replication fork 
advances, the leading strand is synthesised continuously. The clamp loader complex coordinates the cycling 
of sliding clamps and polymerase cores on the lagging strand, which is synthesised discontinuously. 
Reproduced from Johnson and O’Donnell, 2005.254 
 
 
4.1.3 Focus on the E. coli 2 sliding clamp 
The 2 sliding clamp is now recognised as not only being essential for processive DNA synthesis 
during the elongation phase of replication, but also as a key component used by other DNA 
polymerases and proteins involved in maintaining the integrity of the chromosome.261 Its ability to 
stall at sites of DNA damage suggests it may have a role in recruiting appropriate protein 
assemblies involved in repair.261,262 The interactions between sliding clamps and DNA polymerases 
are essential in a wide variety of organisms from viruses and prokaryotes to higher eukaryotes.252 
The sliding clamps of the T4 phage (gp45) and eukaryotes (proliferating cell nuclear antigen, PCNA) 
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have the same ring-shaped structure as the E. coli 2 clamp, yet they share almost no sequence 
similarity. The structure of the E. coli 2 sliding clamp is described in more detail below. 
 
4.1.3.1 Sliding clamp structure 
The  sliding clamp (366 amino acids) is encoded by the dnaN gene and has a monomeric 
molecular weight of 40,586 Da. The crystal structure was first determined in 1992245 and was later 
solved at higher resolution123 (see Figure 4.5A). As mentioned previously, the dimer ring produces 
a C-terminal face and an N-terminal face (Figure 4.5B). It is the C-terminal face that is the site of 
interaction with other proteins.263 While the ring as a whole is asymmetric, it contains internal 
symmetry. Each  monomer has a crescent shape and consists of three domains, giving an overall 
pseudo six-fold symmetry.245 The site of interaction on 2 with the polymerases and other proteins 
is a hydrophobic binding pocket on the C-terminal face that is located between two domains on 
each protomer.264 Figure 4.8 shows the crystal structure of the complex between 2 and the C-
terminal peptide of Pol IV, highlighting the position of the binding pocket. This is also the same 
region where the  subunit of Pol III has been shown to bind.265 Competition experiments suggest 
that the  subunit also binds at this site.264 
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Figure 4.8. Ribbon representation of the 2 clamp bound with the C-terminal peptide of Pol IV (shown in 
yellow), showing the location of the hydrophobic binding pocket. The monomers of 2 are labelled A or B, 
and each domain is numbered. Reproduced from Burnouf et al. 2004.264 
 
In this structure, only one ligand bound to 2 is shown; however, there are two binding pockets 
located on the 2 ring, one near the C-terminal end of each monomer. The presence of two 
identical binding sites on 2 that can bind a number of polymerases and other proteins suggests at 
least two proteins might bind simultaneously. This suggests a mechanism for cycling and 
interchange of protein binding partners during DNA replication. This was the focus of a recent 
study in which a heterodimeric mutant of 2 containing one wild-type  monomer and a  
monomer with its five C-terminal residues removed was investigated. In the mutant, residues 
were deleted to disrupt the hydrophobic binding pocket, resulting in a 2 ring with only one 
available binding pocket.266 This mutant 2 retained its ability to bind the  subunit, showing that 
one binding pocket on 2 was sufficient for this interaction. The 2 mutant was also able to 
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stimulate replication in vitro as judged by primer extension assays. These observations are 
consistent with the proposal that multiple polymerases can bind the clamp simultaneously and 
that a switching mechanism may be utilised in DNA repair.266 These studies emphasise the 
importance of the structure of 2 with regard to its function in DNA replication. 
 
4.1.3.2 DNA-sliding clamp interaction 
An interaction between the sliding clamp and DNA is essential to its function of tethering the 
polymerase core to DNA during synthesis. Early experiments indicated that the sliding clamp forms 
a topological link with dsDNA rather than binding at specific sites, in accordance with its function 
which is to “slide” along DNA. The clamp could be stably assembled on circular dsDNA, but when 
restriction endonucleases were used to linearise the DNA, the clamp would simply slide off244. This 
proposed interaction was supported by the crystal structure of the clamp. The diameter of its 
central cavity is ~35 Å, large enough to accommodate B-form DNA (diameter ~25 Å) without steric 
repulsion245 (shown in Figure 4.9). While the overall protein is negatively charged, the electrostatic 
potential of the centre of the ring is positively charged, enabling favourable interactions with the 
negatively charged backbone of DNA.245 
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Figure 4.9. Modelled structure of the 2 sliding clamp with DNA. The crystal structure of the  dimer with 
modelled dsDNA through the central channel is shown on the left. The figure at the right demonstrates the 
differences in the two faces of the ring. Reproduced from Johnson and O’Donnell, 2005.254 
 
Further investigation into the interaction between the clamp and DNA was aimed at determining 
the structures of DNA required for the clamp loader complex to successfully load the sliding 
clamp.267 It was found that the  complex was able to load the 2 clamp onto a ssDNA/dsDNA 
junction. It was also shown that it is loaded at the 3' end of the primer so that the clamp is 
oriented properly for interaction with the polymerase core (and other proteins). Recent work by 
O’Donnell suggests that this might not be so simple,268,269 and further investigation is required. 
More recently, the structure of the E. coli 2 clamp has been solved in complex with primed 
DNA.270 DNA has generally been modelled as going straight through 2 perpendicular to the plane 
of the ring (as shown in Figure 4.9); however, the recent structure shows that DNA passes through 
the ring at an angle of 22 º (Figure 4.10). 
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Figure 4.10. Front and side views of the 2-DNA complex shown in ribbon representation. DNA is sharply 
tilted within the central channel of 2 at an angle of 22°. The tilt allows dsDNA to contact residues R24 and 
Q149, which are located on the protruding loops of the C-terminal face of 2. Reproduced from Georgescu 
et al. 2008.270 
 
A saturable 2-DNA complex with linear DNA (but not circular DNA) was formed in solution studies 
(where solutions containing  labelled with a fluorophore were titrated with either circular or 
linear DNA). In addition, a  mutant that could not form a dimer could bind both linear and circular 
DNA. These observations prompted the researchers to pursue conditions for crystallisation of 2-
DNA complexes. The ssDNA template of primed DNA formed a crystal contact with 2. 
Interestingly, in this structure the primed site is in the reverse orientation in the crystal compared 
to the physical orientation that would be provided by the clamp loader, where the primed/ssDNA 
junction would protrude out from the C-terminal face of 2. This was explained by the absence of 
the clamp loader, without which 2 cannot discriminate the orientation of the symmetric dsDNA. 
Further research on this interaction has been undertaken.271 A mutant of  where the proposed 
DNA interactive residues (148-152 HQDVR) were substituted for five alanine residues was found to 
be impaired for loading onto DNA and for retention on linear primed DNA. This was shown to be 
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purely a result of disruption of the DNA- 2 interaction. Once loaded on DNA, the 2 mutant was 
proficient in DNA replication, but was found to be impaired in its ability to assist in Pol II and Pol IV 
(polymerases for DNA damage and translesion synthesis) activity.271 These recent findings indicate 
a more important role for the 2-DNA interaction than originally thought and further research is 
required in this area. 
 
4.1.3.3 Polymerase-sliding clamp interaction 
The interaction between the 2 sliding clamp and the  polymerase subunit is essential for 
processive DNA replication. Proteins that bind to the 2 clamp contain a pentapeptide consensus 
binding motif QL[S/D]LF252 or a hexapeptide with the consensus sequence QLxLx[L/F].272 The 
sequence in  was identified as residues 920-924 (QADMF), which is consistent with previous 
studies that localise the 2-binding site of  within the C-terminal region.
246 A second sequence in 
 at the extreme C-terminal end (residues 1154-1159 QVELEF) was also identified as a site of 
interaction with 2.
260 The presence of two possible sites on  for interaction with the clamp can 
indicate a range of mechanisms for this interaction, and also has implications for the cycling of 
different proteins that also interact with the clamp. This has been the focus of extensive research 
and there have been some conflicting results with regard to the roles of the two 2 binding sites 
identified in . This will be discussed in more detail in section 4.2.2. 
 
4.1.4 Scope of this chapter 
In this chapter, the results of an ESI-MS investigation into the binding interactions of the E. coli 2 
sliding clamp with the  polymerase subunit are presented. The binding affinity of wild-type  was 
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compared to a mutant of  ( t) with the 2-binding consensus sequence inserted at its internal 2 
binding site. Peptide sequences corresponding to the wild-type and consensus sequences of the 
internal and C-terminal binding sites of  were assessed for binding with 2 to probe the roles of 
the two different sites. Competitive binding experiments involving 2 and c16 with t were 
performed to further investigate these binding mechanisms. Finally, experimental conditions were 
determined to obtain nanoESI-MS spectra of core ( ) with 2. These conditions have provided a 
starting point for experimental protocols for assembly of a complete Pol III molecule and have 
indicated relatively stable subassemblies to target for preparation of crystals with a view to X-ray 
structure determination. 
 
4.2 Results and discussion 
4.2.1 Characterisation of  
Before commencing a more detailed mass spectrometric study of the protein-protein interactions 
of , it was first necessary to confirm its molecular mass and purity. Further, optimal conditions 
were determined for mass spectrometric analysis of the protein under solution conditions where it 
was expected to maintain its native, folded structure. 
 
4.2.1.1 NanoESI-MS of monomeric  
The nanoESI mass spectrum of  dialysed against 100 mM NH4OAc, pH 7.2, and acidified by 
addition of acetic acid to 5% (v/v) is shown in Figure 4.11. The addition of acid to the sample prior 
to analysis promotes the denaturation and unfolding of proteins by disrupting noncovalent 
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interactions. This results in highly charged monomers in mass spectra and allows more accurate 
molecular mass determination. The spectrum shows several different charge envelopes consistent 
with the presence of  in several partially unfolded states in the sample.108 From this spectrum the 
molecular mass of  was determined as 40,592±1 Da, which is in reasonable agreement given the 
quality of the spectrum, with the calculated average monomeric mass of 40,586.6 Da calculated 
from the amino acid sequence (accession code, P0A988).245 
 
 
Figure 4.11. Positive ion nanoESI mass spectrum of the  subunit of the E. coli DNA Pol III following 
treatment with acetic acid. The [M+23H]23+, [M+17H]17+ and [M+12H]12+ ions are at m/z 1765.9, 2388.7, and 
3383.5, respectively. 
 
4.2.1.2 NanoESI-MS of 2 
To allow observation of intact oligomeric proteins, solution conditions which preserve the 
noncovalent interactions holding the subunits together must be optimised. An aliquot of  was 
dialysed against 100 mM NH4OAc, pH 7.2. Concentrated NH4OAc was added to samples of the 
dialysed  to give solutions of a range of NH OAc concentrations. The resulting mass spectra of 
these samples varied in quality (not shown). At lower NH4OAc concentrations (10-50 mM), ions at 
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lower m/z appeared in the spectrum, indicating a greater extent of unfolding, while a folded form 
was observed at higher NH4OAc concentrations. The nanoESI mass spectrum of 2 in 500 mM 
NH4OAc is shown in Figure 4.12. The most abundant ion in the spectrum was [M+18H]
18+ at m/z 
4512.4. This is the centre of the peak representing this ion which has a peak width at half height of 
2.8 Th. The low m/z side of this peak (4510.6) gives a mass that is in close agreement with the 
calculated mass of 81,173.2 Da. This is the case for all spectra shown in this chapter. The molecular 
mass calculated from this spectrum using the Transform function in MassLynx™ (picking the centre 
of the peak) was 81,205 Da, which corresponds well with the expected mass of 2. 
 
Figure 4.12. Positive ion nanoESI mass spectrum of 2 dialysed against 100 mM NH4OAc, pH 7.2, with 
NH4OAc added to 500 mM prior to analysis. The mass of 2 from the spectrum was 81,205±1 Da. The error 
relates to the ability of the Transform software to pick the centre of each peak and does not relate to the 
width of the peak. The width is related to other factors such as water and salts associated with the 
noncovalent complexes.  
 
The crystal structure of 2 (Figure 4.5), shows that it forms a stable, ring-shaped dimer. The 
observation of a stable  dimer using nanoESI-MS shows that the interactions holding the  dimer 
together are maintained in the mass spectrometer. When using native conditions to preserve 
noncovalent interactions in MS, the mass measurement can be less accurate owing to the 
broadness of the peak.  
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4.2.2 Preparation of a complex of  and 2  
The assembly of the DNA Pol III holoenzyme will be an important milestone in a program of 
research aimed at investigating the mechanism of assembly and the dynamics of the replisome. 
Since 2 is thought to have important roles in trafficking of replication and repair proteins, 
investigation of its interactions with the polymerase subunit, , is important to understanding the 
dynamics of replication. 
The 2 sliding clamp functions to tether the core ( ) of Pol III to DNA during DNA replication by 
binding the  subunit and encircling dsDNA. An essential component of this function is the 
interaction between  and 2. Previous studies have utilised techniques such as gel 
filtration,244,246,260,273 SPR,246,272 electrophoretic mobility shift assays,253 fluorescence resonance 
energy transfer (FRET)274 or isothermal titration calorimetry (ITC)275 to study this interaction, but 
ESI-MS provides an advantage over these other techniques through its ability to determine the 
precise subunit stoichiometry of protein-protein interactions. 
Protocols for preparing an  or 2 complex and the effects of different dialysis conditions on 
formation of the complex were examined. First,  and 2 were dialysed separately against 200 mM 
NH4OAc, pH 7.2, and combined in different ratios. Samples in solutions containing a range of 
NH4OAc concentrations (100, 200, 500, 650 mM, all at pH 7.2) were also prepared. In the resulting 
nanoESI mass spectra, peaks corresponding to both  and 2 were observed, but very little or no 
complex was observed. The greatest abundance of 2 was observed when :  was 1:1 in 500 
mM NH4OAc (Figure 4.13). 
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Figure 4.13. Positive ion nanoESI mass spectrum of  and 2 dialysed separately and added together in a 1:1 
ratio in 500 mM NH4OAc, pH 7.2 prior to analysis. The final concentration of proteins was ~ 1 M. Ions 
corresponding to 2,  or 2 are indicated. The most abundant ions for 2,  and 2 were [M+18H]
18+ (m/z 
4517), [M+20H]20+ (m/z 6519) and [M+27H]27+ (m/z 7853), respectively. The masses of 2,  and 2 were 
calculated from the middle of the m/z peak. The inset shows an expanded view of the ions from 2. 
 
The ions of highest abundance in the spectrum are at m/z 4000-5000 and correspond to 2 alone. 
Since  and  were present in solution in equimolar amounts, the very high abundance of 2 
relative to  shows that the “response factor” for 2 was greater than . The response factor takes 
into account factors that affect the ionisation efficiency of the analytes including solution 
conditions and mass spectrometry parameters that affect focusing of the ion path that affect 
detection of the ions. Previously in our laboratory,  has proven to be a challenging protein for 
ESI-MS analysis. For example, it is not stable over periods of more than a day in ammonium 
acetate solutions.276 
Ions of lower abundance at m/z 6000-7000 correspond to  alone. Ions of very low abundance at 
m/z ~8000 are consistent with the mass of the 2 complex (211,043 Da; calculated mass 211,078 
Da). The masses were determined from the m/z value at the centre of the peak. The peak width at 
half height was 35 Th. Another attempt at producing the complex involved dialysis of the two 
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proteins together in 200 mM NH4OAc, but only a small amount of complex relative to  and 2 was 
observed (spectrum not shown). 
These early experiments highlight the difficulty in obtaining a spectrum of the 2 complex. This is 
consistent with previously published work which showed the interaction between  and  to be 
weak in the absence of DNA and other subunits as judged by SPR and gel filtration.263,272  
 
Overexpression and purification of mutant  ( t) 
The ability of the 2 sliding clamp to interact with multiple polymerases and other proteins led to 
the discovery of the 2 binding consensus sequence in these proteins, QL(S/D)LF.
252 The sequence 
of  proposed to be involved in the clamp interaction is amino acid residues 920-924 (QADMF). To 
aid in the investigation of 2 in context with the rest of the replisome, a mutant of  (called t) in 
which residues 920-924 were substituted by the consensus sequence QLDLF was prepared. This 
was based on the work of McHenry and co-workers277 who showed by SPR that  with this 
consensus sequence bound more >120-fold tightly to 2.    
Since this is the first time this mutant has been prepared in our laboratory, the development of 
a method for its isolation is included in this thesis. These experiments were carried out under the 
direction of, and with the assistance of Dr. Slobodan Jergid. Details of buffers and reagents used 
are shown in section 2.2.5. The original plasmid containing the dnaE gene, pKO1341, was prepared 
by Dr. Kiyoshi Ozawa (ANU, Canberra). Expression of dnaE is under the control of a phage T7 
promoter in expression vector pETMCSI.60 The nucleotide sequence for  (residues 6250-7080) is 
shown in Figure 4.14. 
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GGT AAG AAA AAG CCG GAA GAG ATG GCT AAG CAA CGT TCT GTA TTT GCT GAA 
GGT GCA GAA AAG AAC GGA ATC AAC GCT GAA CTG GCG ATG AAA ATC TTC GAC 
CTG GTG GAG AAA TTC GCT GGT TAC GGA TTT AAC AAA TCG CAC TCT GCG GCC 
TAT GCT TTG GTG TCA TAT CAA ACG TTA TGG CTG AAA GCG CAC TAT CCT GCG 
GAG TTT ATG GCG GCG GTA ATG ACC GCC GAT ATG GAC AAC ACC GAG AAG GTG 
GTG GGT CTG GTG GAT GAG TGC TGG CGG ATG GGG CTG AAA ATC CTG CCA CCA 
GAT ATA AAC TCC GGT CTT TAC CAT TTC CAC GTC AAC GAC GAC GGC GAA ATC 
GTG TAT GGT ATT GGC GCG ATC AAA GGG GTC GGT GAA GGT CCG ATT GAG GCC 
ATC ATC GAA GCC CGT AAT AAA GGC GGC TAC TTC CGC GAA CTG TTT GAT CTC 
TGC GCC CGT ACC GAC ACC AAA AAG TTG AAC CGT CGC GTG CTG GAA AAA CTG 
ATC ATG TCC GGG GCG TTT GAC CGT CTT GGG CCA CAT CGC GCA GCG CTG ATG 
AAC TCG CTG GGC GAT GCG TTA AAA GCG GCA GAT CAA CAC GCG AAA GCG GAA 
GCT ATC GGT CAG GCC GAT ATG TTC GGC GTG CTG GCC GAA GAG CCG GAA CAA 
ATT GAA CAA TCC TAC GCC AGC TGC CAA CCG TGG CCG GAG CAG GTG GTA TTA 
GAT GGG GAA CGT GAA ACG TTA GGC CTG TAC CTG ACC GGA CAC CCT ATC AAC 
CAG TAT TTA AAA GAG ATT GAG CGT TAT GTC GGA GGC GTA AGG CTG AAA GAC 
   ATG CAC CCG ACA GAA 
 
Figure 4.14. Nucleotides 6250-7080 of dnaE (encoding ) sequence. The 2-binding sequence to be mutated 
is highlighted in pink. The nucleotides highlighted in yellow represent the primer sites used for PCR, and 
those highlighted in green represent the restriction sites for the endonucleases, SexA1 and Stu1.  
 
Mutagenesis of the 2-binding site to the consensus sequence derived by Dixon and coworkers
252 
was carried out in the following way. The mutation was introduced by overlap extension PCR 
(polymerase chain reaction) using the primers highlighted in yellow in Figure 4.14.  
The resulting PCR fragment containing the mutation was inserted between the SexAI and StuI 
restriction sites (highlighted in green) of pKO1341 to create pSJ1392. The mutagenesis was 
confirmed by nucleotide sequencing analysis. 
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E. coli strain BL21(DE3)/pLysS/pSJ1392 was grown in 1 L cultures at 39 °C in LBT media containing 
ampicillin (200 g/L) and chloramphenicol (35 g/L) to A600 = ~0.3. The temperature was then 
reduced to 30 °C and cells grown to A600 = 0.5. To induce overproduction, IPTG (1 mM) was added 
and the cultures shaken for a further period of three hours, then chilled on ice. Cells were 
harvested by centrifugation at 7,000 x g for six minutes. The successful overproduction of the  
mutant was analysed by SDS-PAGE and is shown in Figure 4.15. 
 
Figure 4.15. SDS-PAGE of t following successful overproduction. Control lanes containing the sample before 
induction are indicated. 
 
The cell pellets (3.3 g from 4.5 L of culture) were resuspended in 50 mL of lysis buffer A (section 
2.2.5), and lysozyme added to a concentration of 0.2 mg/mL (a protease inhibitor tablet, GE 
Healthcare, was also added to the buffer). Lysis was performed by heating to 37 °C for four 
minutes, followed by addition of PMSF (another protease inhibitor) to 0.5 mM. The lysate was 
clarified by centrifugation (27,000 x g for 30 minutes) to yield soluble Fraction I. Proteins that were 
precipitated from Fraction I by addition of solid ammonium sulfate (0.36 mg/mL) and stirring at 4 
(130 kDa) 
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°C for one hour were collected by centrifugation (27,000 x g for 30 minutes) and dissolved in 
buffer B (17 mL). After clarification (27,000 x g for 20 minutes), the solution was dialysed against 3 
x 2 L of buffer B (containing 200 mM NaCl) to yield Fraction II. Fraction II was applied at 1 mL/min 
onto a column (2.5 x 16 cm) of Toyopearl DEAE-650M anion-exchange resin that had been 
equilibrated in the same buffer. At this salt concentration, t did not bind to the column but 
contaminating DNA was retained, and fractions containing t were pooled and dialysed against 3 x 
2 L of buffer C (containing 30 mM NaCl). The dialysate (Fraction III, 40 mL) was loaded at a flow 
rate of 1 mL/min onto a column of the same resin, now equilibrated with buffer C. The t was 
eluted in a gradient from 30-500 mM NaCl over five column volumes. Fractions containing t were 
pooled (see Figure 4.16) and dialysed against 3 x 2 L of buffer C.  
 
Figure 4.16. SDS-PAGE of t following DEAE elution. * Indicates the fractions that were pooled to give 
Fraction IV. 
 
The dialysate (Fraction IV, 40 mL) was loaded at a flow rate of 1 mL/min onto a 5 mL heparin 
sepharose HiTrap™ column (GE Healthcare, Uppsala, Sweden) and eluted in a gradient from 30-
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1000 mM NaCl over 18 column volumes. Fractions containing t were pooled and dialysed against 
3 x 2 L of buffer D and the dialysate (Fraction V, 12 mL) was loaded at flow rate of 1 mL/min onto a 
phosphocellulose column and eluted in a gradient of 30-600 mM NaCl over approximately four 
column volumes. Fractions containing purified t (see Figure 4.17) yielded a total of 2.5 mg of 
protein and were stored at -80 °C. A small amount of proteolytic contamination is apparent in the 
gel; however, further purification steps were not carried out considering the likely loss in yield that 
would be incurred and since sample was to be used in trial MS experiments where proteolytically 
cleaved t would be readily detected.  
 
Figure 4.17. SDS-PAGE of t from fractions from the final purification step of the phosphocellulose column.  
* Indicates the fractions that were collected and stored. 
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To compare the purified t mutant with wild-type , a sample of each was dialysed separately 
against 200 mM NH4OAc and nanoESI mass spectra obtained. The resulting spectra are shown in 
Figure 4.18. 
 
Figure 4.18. Positive ion nanoESI mass spectra of  samples dialysed against 200 mM NH4OAc, pH 7.2, with 
NH4OAc added to 500 mM prior to analysis. A. Wild-type  and B. Mutant t. 
 
The nanoESI mass spectrum of t (spectrum B) is very similar to that of wild-type  (spectrum A). 
The most abundant ion in each spectrum is the [M+21H]21+ ion. For wild-type , this is at m/z 
~6182 and for t this ion is at m/z ~6184. The masses for wild-type  and t calculated from the 
amino acid sequence are 129,774 and 129,798 Da, respectively. The ions shown in Figure 4.18 are 
in good agreement with the calculated values within experimental error. The peak width at half 
height was ~20 Th. Given this peak width, the different masses of the mutant protein cannot be 
readily distinguished from these spectra (expected mass difference of 24 Da). The similarity of the 
two spectra indicates that the mutation of the residues (920-924) has not substantially affected 
the conformation, as a significant change in the availability of ionisable amino acid residues at the 
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surface of the electrosprayed droplets is expected to result in a different population of charge 
states. 
 
Complexes of 2 with  or t 
The interaction of t with 2 was compared with the wild-type interaction using nanoESI-MS. 
Samples of the t, wild-type  and 2 were dialysed separately against 200 mM NH4OAc, pH 7.2. 
Samples containing 1:1 molar ratios of  with wild-type  or t were prepared with the addition of 
5% (v/v) methanol and the resulting spectra are shown in Figure 4.19. Spectra that were acquired 
in this experiment without methanol showed dominant ions of 2 with only very low abundance 
ions for free  and the 2 complex. Since previous spectra obtained (Figure 4.13) showed free  
of higher abundance, different solution conditions were examined as it was thought this was the 
result of variability in ionisation efficiency, possibly depending upon variations in cutting 
nanospray capillaries. The spectra obtained from solutions containing methanol contained ions 
from several species: free 2, free  (or t) and the 2 (or t 2) complex. 
Substantial differences are evident upon examination of the spectra in Figure 4.19. When the wild-
type  was present with 2 (spectrum A), the ions of highest abundance (at m/z 6000-7000) are 
from  alone with only a small amount of the 2 complex (m/z 7000-8000) observed. A small 
amount of 2 alone (m/z ~4500) is also present. When the  mutant was present with 2 
(spectrum B), the 2 complex was of much greater abundance, and the relative abundance of  
alone was reduced. This is consistent with previous studies which used surface plasmon resonance 
to investigate the binding of a series of mutants (including the mutant t used in this work) to 
2
277. The binding affinity of this mutant for 2 was >120-fold higher than that of wild-type. 
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A number of low abundance ions are present that correspond to 2 2 (m/z ~9500). The [M+35H]
35+ 
and [M+36H]36+ ions for 2 2 are at m/z 9747 and 9476, corresponding to a molecular mass of 
340,982 Da. The low m/z side of the peak for the observed ions in the spectrum are at m/z 9745, 
and 9477. The presence of this complex could mean that the two hydrophobic binding pockets of 
2 are each occupied by an  subunit. 
 
Figure 4.19. Positive ion nanoESI mass spectra of the 2 complex in 200 mM NH4OAc, 5% (v/v) in methanol. 
Each protein was present at a final concentration of 1 M (based on the monomer). A. Wild-type  with . 
B. Mutant  ( t) with . Ions corresponding to 2, , 2 or 2 2 are indicated. The most abundant ions for 
2, , 2 and 2 2 were [M+18H]
18+
 (m/z 4514), [M+20H]
20+
 (m/z 6493), [M+27H]
27+
 (m/z 7819) and 
[M+35H]35+ (m/z 9749), respectively. The masses were calculated from the middle of the m/z peak, resulting 
in a slightly increased estimation of molecular mass.  
 
The 2 sliding clamp is known to interact with other polymerase subunits that are involved in such 
functions as DNA repair (section 4.1.2.2). It has been previously suggested that it is possible for 2 
to interact with other polymerases (like DNA polymerase IV) simultaneously with , which 
suggests it may also be possible for it to bind two  subunits simultaneously. However, it is still 
t
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possible that the observation of an 2 2 complex is the result of a non-specific association of the  
subunit with a second  subunit in the mass spectrometer. 
In the case of the 2 complex it is not useful to use ESI-MS to determine values for dissociation 
constants. This is because the “response factors” of , 2 and 2 are likely to be greatly different. 
Response factors refer to the peak intensities for a given concentration of analyte and are 
dependent upon many factors from the stability of the protein in the electrospray solution 
through to the transmissibility of ions through the mass spectrometer. In the experience of our 
laboratory (see above),  has a relatively low “response factor”.276  Nevertheless, the ability of 
nanoESI-MS to act as a screen for relative binding affinities of wild-type and mutant replication 
protein complexes is significant. Given the availability of the appropriate instrumentation, the 
technique provides a rapid assessment and precise binding stoichiometries. The enhanced stability 
of an t 2 complex will be exploited in crystallography trials. The demonstrated stability in the 
mass spectrometer of the complex suggests it as a starting point on which to build larger 
subassemblies of the replisome. 
There have previously been conflicting interpretations of experimental results with regard to the 
importance of the two putative 2 binding sites on . O’Donnell and coworkers
253 performed a 
number of experiments investigating this interaction. They used an electrophoretic mobility shift 
assay to determine whether peptide sequences corresponding to the C-terminal site (residues 
1141-1160) or a number of peptide sequences spanning the internal region (from residues 812-
991) of  were essential for binding to 2. The peptides were complexed to streptavidin in 
solution and tested for binding [32P]-labelled 2 by observation of a mobility shift in a native 
polyacrylamide gel. The results showed that under the conditions the C-terminal peptide 
demonstrated an interaction with 2 while the internal peptide did not. A fluorescence assay was 
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also used to probe an interaction between  with seven C-terminal residues removed ( C7) and 
2 with a fluorescent tag at its Cys333 residue. The C7 had a 10-fold reduced affinity for 2 
compared to wild-type . A DNA synthesis assay was performed to assess the ability of C7 to 
participate in replication and it was found that it exhibited lower activity when compared to wild-
type . It was concluded that the C-terminal sequence of  is necessary for functional interaction 
with 2. Further work by the O’Donnell group supported this hypothesis.
275 Two nonapeptides 
corresponding to the C-terminal site (residues 1152-1160) and the internal site (residues 918-926) 
were studied for 2-binding affinity using isothermal titration calorimetry (ITC). The results showed 
that the C-terminal peptide binds 2 more than 10-fold tighter than the internal peptide.
275 
McHenry’s group also investigated the interaction between  and 2. They made a series of full-
length  subunits with different mutations in either the C-terminal or internal binding sites.277 In a 
Pol III holoenzyme reconstitution assay that measures the processive function of Pol III on long 
ssDNA templates, it was found that only the internal 2 binding site was essential for processive 
DNA replication. A mutant with the C-terminal site completely removed, displayed only slightly 
reduced activity. SPR was used to measure the strength of interaction between 2 and the 
different  mutants. Deletion of the C-terminal site gave only a four-fold reduction in 2 binding. 
Substitution of the internal site with the consensus 2-binding sequence ( t, also used in this 
project) increased its affinity for 2 over 100-fold, while the same substitution at the C-terminal 
site did not significantly affect binding. These results supported the hypothesis that the internal 2 
binding site of  drives 2 binding and processive DNA replication.
277 Further work is necessary to 
resolve these apparently conflicting observations. 
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Peptide binding sites on 2 
In earlier work, peptides derived from the two C-terminal 2-binding sites on  were used to test 
binding affinities.272,275,277 The sequences (and lengths), the methods used and the findings of 
these studies are summarised in Table 4.1. Also included in the table are the sequences chosen for 
this work (explained in more detail below).  
Table 4.1. Summary of previous work investigating the two 2-binding sequences of . 
Peptides/proteins by: Internal sequence C-terminal sequence 
 
Dixon group 2004 (SPR)252 
Nonapeptides of  
IGQADMFGV  
IGQLDMFGV  
IGQADMAGV  
IGQLDLFGV
a
  
IGQLSLFGV  
 
McHenry group 2005 (SPR)277 
Proteins  
QADMF QVELEFD 
QADMK QVELEKD 
AAAKK QLDL_FD 
QLDLFa (M3) QLDLFFDa (M9) 
AADMF AVELEFD 
QADMA QVEAEFD 
QCDMF QVELEAD (M12) 
 C7 
O’Donnell group 2008 (ITC)275 
Nonapeptides of  
IGQADMFGV SEQVELEFD* 
This work 2010 (ESI-MS) 
Nonapeptides of b 
IGQADMFGV SEQVELEFD 
IGQLDLFGV
a
 (M3) SEQLDLFFD
a
 (M9) 
QLDLF
a
 SEQVELEAD (M12) 
 
Sequences highlighted in green indicate an improved interaction with 2 was observed compared to wild-
type (IGQADMFGV). Sequences in red indicate a reduced interaction with 2 was observed.
 a 
Contains the 
consensus sequence for the internal 2 binding site on . 
b M3, M9 and M12 here refer to the corresponding 
sequences in full-length  used by the McHenry group. * Indicates the sequence with the stronger 
interaction with 2 as measured by O’Donnell (both sequences were wild-type). 
167 
 
NanoESI-MS was used in this project to probe further the interaction of the polymerase and sliding 
clamp. The binding of 2 with a series of nonapeptide sequences corresponding to the C-terminal 
(SEQVELEFD) and internal (IGQADMFGV) 2 binding sites of wild-type , as well as sequences 
containing the identified 2-binding consensus sequence (QL(S/D)LF), were investigated. The nine 
residue length of the peptides was chosen so that the masses of the different peptide- 2 
complexes were able to be distinguished using MS. This length of peptide had been used 
previously by both the O’Donnell and Dixon groups (Table 4.1).272,275 McHenry’s group investigated 
a series of full length subunits with mutations based largely on the work of Dixon and coworkers 
in the 2 binding sites, including the insertion of the 2-binding consensus sequence.
277 The binding 
affinities of the mutants for 2 were compared with wild-type  using SPR. In the current project, 
nonapeptides were chosen that contained some of the mutant sequences that were studied by 
McHenry. Table 4.2 shows the dissociation constants for the binding of the full-length  mutants 
studied by McHenry that were chosen for this work.  
Table 4.2. 2 binding affinity of mutant  subunits. Reproduced from Dohrmann and McHenry, 2005.
277 
 subunit Sequence KD ( M) Affinity compared to WT 
WT internal (920-924) QADMF 0.8 ± 0.1 1 
M3 internal QLDLF 0.0069 ± 0.0028 120-fold greater 
WT C-terminal (1154-1160) QVELEFD 0.8 ± 0.1 1 
M9 C-terminal QLDLFFD 0.7 ± 0.1 1.1-fold greater 
M12 C-terminal QVELEAD 1.7 ± 0.3 2.1-fold lower 
 
First, the binding to 2 of the wild-type C-terminal and internal binding sequences were compared. 
A sample of 2 was dialysed against 100 mM NH4OAc, pH 7.2, and titrated with increasing amounts 
of either the C-terminal (SEQVELEFD) or internal (IGQADMFGV) peptides. The nanoESI mass 
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spectra showing the m/z range 4,000-5,200 for the 1:1 ratio of :peptide is shown below in Figure 
4.20 (A and B) and the spectra transformed to a mass scale are shown in C and D. 
 
Figure 4.20. Positive ion nanoESI mass spectra of the 1:1 ratio of  with the different wild-type  peptide 
sequences. The final concentration of  was 20 M. A. 2 with the WT internal peptide sequence 
(IGQADMFGV). B. 2 with the WT C-terminal peptide sequence (SEQVELEFD). C. The spectrum from A 
transformed to mass scale. D. The spectrum from B transformed to mass scale. The binding of different 
numbers of the peptide sequences is indicated by 0, 1, 2 or 3. The calculated masses of 2, 2+1 internal 
peptide, 2+1 C-terminal peptide and 2+2 C-terminal peptides are 81,173, 82,110, 82,268 and 83,363 Da, 
respectively. The calculated average masses of internal and C-terminal peptides are 937.1 and 1094.7 Da, 
respectively. 
 
When the internal peptide sequence was added to 2 (spectrum A) the most abundant ions in the 
spectrum were from free 2 such as [M+19H]
19+ at m/z 4274.4, with a very low abundance ion at 
m/z 4324.2 corresponding to 2 + 1 peptide. When the C-terminal peptide sequence was present 
(spectrum B) the most abundant ion corresponded to 2 + 2 peptides. This is consistent with the 
occupation of two hydrophobic binding pockets on opposite sides of the 2 ring. Other ions 
corresponding to 2 + 1 peptide, free 2, and a very low abundance ion from 2 + 3 peptides are 
also present. The presence of the 2 + 3 peptide complex could be explained by non-specific 
association of two peptides together that have bound in one of the 2 binding pockets, with the 
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other occupied by a single peptide, or more likely non-specific association elsewhere in 2. These 
results indicate that the C-terminal peptide sequence has a much stronger interaction with 2 than 
the internal peptide sequence. A competition experiment was also performed where the WT 
internal and C-terminal peptide sequences were added simultaneously to 2. The resulting 
spectrum showed only binding of the C-terminal peptide to 2. These results are consistent with 
O’Donnell’s work which showed stronger binding of the nonapeptide C-terminal sequence to 2 
using ITC and an electrophoretic shift assay.253,275  
The interaction of 2 with the internal and C-terminal peptides containing the 2-binding 
consensus sequence was also investigated. The peptides used in this work were based on some of 
the sequences that were studied by McHenry (Table 4.1). These were: the internal peptide 
substituted with the 2-binding consensus sequence (IGQLDLFGV, termed M3), and two C-terminal 
peptides; one with a pseudo-consensus sequence (SEQLDLFFD, termed M9) to preserve the 
hexameric format of the C-terminal site, and one with a single mutation of F to A (SEQVELEAD, 
termed M12) that has previously been shown to abolish 2-binding activity.
253,277 In McHenry’s 
study using SPR, the full-length  mutant with the 2-binding consensus sequence at the internal 
site (termed M3, the same as t used in this project) showed a much higher affinity for 2 (KD = 
0.0069 M for t cf KD = 0.8 M for WT ), while the consensus sequence at the C-terminal site 
(M9) showed only a very small increase in affinity (KD = 0.7 M) (Table 4.2). Dohrmann and 
McHenry277 investigated the binding of 2 to biotinylated, his-tagged  subunits immobilised on an 
SPR chip. Dixon and co-workers252 immobilised the biotinylated peptides IGQADMFGV and 
IGQLDLFGV (the same as those used in the current work) onto an SPR chip via a 12-amino acid 
linker and found, in agreement with Dohrmann and McHenry277, that the KD values for binding to 
2 were 2.70 and 0.78 M, respectively, a 3-4-fold difference. It was the aim of the current work to 
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compare the SPR results of McHenry using a protein and Dixon using peptides with binding of 2 to 
nonapeptides of the same sequences by nanoESI-MS. A sample of 2 was titrated with increasing 
amounts of the peptide sequences and compared to the wild-type peptide sequences. The 
resulting nanoESI mass spectra corresponding to the 1:1 ratio of :peptide transformed to a mass 
scale are shown in Figure 4.21. 
 
Figure 4.21. Positive ion nanoESI mass spectra of the 1:1 ratio of  with the wild-type  peptide sequences 
and the mutant  peptide sequences, transformed to a mass scale. The final concentration of  was 20 M. 
A. WT  internal peptide sequence (IGQADMFGV) with 2. B. M3  internal peptide sequence (IGQLDLFGV) 
with 2. C. WT  C-terminal peptide sequence (SEQVELEFD) with 2. D. M9  C-terminal peptide sequence 
(SEQLDLFFD) with 2. E. WT  C-terminal peptide sequence with 2 (same as C, repeated for ready 
comparison with F). F. M12  C-terminal peptide sequence (SEQVELEAD) with 2. The binding of peptide 
sequences is indicated by 1, or 2.  
 
Comparison of the WT internal peptide sequence (Figure 4.21A) and the internal peptide 
containing the 2-binding consensus sequence (M3, Figure 4.21B) show very similar interaction 
with 2. Only a low abundance ion corresponding to 2 + 1 peptide bound was observed. The most 
abundant ion was from free 2. This peptide sequence is the same consensus sequence that was 
incorporated into the full-length  mutant ( t) prepared earlier in this study (see Figure 4.19). The 
nanoESI mass spectra of t showed a stronger interaction with 2. This result was in agreement 
with McHenry’s SPR work, which showed that this  mutant had over 100-fold higher affinity for 
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2 than wild-type (see Table 4.2). Using peptides, but analysis by SPR, Dixon and co-workers 
showed only a 3-fold increase in binding affinity. These observations suggest that full-length  is 
required for the effect of mutation from QADMF to the consensus sequence QLDLF to be fully 
exerted. Given that the difference in binding is not as great when only peptides are examined, the 
nanoESI-MS method does not allow for discrimination between the binding affinity of the two 
complexes in this case.  
Comparison of the WT C-terminal peptide sequence (Figure 4.21C and E) and the two mutant 
sequences (Figure 4.21D and F) show differing results. The C-terminal peptide containing the 2-
binding consensus sequence (M9, Figure 4.21D) shows a similar interaction compared to the WT C-
terminal sequence (Figure 4.21C and E). The most abundant ion in the spectrum is from 2 + 1 
peptide, with ions of slightly lower abundance from 2 + 2 peptides and free 2. This is in 
agreement with the results of Dohrmann and McHenry277 where similar binding affinities were 
observed for WT  (KD = 0.8 M) and M9 (KD = 0.7 M). Also in agreement with that work
277, the 
M12 C-terminal sequence showed substantially reduced binding to 2, with the most abundant ion 
corresponding to free 2 (Figure 4.21F). The KD measured by the McHenry group was 1.7 M (~2-
fold higher). The results observed using nanoESI-MS suggest a binding affinity reduced by more 
than 2-fold. This discrepancy again may arise from differences in comparing binding of peptides 
with a protein, but may also represent a bias in either one of the techniques for a particular 
interaction (e.g. differences in the response factor for ESI-MS or effects of immobilisation near a 
surface in SPR results). It is also important to note that different solvent conditions are 
necessitated by the different techniques.   
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4.2.3 Interactions between , 2 and  
The interactions of  with 2 need to be considered along with the binding of , since the C-
terminal region of  that interacts with the 2 clamp is also known to interact with the  subunit. 
McHenry’s group also used SPR to investigate the binding of the subunit with the series of 
mutants (including those listed in Table 4.2). An  mutant (not listed in Table 4.2, with residues 
920-QADMF-924  AAAKK; internal 2-binding site) that showed ≥ 130-fold lower affinity for 2, 
was shown to interact as strongly with  as wild-type. This suggested that the internal 2-binding 
site of  does not interact directly with . Another  mutant where the extreme C-terminal 
sequence of  was deleted ( C7) showed a 440-fold reduction in  binding, suggesting that the 
C-terminal site of  has a more important role interacting with than with 2.
277 The interaction of 
the  subunit with the  polymerase subunit has been previously investigated in the laboratory of 
our collaborators (Dixon group), using a ~16 kDa fragment consisting of the C-terminal domain of  
(residues 499-643, c16), as well as a number of c16 mutants. Their binding affinity to  was 
measured with SPR121 (shown in Figure 4.22). The SPR results of that study are summarised in 
Table 4.3. It was found that the extreme C-terminal residues of  are important in the interaction 
with . A complex of - c16 but not - c14 was isolated using gel chromatography. 
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Figure 4.22. Domain structure of the subunit of E. coli DNA Pol III. The -binding domain of is located in 
Domain V, the 16 kDa C-terminal fragment, c16. Schematic representation of the c16 and c24 (the 24 kDa 
domain of  that also incorporates DNA binding) derivatives that were examined by Jergid et al.121. M+ 
indicates that c24 and c16 and derivatives constructed by deletion of the indicated numbers of residues from 
the C-terminus contain an N-terminal methionine. Adapted from Jergid et al. 2007.121 
 
Table 4.3. Equilibrium constants KD for interactions of  with c16 and derivatives. Reproduced from Jergid et 
al. 2007.121 
Interaction KD (M) 
Direct SPR assay:  
-bio- c16 2.64 ± 0.02 x 10
-10
 
Competitive SPR assay:  
- c16 1.3 ± 0.4 x 10
-10 
- cpep32 3.8 ± 0.2 x 10
-6 
- c16 7 6.7 ± 1.8 x 10
-6 
- c16 11 >10
-5 
- c14 ( - c16 18) >10
-5
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To test whether the  peptide sequences proposed as 2 binding sites are also involved in the -  
interaction, the binding of c16 with the sequences of  corresponding to the WT C-terminal and 
internal 2 binding sites, and the mutant sequences (M3, M9 and M12), were investigated using 
nanoESI-MS. The full length  subunit has proven difficult to study using ESI-MS previously in our 
laboratory, giving spectra of poor quality. Similar difficulties were encountered when our protein 
samples were analysed in the laboratory of Prof. Carol Robinson (Cambridge University, now 
Oxford).278 The c16 fragment has been studied extensively by nanoESI-MS in our laboratory. The 
interaction of c16 and various c16 mutant proteins with  was investigated and the relative orders 
of binding affinity were in agreement with those obtained using SPR.121,276 A sample of c16 was 
dialysed against 200 mM NH4OAc, pH 7.2, and aliquots of each of the peptide sequences were 
added. NanoESI-MS of a solution containing a 1:1 ratio of c16:peptide did not reveal any 
interaction (spectra not shown), so a higher excess of peptide was used. Figure 4.23 shows the 
nanoESI mass spectra obtained when the peptides were in 10-fold molar excess over c16. 
From these spectra, it is apparent that neither the WT internal binding sequence (spectrum E), nor 
the M3 internal sequence (containing the 2-binding consensus sequence) (spectrum F) shows an 
interaction with c16. The WT C-terminal binding sequence (spectrum B) does show some binding 
interaction with c16, with an ion of very low abundance at m/z 2517 corresponding to c16 + 1 
peptide bound. Even when the peptide was in 10-fold excess of c16, the most abundant ion in the 
spectrum is at m/z 2361, corresponding to free c16. The M9 C-terminal sequence (SEQLDLFFD, 
spectrum C) shows a slightly lower binding affinity for c16 compared to the WT C-terminal 
sequence, and the M12 C-terminal sequence (spectrum D) showed much lower binding to c16 with 
a decreased abundance of the c16 + 1 peptide ion at m/z 2507. 
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Figure 4.23. Positive ion nanoESI mass spectra of the 1:10 ratio of c16 with the different  peptide 
sequences. A. c16 alone (5 M). B. c16 with the WT C-terminal peptide sequence (SEQVELEFD). C. c16 with 
the M9 mutant C-terminal peptide sequence (SEQLDLFFD). D. c16 with the M12 mutant C-terminal peptide 
sequence (SEQVELEAD). E. c16 with the WT internal peptide sequence (IGQADMFGV). F. c16 with the M3 
mutant internal peptide sequence (IGQLDLFGV).  Indicates c16 alone and  indicates c16 with one 
peptide bound. The calculated masses of c16, c16-WT C-terminal peptide, c16-WT internal peptide, c16-M12 
and c16-M3 are 16,523, 17,618, 17,460, 17,542 and 17,636 Da, respectively. The ions at m/z below 2000 
correspond to c16 alone. Ions from free peptide are at m/z < 1600 (not shown). 
 
These results are reasonably consistent with the results of McHenry’s group.277 Using SPR, they 
found that the  mutant containing the 2-binding consensus at the C-terminal site (M9) showed 
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26-fold lower affinity for  compared to wild-type , and the M12 C-terminal sequence showed 
740-fold lower affinity. In the current nanoESI-MS experiments where synthetic peptide sequences 
rather than mutant  subunits were studied, the differences in binding affinity are less marked but 
binding is weak in both cases. In addition, the values of KD are M or greater (since the protein and 
peptide concentrations were in the M range), while in Dohrmann and McHenry’s work the KD for 
the binding of M9  with full length  was 2.1 nM. The differences may be the result of differences 
in the shape of the full-length  protein compared to a short peptide sequence. It should also be 
noted that McHenry’s group used the full length  protein while the c16 fragment was used in 
these nanoESI-MS experiments, which may also have some effect on the interaction. It is also a 
possibility that the interactions between c16 and the peptides are too weak to be maintained in 
the mass spectrometer. It should be noted that there is evidence that c16 interacts with regions on 
 other than at the C-terminus.121 
The O’Donnell group has previously proposed a model where  displaces 2 from the C-terminal 
site of  upon completion of an Okazaki fragment, with the  subunit acting as a switch upon 
sensing the presence of duplex DNA.260 To investigate this model further, competitive binding 
experiments between 2 and c16 for the full length  mutant ( t, described in section 4.2.2) were 
carried out. Samples of the t, 2 and c16 were dialysed separately against 200 mM NH4OAc, pH 
7.2. An aliquot of 2 was added to c16, followed by t and the resulting spectrum is shown in 
Figure 4.24. In the same experiment, t,  and c16 were added together in different orders, but 
the highest abundances of complexes were observed in this spectrum shown in Figure 4.24. This 
experiment was also attempted using the full-length  subunit; however, spectra of poor quality 
were obtained, making it difficult to assign ions (not shown).  
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Figure 4.24. Positive ion nanoESI mass spectrum of a 10:1:10 mixture t, 2 and c16. The final concentration 
of  was 1 M. The ions corresponding to c16, 2 or t c16 are indicated. Ions circled in red are highlighted in 
Figure 4.25. 
 
The most abundant ions in the spectrum were observed at values of m/z around 2500, 4500 and 
6500, corresponding to free c16, free 2 and t c16. This is expected since ions that correspond to 
free 2 and free t were present when t and  were added together previously (see Figure 4.19). 
The t in the presence of c16 forms an t c16 complex (mass 146,401 Da). When the m/z range 
7000-10,500 is expanded (Figure 4.25), ions from several species were observed: t 2, t 2 c16, 
t2 2( c16)2 and t2 2 c16.  
 
Figure 4.25. Positive ion nanoESI mass spectrum of the expanded m/z region 7500-10,500 showing the 
interactions between t,  and c16.  indicates t 2,   indicates t 2 c16,  indicates t alone,  
indicates t2 2( c16)2 and  indicates t2 2 c16. 
t 
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These results show that t is capable of binding both 2 and  simultaneously. This is consistent 
with previous results from the McHenry laboratory, in which gel filtration and SPR experiments 
showed that the C-terminal region of  could bind both 2 and  at the same time.
246 The 
observation of a complex of t2 2( c16)2 suggests that the presence of two  subunits binding to 2 
is not just a non-specific association of two  subunits, but that one  is binding on either side of 
the 2 ring, and each of these  subunits is able to also interact with a  subunit. McHenry and 
coworkers proposed a model for  based on its ability to bind both 2 and  simultaneously, and 
the stronger interaction between 2 and the internal 2 binding site of  whereby  is associated 
with 2 through both the internal and C-terminal binding sites.
277 Contact between two 2 binding 
sites within  and the two  binding sites within the 2 ring would preclude the association of 2 
with other polymerases. Competition of  for the C-terminal 2 binding site (or communication 
between the polymerase active site and the internal 2 binding site) might reveal one or both sites 
on 2, allowing interaction with other polymerases.
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4.2.4 Preparation of a complex of 2-DNA 
DNA has been shown previously to independently bind to both  and 2.  Furthermore, the 
interaction of  with primed DNA has been shown to increase the affinity of  for the 2 clamp.
263 
When proposing a model for the - 2- interaction, McHenry and coworkers highlighted that the 
internal 2 binding site of  is positioned between two potential DNA binding elements
277 (shown 
in Figure 4.26).  
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Figure 4.26. Modular organisation of the  subunit. The internal and C-terminal 2-binding sites are 
highlighted in red. This domain also contains two putative structural features, the helix-hairpin helix (HhH, 
residues 835-850) and the OB-fold (residues 999-1073) thought to be capable of interacting with DNA. 
Adapted from Dohrmann and McHenry, 2005.277 
 
It was suggested that these DNA binding elements may act as sensors, altering the conformation 
of the 2 binding site depending on the DNA-binding state of 
277 Recent work using a 
fluorescence anisotropy DNA-binding assay suggested that the interaction between the OB 
domain of  and ssDNA is involved in the regulation of the affinity of for 2 during the cycling of 
Okazaki fragments on the lagging strand.279 The possibility for the two sites on  interacting 
simultaneously with the two sites on 2 while DNA interacts with  has been put forward by both 
Wijffels and coworkers272 and the O’Donnell group.235 These studies indicate DNA is of high 
importance to the interaction between  and 2. With this in mind, it was thought that the 
presence of DNA would stabilise the 2 complex, helping to build larger subassemblies of the 
replisome using ESI-MS. Recently, the structure of the 2 sliding clamp on primed DNA has been 
solved which showed that the clamp directly binds the DNA duplex and also forms a crystal 
contact with the ssDNA template strand270 (see Figure 4.10). In a preliminary experiment, the 
interaction between 2 and ssDNA was investigated using nanoESI-MS. A sample of 2 was 
dialysed against 100 mM NH4OAc, pH 7.2, and titrated with increasing concentrations of a ssDNA 
sequence (dA16 - a sequence consisting of 16 adenine nucleotides). The resulting spectra are 
shown in Figure 4.27. 
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Figure 4.27. Positive nanoESI mass spectra of 2 titrated with increasing concentrations of dA16. The final 
concentration of  for all samples was 15 M. A. 1:1 ratio of :dA16. B. 1:5 ratio of :dA16. C. 1:10 ratio of 
:dA16. D. 1:20 ratio of :dA16. E. 1:40 ratio of :dA16. Ions corresponding to free 2, 2+dA16 and 2+2dA16 
are indicated.      
 
An expanded view of the m/z range 4700-4900 of the spectrum of the 1:10 mixture of :dA16 is 
shown in Figure 4.28. When greater excesses of dA16 were added to samples, no further ssDNA 
binding to 2 was observed but spectral quality was reduced, indicating a maximum of two dA16 
strands were capable of binding. 
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Figure 4.28. Positive ion nanoESI mass spectrum of the interaction between 2 and ssDNA. Ions at m/z 4778, 
4788 and 4796 corresponding to 2, 2 +ssDNA and 2 +2ssDNA are indicated. The masses of 2+ssDNA and 
2+2ssDNA are 86,122 and 91,071 Da, respectively. 
 
The calculated masses of 2, 2+ssDNA and 2+2ssDNA were 81,173, 86,122 and 91,071 Da, 
respectively. The ions at m/z 4778, 4788 and 4796 correspond to the [M+17H]17+ ion of free 2, the 
[M+18H]18+ ion of 2 + ssDNA and the [M+19H]
19+ ion of 2 + 2 ssDNA, respectively. These results 
are consistent with the findings of the crystal structure, as it was observed that the ssDNA 
template strand bound in the protein binding pocket of the 2. As there are two binding pockets in 
the 2 ring, it is possible that two separate ssDNA strands are able to bind 2 as was observed in 
the spectrum.  
 
4.2.5 NanoESI-MS of the core complex 
The next goal of this work was to construct larger subassemblies of the replisome based on the 
conditions determined above. A sample of the core ( ) complex that had been purified by gel 
filtration (Jergid and Dixon) was used to investigate the interactions of  in the context of the 
entire core complex. 
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First, optimal instrument conditions were determined for mass spectrometric analysis of the core 
complex under solution conditions expected to maintain the protein-protein interactions. The 
spectra in Figure 4.29 compare core under non-optimised and optimised conditions.  
 
Figure 4.29. Positive ion nanoESI mass spectrum (Waters ESI-QTOF Ultima™) of the core ( ) complex 
following dialysis against 100 mM NH4OAc, pH 6.9. A. Spectrum of core (1 M) under non-optimised 
conditions. B. Spectrum of core (1 M) under optimised conditions. These conditions are described in 
section 2.2.5. Ions corresponding to free , free , free ,  and  are indicated. 
 
Spectrum A shows core prior to optimisation of solution and instrument conditions, specifically, in 
500 mM NH4OAc and with a cone voltage of 300 V. The ions in this spectrum correspond to free 
, free and free , indicating that these conditions caused dissociation of the complex. More 
gentle conditions were used to acquire spectrum B (100 mM NH4OAc and a cone voltage of 150 V). 
The most abundant ions in this spectrum correspond to a mass of 165,720 Da, which is consistent 
with the intact  complex (around m/z 7000, the calculated mass from the middle of the m/z 
peaks). Some less abundant ions of  (at m/z 8000-10,000) and  (at m/z 2000) are also present. 
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This indicates that a small amount of dissociation has occurred. Since the  ions are at higher m/z 
values, this would suggest the complex has been dissociated within the mass spectrometer. This is 
because  in a complex with  would have fewer charges associated with it during the ionisation 
process (compared to  on its own). On dissociation  would carry fewer charges with it.  
The interaction between core and the 2 sliding clamp was then investigated. Aliquots of  were 
added to core in different ratios to maximize the amount of 2 complex observed. The best 
spectrum was obtained when 2 was added in three-fold excess of core and is shown in Figure 
4.30. The most abundant ions observed in the spectrum correspond to free 2 (at m/z ~4000, not 
shown in the spectrum). Other species observed in the spectrum include free , , and 2 
complex. The abundance of the 2 ions in the spectrum may not reflect what is present in solution, 
but may be as a result of the ionisation efficiency of 2 compared to the core complex (not 
shown). Ions corresponding to core alone were observed at m/z ~6000. Ions from the 2 
complex (mass 247,040 Da) are of higher abundance and observed at m/z 7500-9000. In this 
experiment, the core complex was produced using wild-type . 
 
Figure 4.30. Positive ion nanoESI mass spectrum of core upon addition of the subunit. The final 
concentration of core was 1 M. Ions corresponding to the core complex are labelled as , and those 
corresponding to the core- 2 complex labelled as 2. 
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In future experiments a core complex will be prepared using the mutant t to determine whether 
a greater relative abundance of 2 compared with the 2 can be observed. 
The interaction between core and the  subunit was also studied. This was first attempted using 
the full length  subunit. The  subunit can form multiple oligomers and there is a possibility each 
subunit can bind to  from the core complex. However, as with previous experiments attempted 
in this laboratory with full length , spectra were difficult to obtain and no interactions were 
observed. Instead, c16 was used. A sample of core was titrated with increasing amounts of c16 and 
nanoESI-mass spectra were obtained. The spectrum of core with a three-fold excess of c16 is 
shown in Figure 4.31.  
 
Figure 4.31. Positive ion nanoESI mass spectrum of wild-type core ( ) upon addition of a three-fold excess 
of c16. The final concentration of core was 1 M.  indicates c16,  indicates c16 and  indicates 
c16. 
 
This spectrum contains ions from several species: c16, c16 and c16. As was observed when 
the spectrum of core alone was obtained, some of the complex dissociated to give some free  
and , and these species have bound with the added c16 consistent with the binding of c16 to the 
 subunit. The species of highest abundance is the core- c16 complex, so this interaction is readily 
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maintained in the mass spectrometer. These conditions pave the way for preparation of 
complexes that might be amenable to crystallisation. 
 
4.3 Summary and future directions 
The E. coli 2 sliding clamp was readily amenable to nanoESI-MS analysis. The interaction between 
the 2 sliding clamp and the  polymerase subunit was examined. A relatively weak interaction 
with wild-type  was observed using MS, so a mutant of  with a consensus 2-binding sequence 
was over-expressed and purified ( t). The mutant t interacted more strongly with 2, and an 2 2 
complex was observed. 
NanoESI-MS was also used to probe the binding of 2 with a series of short peptide sequences 
corresponding to the two wild-type 2-binding sites on , and these sites with the 2-binding 
consensus sequence. The wild-type C-terminal sequence (SEQVELEFD) interacted more strongly 
than the wild-type internal sequence (IGQADMFGV) or the internal sequence containing the 
consensus sequence (IGQLDLFGV, M3) and the wild-type and consensus internal peptide 
sequences showed little difference in their interaction with 2. This is in contrast to previous work 
and the findings in this study where the full-length  mutant ( t) with the consensus sequence at 
the internal site showed a stronger interaction. It was concluded that the secondary or tertiary 
structure of full-length  must have some effect on the 2 interaction. 
Preliminary work on larger subassemblies of the core with other subunits such as 2 and c16 was 
also undertaken. Future work will involve observing these interactions with a sample of core 
containing the stronger 2-binding  mutant to form a more stable complex, and the addition of 
DNA. Since this thesis has been completed, researchers in our laboratory280 have used the 
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conditions and information from this work to obtain nanoESI mass spectra of core- 2 mixtures 
where core was assembled from individual t, ,  and 2 subunits. The spectra showed ions of 
negligible abundance from free core, confirming a direct interaction of  in the core with 2. In 
addition, our collaborators Jergid and Dixon, identified a potential weak 2 binding sequence 
(QTSMAF) from amino acids 182-187 of  (proofreading subunit). A proposed stronger 2 binding 
mutant ( L) was created by replacing QTSMAF with QLSLPL. NanoESI mass spectra
280 showed that 
t L - 2 complexes were more abundant relative to subassemblies and free subunits than - 2 
showing that t and L subunits contribute synergistically to the stability of core- 2 complex. This is 
the first evidence for a direct interaction of 2 with . In the current work, an apparently stronger 
interaction between 2 and wild-type  core than with isolated wild-type  (Figure 4.13 cf. 
Figure 4.29) was observed. This would be consistent with an additional interaction occurring with 
the core compared to alone. 
Preliminary studies on the role of DNA in the - 2 interaction were carried out. Incubation of 2 
with an excess of a ssDNA sequence (dA16) showed that a maximum of two single strands of DNA 
were able to bind to the 2 clamp. The role(s) of 2 during the replication process may have 
implications for the properties of the DNA it will most likely interact with. A sequence of DNA has 
been designed that would best aid in the observation of a stable - 2 and DNA complex, and 
this will be the focus of continuing work on this project. The ability of 2 to interact directly with 
DNA, rather than forming a topological link as previously thought has functional implications. It 
was thought that this interaction may have a role in the clamp loading mechanism.270 The 2 clamp 
interacts with the clamp loader complex and is opened through specific interaction with the  
subunit of the clamp loader. The DNA is positioned through the open clamp and the DNA 
interactive residues of the clamp are attracted to DNA and induce the clamp to close around it. 
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The template ssDNA binding to the binding pocket of 2 may help release  from the clamp and 
result in ejection from the clamp loader. It was also proposed that the 2-ssDNA interaction may 
have a “placeholder” role, preventing the clamp from diffusing along the duplex DNA before an 
interaction with the polymerase can be established.270 The tilted angle of DNA through the 2 
clamp also has functional implications. Since 2 is capable of binding two separate polymerases 
simultaneously at its two binding sites, the DNA would be able to switch between the two 
polymerases bound to the same clamp.270 These possible functions of the 2-DNA interaction are 
summarised schematically in Figure 4.32. 
 
Figure 4.32. Possible roles of the 2-DNA interaction. A. Proposed role during clamp loading. The clamp 
loader complex binds the open 2 clamp. Primed DNA is attracted to the inside of the clamp and the clamp is 
induced to close around the DNA. Template ssDNA binds the hydrophobic pocket of 2, displacing the  
subunit. B. Proposed “placeholder” role. The contact between the template ssDNA and the binding pocket 
of 2 may help to keep it near the 3' terminus of DNA. Upon binding the  subunit, the ssDNA contact is 
released for 2 to allow it to slide along dsDNA. C. Proposed role of DNA tilt for polymerase switching. The 
two identical binding sites of 2 means DNA may alternate from one to the other, allowing interaction with 
different polymerases bound to the same clamp. Reproduced from Georgescu et al. 2008.270  
2 
2 
2 
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In consultation with Assoc. Prof. Aaron Oakley and Prof. Nick Dixon a duplex DNA structure that 
would best facilitate formation of an - 2-DNA complex was determined. A model was 
proposed based on the crystal structures of 2 with dsDNA, 2 with  peptide, and  (from 
Thermus aquaticus) with DNA237,281,282 as well as structures of the core subunits (see Figure 4.33). It 
has been observed that 2 has a stronger interaction with primed DNA compared to blunt duplex 
DNA,270 so the first feature to be included in the DNA for future work is a dsDNA strand with a 
ssDNA overhang. The length of the dsDNA region required was determined based on the width of 
the 2 ring and the region of  that interacts with DNA. A dsDNA region consisting of 20 base pairs 
(bp) was deemed appropriate. The ring shape of the clamp means that it is capable of sliding along 
duplex DNA. To prevent this possibility, a “hook” region was included at the end of the DNA 
structure that would hold the complex in place and prevent it from sliding off. Rather than having 
two complementary strands of ssDNA that are annealed, the DNA sequence used in this study will 
consist of a single strand with a self-complementary region. The stronger 2 binding  mutant ( L) 
identified by our collaborators would also be included in the core complex. Attempts will be made 
in the future in our laboratory to obtain nanoESI mass spectra of the resulting - 2-DNA 
complex. 
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Figure 4.33. A proposed model for the E. coli - 2-DNA complex. This model was created by Dr. Thomas 
Huber (ANU, Canberra) using the structure for the 2 subunit in complex with DNA,
270 the structure of the  
subunit (residues 1-917),235 the structure of the full length  subunit from Thermus aquaticus,237 the 
structure of the  subunit in complex with N-terminal domain of 186232 and the structure of the C-terminal 
domain of  (residues 209-243) in complex with the N-terminal PHP domain of the  subunit (residues 2-
270) solved in Horan, 2010280. The flexible linker between the  subunit C-terminal and N-terminal domains 
was computationally modelled from residues 188-208. The  (brown) and 2 (purple) are displayed in 
spacefill. The  (red) and  (green) subunits are displayed in ribbon representation. Modelled DNA is shown 
in orange. The structure is displayed from different viewpoints; (A), (B) and (C). Reproduced from Horan, 
2010.280 
 
This work has shown that nanoESI-MS for studying noncovalent protein complexes holds great 
promise for answering some of the questions involving the interactions of the 2 sliding clamp and 
its mechanism and dynamics during replication and other processes. Future experiments using this 
technique (and other complementary methods) will build upon the information gained from this 
project to provide a deeper understanding of the interactions among different replisome proteins. 
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Chapter 5 
 
Resolution of Protein Conformers Using 
a Travelling Wave Ion Mobility Mass 
Spectrometer 
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5.1 Introduction 
The development of gentle ionisation techniques such as ESI has led to the routine use of MS as a 
tool for structural biology that is capable of studying large, multi-protein complexes. The coupling 
of ion mobility with MS has added a further dimension to the study of these complexes, with 
mobility separation of ions on the basis of size (e.g. oligomeric forms) and shape, in addition to 
mass.283 
There are several reviews that describe the development of different types of ion mobility mass 
spectrometers.116,284 Generally, ions under the influence of an electric field experience collisions 
with inert gas; ions of greater collisional cross section (CCS) will therefore be retarded relative to 
ions of smaller CCS. Early IMMS experiments involved the study of atoms or small molecules.283 
Initial work by the Bowers group using a coupled ‘drift-time’-IMMS116,285 (DTIMS) instrument to 
study thermal reaction rates and product distributions of mass-selected metal cluster ions.286 The 
Jarrold group used a similar instrument to study the thermal reactions of mass-selected (NaCl)nCl- 
clusters, as well as to resolve isomers of laser desorbed metallofullerenes.287 This work led the 
Jarrold and Clemmer groups to analyse larger biomolecules using this method. After initially 
working on peptides (such as bradykinin) and small proteins (cytochrome c),114,288 a modified ESI 
DT-IM-TOF mass spectrometer was designed that enabled the simultaneous measurement of 
mobilities and m/z ratios for multiple ions.118 An instrument was also later designed by the Bowers 
group to investigate structural changes in biomolecules.289 Drift time IMS has high resolving power 
but suffers from low sensitivity because of inefficient transmission of ions from ambient pressure 
into the high vacuum region of the mass spectrometer.284 
Recently, a new type of IMS has been released commercially. This is the travelling wave ion 
mobility mass spectrometer (TWIMS).290,291 In the TWIMS device, travelling waves of voltage pass 
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through a stacked ring ion guide filled with inert gas. Ions of lower mobility (e.g. greater cross 
section) fall behind the waves more often than high mobility ions, thus effecting ion mobility 
separation.  
The commercially available TWIMS instrument is the Synapt™ HDMS™, released by Waters in 2007 
(shown in Figure 5.1).291 Ruotolo et al. used a forerunner of this instrument to investigate the 
topology of the trp RNA binding attenuation protein (TRAP).292 This protein has an 11-membered 
ring structure and TWIMS was used to investigate the collisional cross sections of various TRAP-
complexes. The ring topology of TRAP was found to have been maintained in the gas phase, and 
the work demonstrated the ability of TWIMS to provide information about protein structure and 
conformational changes.292  
 
Figure 5.1. Schematic representation of the ESI Synapt™ HDMS™ instrument. Reproduced from Pringle et al. 
2007.291 
TWIMS 
193 
 
5.1.1 The Synapt™ HDMS™ instrument 
The Synapt™ instrument consists of a Z-electrospray ionisation source, followed by a quadrupole 
mass analyser for m/z selection of ions (see Figure 5.1). The IM section consists of three travelling 
wave stacked ring ion guides (see below). The trap ion guide is used to accumulate ions then 
release the ion packet to the IM ion guide where they are separated by differences in mobility. The 
transfer ion guide transmits the mobility separated ions to the TOF where they are mass 
analysed.291 
The stacked ring ion guide (or travelling wave ion guide, TWIG) is made up of a series of planar ring 
electrodes, arranged so that the transmission of the ion is perpendicular to the rings, as shown in 
Figure 5.2. 
 
Figure 5.2. Schematic diagram of the stacked ring (travelling wave) ion guide (SRIG). Reproduced from 
Pringle et al. 2007.291 
 
Alternating positive and negative RF voltages are applied to the ring electrodes, creating a radially 
confining effective potential barrier.291 A DC voltage is applied in pulses to propel the ions through 
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a background gas. The transient DC voltage is superimposed on the RF applied to a pair of adjacent 
ring electrodes in a repeating sequence. This generates a series of potential “hills” that are 
subsequently applied to the next electrode pair providing a continuous sequence of “travelling 
waves”. The ions are driven away from the potential hills and are thus carried through the device 
with the waves. This process is illustrated in Figure 5.3. 
Owing to the reverse gas flow in the TWIG, ions with lower mobilities (i.e., higher collisional cross 
section) experience the most friction and eventually roll over the crest of the wave and exit the 
cell later than ions with high mobility.283,290,291 
 
 
Figure 5.3. Schematic diagram of ion separation in the travelling wave ion guide (TWIG). Reproduced from 
Pringle et al. 2007.291  
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5.1.2 Protein conformation in the gas phase by IMMS 
Early experiments using IMMS to study proteins were aimed at investigating the behaviour of 
proteins in the gas phase, in particular, the effects of desolvation and charge on the protein 
structure.283 For example, Clemmer et al. used a DTIMS to show that different conformations of 
cytochrome c exist in the gas phase, based on the differences in collisional cross section.288 The 
ions at lower charge state (higher m/z) corresponded to the most compact conformations, while 
more extended forms were observed at higher charge states. It was also observed for some 
intermediate charge states, that more than one conformation could be resolved for a particular 
ion.288 A similar trend was observed for carbonic anhydrase 2 using TWIMS.293 A bimodal CSD was 
observed, with several ions with different mobility observed for the same m/z value, suggesting 
carbonic anhydrase 2 ions consist of several components with different folding states.293 
The ability of IMMS to monitor changes in protein conformation make it a suitable technique for 
investigating proteins that are involved in protein misfolding or amyloidogenic diseases.283 For 
example, the accumulation of fibrillar plaques and aggregates of -amyloid peptide (A ) in the 
human brain is a recognised characteristic of Alzheimer’s disease.294 IMMS has been used to 
identify the components of the A  oligomers, as well as to characterise their structure and 
topology.294 The IMMS data showed the presence of at least two different conformational forms 
involved in A  aggregation, and a modified A  which had been oxidised at the Met35 residue 
during oligomerisation and aggregation.294  TWIMS has also been utilised as a tool to monitor 
copopulated conformational states during protein folding events, such as the amyloidogenic 
protein 2-microglobulin.
295 A comparison of wild type 2-microglobulin with mutants of varying 
folding stabilities and propensities for amyloid fibril formation gave insight to the possible roles of 
different conformers in protein stability and amyloidogenic aggregation.295  
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The proper assembly of subunits can be important to the function of a protein complex and IMMS 
can be used to monitor this. Haemoglobin is a tetrameric complex made up of two - and two -
globin chains, with each subunit containing a haem group.296 The pathway of assembly is still not 
fully understood. Previous work by Konermann and coworkers297 using native ESI-MS revealed 
some insights to the folding pathway. It is known that two heterodimers of one - and - 
monomer associate together to form the tetramer, but it is unclear if the haem groups are 
attached to both - and - monomers before formation of the heterodimer or whether 
association leads to haem recruitment.296 Konermann had observed with ESI-MS haem binding to 
both the - and - subunits in their monomeric forms. This indicated a different pathway to the 
previous proposal, which suggested the -subunit could only bind haem after the formation of the 
-(holo) and -(apo) heterodimer.297 IMMS was used to further probe the gas-phase 
conformations of haemoglobin tetramers and their constituents.296 A haem-deficient dimer was 
not observed, suggesting this is not an essential intermediate in the assembly pathway. The apo- 
and holo- forms of the - and -monomers were also analysed and it was found that there was no 
significant difference in their collisional cross sections. This suggests that the monomers retain 
similar structure in the absence or presence of the haem group.296 
Before the introduction of IMMS, native MS has been a technique for the determination of the 
stoichiometry, stability and topology of protein complexes (discussed in Chapter 1).283 CID 
experiments using MS can also provide information about subunit interactions through 
investigation of pathways of dissociation of the protein complex. IMMS can be used to gain more 
information than native MS in this way, as it can provide information about the unfolding of a 
subunit from a complex as it dissociates from the assembly.283 Ruotolo et al. used this method to 
investigate the activated dissociation of the tetrameric transthyretin (TTR) complex.298 Upon 
increased energetic activation, the collisional cross section distributions were observed to broaden 
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towards larger tetrameric TTR structures, indicating the presence of partially folded intermediate 
states where one or more subunits was unfolded. Molecular modelling was used to confirm that 
partial unfolding of subunits within the complex was happening prior to dissociation.298 These data 
are shown in Figure 5.4. 
 
 
Figure 5.4. Collisional cross section distributions of the 15+ charge state of the TTR complex subject to 
increased activation. Modelled TTR structures at the various levels of activation are also shown. The 
structures correspond to tetrameric TTR, one monomer unfolded 21%, one monomer unfolded 50%, two 
unfolded monomers at 50 and 30%, four 30% unfolded monomers, and three 50% unfolded monomers. 
Reproduced from Ruotolo et al. 2005.298 
 
Ligand binding to protein complexes can often induce large conformational changes. 
Understanding these changes can be important for drug development, not only in identification of 
the site of interaction but also for understanding biological implications.299 TWIMS has been 
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recently used to investigate the binding of the protein ubiquitin with the widely used anticancer 
drug cisplatin. Cisplatin (cis-[PtCl2(NH3)2]) exerts its toxic effect on cancer cells through interaction 
with DNA; however, it can also readily interact with a number of proteins and peptide targets in 
the body.299 Ubiquitin is a potential drug target in cancer cells, due to its role in ubiquitination 
pathways and tumour cell propagation.299 The platination of ubiquitin by cisplatin resulted in the 
appearance of up to three different conformations for each charge state. The collisional cross 
sections estimated by IMMS of each conformation were contracted in size compared to 
unmodified ubiquitin. The platination site of ubiquitin was identified as the N-terminal methionine 
by CID experiments.299 The change in shape was suggested to have a significant effect on its 
function in vivo.299 Ligand binding can also affect protein conformation stability. This has been 
investigated using TWIMS by comparing the stability of compact conformations of proteins (such 
as FK-binding protein, lysozyme and myoglobin) in the presence and absence of bound ligands in 
the gas phase to known solution behaviour.300 
TWIMS has also been used to study the structural conformations of different chaperonin 
complexes.301 In E. coli, the chaperonin complex is comprised of the tetradecameric GroEL and 
heptameric GroES, which together assist in the proper folding of newly synthesised proteins. 
During this process, folding of the substrate protein takes place within the cis cavity of the GroEL-
GroES complex.301 The TWIMS results showed that the collisional cross sections determined for 
GroEL and GroEL bound with a polypeptide substrate, gp23, were similar, indicating that the 
protein substrate is most likely bound inside the GroEL cavity. Binding of the GroES subunit 
increased the collisional cross section as expected, but binding of the substrate gp23 to this 
complex again did not have an effect on the cross section. The observed cross section distributions 
for each of these complexes are shown in Figure 5.5. 
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Figure 5.5. Collisional cross section distributions of the 71+ charge state for free GroEL (black solid), GroEL-
gp23 (black dashed), GroEL-GroES (gray solid) and GroEL-GroES-gp23 (Gray dashed). Reproduced from van 
Duijn et al. 2009.301 
 
As a control experiment, an excess of folded bovine serum albumin (BSA) was analysed with 
GroEL. Since folded BSA is not a substrate, it will not bind within the GroEL cavity, but is instead 
expected to bind to the outside of the complex, effectively increasing the collisional cross section. 
The IMMS data confirmed this, with an observed increase of the cross section compared to free 
GroEL.301 
A limitation associated with applying the travelling wave to the ion mobility cell as used in the 
TWIMS setup, is that the collisional cross sections cannot be directly measured from the drift 
times of the ions.283 Instead, the collisional cross section is extrapolated from a calibration curve 
generated from proteins or other analytes for which the collisional cross section has been 
previously determined (usually using DTIMS). The Robinson group has published a procedure for 
calibrating travelling wave drift times to collisional cross sections.117 Calibration curves are 
generated at three different wave heights (magnitudes of the voltage “wave”), to reduce the 
influence of electric field on mobility separation. Unfortunately, there are a limited number of 
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calibrant ions with known cross sections. The calibrant ions used in the protocol published by the 
Robinson group consist of a number of smaller protein ions (such as myoglobin, cytochrome c and 
ubiquitin) and larger values are extrapolated from the relationship between the drift time and 
collisional cross section.117 An example of a calibration curve generated using this procedure is 
shown in Figure 5.6. To assess whether the values of collisional cross section estimated from 
TWIMS data are valid, they were compared with values from published X-ray crystallography and 
NMR structures.302 It was found that the estimated cross sections were in good agreement with 
cross sections determined from the structures. 
 
 
Figure 5.6. Example of a calibration curve from data of bradykinin, ubiquitin, cytochrome c and myoglobin, 
displayed as linear plots of collisional cross section and corrected drift time. Plots are shown for three 
magnitudes of wave height. Reproduced from Ruotolo et al. 2008.117 
 
Ashcroft and coworkers284 have compared cross sectional areas of a range of folded proteins 
determined from ESI-TWIMS data with cross sectional areas calculated using NMR coordinates 
from the Protein Data Bank. The data were in good agreement (to within ~7%). 
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5.1.3 Scope of this chapter 
In 2008 this laboratory acquired a Synapt™ HDMS™ instrument. This IMMS instrument utilises a 
TWIMS cell. This provided a new opportunity to gain more information about protein complexes 
and their different conformational structures than can be achieved using native MS alone. The 
focus of this chapter was the application of IMMS to study protein conformation, in particular, the 
ability of the Synapt™ HDMS™ to resolve protein conformers. This instrument can achieve greater 
sensitivity than other types of IMMS, but since TWIMS is relatively new, it is of interest to 
determine its limitations in resolution of protein conformers. The instrument in the School of 
Chemistry (UOW) is a “first generation” instrument. During the course of this project, Waters 
released its second generation instrument, the G2. 
First, TWIMS was used to separate a mixture of the 2 sliding clamp of the bacterial replisome and 
transferrin, two proteins with a similar mass but different shape. Then, TWIMS parameters were 
optimised to resolve a linear and cyclised version of the protein, DnaB-N; these two proteins differ 
only by the mass of a water molecule. MS alone of linear and cyclised DnaB-N suggested that a 
shift in charge state distribution (CSD) to lower m/z may be the result of protein unfolding. TWIMS 
drift times were compared to test this hypothesis. Finally, TWIMS was used to compare positively 
and negatively charged calmodulin (CaM), and CaM complexes. The binding of calcium ions and 
antipsychotic drugs or peptides to CaM causes dramatic changes in conformation as observed by 
their three-dimensional structures, and previous ESI-MS studies in our laboratory have found 
differences in the charge state distribution observed in positive and negative ion ESI mass spectra 
of these complexes. TWIMS was applied in the current work to determine whether the drift times 
(hence collisional cross sections) of positively and negatively charged CaM and CaM complexes are 
different. Differences in structure will have implications for the choice of ionisation mode used to 
analyse the complexes.  
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5.2 Results and discussion 
5.2.1 TWIMS separation of 2 and transferrin 
The Synapt™ HDMS™ system was first installed in this laboratory in 2008. Considerable time was 
spent investigating the capabilities of the instrument. The first project in this study was focused on 
separating two proteins of similar mass but different shape based on their drift times. Two 
proteins were selected that have a similar molecular mass and were readily available; the 2 
subunit from the E. coli replisome (native mass 81,173 Da) and human holo-transferrin (79,674 
Da). While they have a similar mass, the shapes of these proteins are quite different. The  subunit 
forms a head-to-tail ring-shaped dimer (Figure 5.7A) while transferrin (Tf) is a single polypeptide 
chain consisting of two globular domains (Figure 5.7B).  
    
Figure 5.7. A. Crystal structure of the  dimer from the E. coli replisome. B. Crystal structure of chicken 
(Gallus gallus) transferrin from PDB file 1n04. The two iron atoms are shown as green spheres. The 
structures of human and chicken transferrin have a high degree of similarity. 
 
The 2 clamp has been previously well-characterised during the investigation of interactions 
between different subunits of the E. coli replisome (Chapter 4). The ability of 2 to maintain its 
native dimeric structure has been established, and conditions for observing this form using ESI-MS 
were optimised previously. In this study, it was necessary to first obtain an ion mobility mass 
A B 
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spectrum of 2 alone, before attempting to separate a mixture of the two proteins. A dialysed 
sample of 2 was analysed and the resulting ion mobility mass spectrum is shown in Figure 5.8. 
The driftscope image (Figure 5.8A) and drift plot (B) show that one major drift time distribution is 
observed for the 2 at around 6.4 ms.  
 
 
Figure 5.8. Positive ion nanoESI IM mass spectrum of 2 in 100 mM NH4OAc, pH 7.2. A. Driftscope image. B. 
Drift plot showing a drift time of ~6.4 ms. C. ESI mass spectrum corresponding to A. Refer to section 2.2.5 in 
Chapter 2 for conditions used to obtain these data. The mass spectrum shows that the predominant ion is 
the [M+19H]
19+
 ion at m/z 4194.4 consistent with the expected mass of 2 of 81,173 Da. 
 
A 
B 
C 
19+ 
17+ 
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The addition of acid to a protein sample disrupts noncovalent interactions that maintain the native 
structure, resulting in unfolding of the protein. This has been previously investigated for the 2 
subunit in Chapter 4 using ESI-MS, and it was found to shift the charge state distribution (CSD) in 
the resulting spectrum, indicating that some denaturation had occurred. Figure 4.11 shows that 
several forms were present as evidenced by the presence of several charge envelopes.  To obtain a 
sample where a number of folded and unfolded forms of  and 2 were present, an aliquot of 2 
was treated with formic acid, and an aliquot of 2 in NH4OAc was added immediately before IMMS 
analysis. This gave a final formic acid concentration of 2% (v/v) and 100 mM NH4OAc. The resulting 
spectrum is shown in Figure 5.9. 
In the mass spectrum (Figure 5.9B) at least three charge state distributions (CSDs) are present with 
the most abundant ions at m/z 2537.7 and 2900.1, corresponding to the [ +16H]16+ and [ +14H]14+ 
ions of the monomer, respectively, and at m/z 4060.0 corresponding to the [ 2+20H]
20+ ion of the 
 dimer ( 2). In the absence of ion mobility data it might be speculated that the ions from around 
[ +13H]13+ to lower m/z, for example, [ +25H]25+ are from unfolded  monomer. The presence of 
at least three forms is supported by the ion mobility data. From the driftscope image (A), at higher 
m/z (in the range 3500-5500) there are exclusively dimer peaks, with the [ 2+20H]
20+ ion the most 
abundant. The two distinct conformational populations (charge envelopes) present at lower m/z, 
corresponding to the unfolded and more folded conformations, are evident since the species of 
two different drift times occur at the same values of m/z (m/z <3800). For example, note the 
arrow on the left hand side of Figure 5.9A indicating the [ +16H]16+ ion; two ions of the same m/z 
occur at different times of approximately 9.9 and 17.3 ms. 
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Figure 5.9. Positive ESI-TWIMS of a mixture of 2 treated with 5% (v/v) formic acid and 2 in 100 mM 
NH4OAc. The final concentration of  was ~20 M.  A. Driftscope image. B. ESI mass spectrum corresponding 
to the driftscope image in A. The peaks in the driftscope image corresponding to dimer or monomer are 
indicated. 
 
To clarify this further, the drift plot for [ +16H]16+ at m/z 2537.7, is shown in Figure 5.10. In this 
drift plot, there are two populations observed at m/z 2537.7, which supports the presence of two 
conformational forms. While this could represent monomer, [ +16H]16+, and intact, ring-shaped 
dimer, [ 2+32H]
32+, this is unlikely since ions from intact dimer appear at drift times around 11 ms 
under these experimental conditions. 
 
A 
B 
Dimer 
Monomer 
or 
unfolded 
“linear” 
dimer 
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Figure 5.10. The drift plot for the 2537.7 m/z ion of acidified 2. Two drift times are observed, 9.9 and 17.3 
ms, suggesting two different folded forms of the [ +16H]
16+
 ion are present. 
 
 
The ring-shaped structure of the  dimer contains two interface regions. It is possible in this 
sample that the noncovalent interactions of one interface have been disrupted, while the other 
interface is still intact. This would result in an elongated 2 that is no longer held in the ring-shape 
but is still the same mass and has a drift time of 17.3 ms (Figure 5.10), while unfolded monomer 
has a drift time of 9.9 ms. These possibilities could be explored in future work by modelling the 
cross sections expected for these protein shapes.292,303,304 
Transferrin (Tf) is another protein that has been studied extensively in this laboratory, and its 
behaviour in ESI-MS experiments is well understood. A sample of Tf in NH4OAc was analysed by 
TWIMS and the resulting spectrum is shown in Figure 5.11. There is only one drift time distribution 
in the driftscope image (Figure 5.11A) at a drift time of ~3-4 ms, which indicates that there is only 
one conformation of transferrin present. The most abundant ion in the mass spectrum (Figure 
5.11B) is the [M+18H]18+ ion at m/z 4432.5. 
 
2537.7 m/z ion 
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Figure 5.11. Positive nanoESI-IM mass spectrum of transferrin in 100 mM NH4OAc, pH 7.2. A. Driftscope 
image. B. ESI mass spectrum corresponding to the driftscope image in A. The most abundant ion in the 
spectrum is [Tf+18H]18+ at m/z 4432.5, consistent with the expected mass of Tf of 79,745 Da. 
 
The next step in this investigation was to analyse a sample containing a mixture of both 2 and Tf. 
Considerable effort was spent optimising the conditions to successfully separate the two proteins 
where they were likely to remain folded. Figure 5.12 provides an example of spectra acquired 
prior to optimisation. To obtain these spectra, electrospray ionisation (not nanospray) was used. 
Since ESI was used, a higher capillary voltage was applied (2.5 kV, rather than 1.5 kV for 
nanospray). A higher wave velocity (350 ms-1) and collision energy (6 V) were also used. It is 
apparent that the 2 sliding clamp has undergone dissociation, as there are ions corresponding to 
the monomer in the ESI mass spectrum in Figure 5.12B. When the wave velocity was increased to 
400 ms-1 (Figure 5.12C) there does not appear to be any  monomer in the ESI mass spectrum 
A 
B 
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(Figure 5.12D), but some unfolding may have occurred, as more than one conformation is present 
in the driftscope image (Figure 5.12C). There also seems to be some unfolding of Tf apparent in 
the driftscope image. The peaks corresponding to 2 and Tf in the driftscope images in Figure 5.12 
are overlapping and difficult to assign. It is apparent that these conditions did not result in ion 
mobility separation of these proteins, and have caused some unfolding of their native structures. 
This highlights the importance of optimisation of instrument conditions when using IMMS. 
The TWIMS spectra acquired under optimised conditions for separation of 2 and Tf are shown in 
Figure 5.13. Nanospray ionisation was used for this sample, as it is often considered a more gentle 
ionisation method and ESI may have contributed to the unfolding observed for the previous 
examples. A lower wave velocity (200 ms-1) and collision energy (1 V) were chosen to minimise 
unfolding.  
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Figure 5.12. Non-optimised conditions for positive ESI-IM mass spectrum of a mixture of Tf and 2. A. Driftscope image of the mixture with wave velocity 
350 ms-1. B. Mass spectrum of the mixture with wave velocity 350 ms-1. C. Driftscope image of the mixture with wave velocity 400 ms-1. D. Mass 
spectrum of the mixture with wave velocity 400 ms-1. In the mass spectra, ions corresponding to  monomer, 2 or Tf are indicated. 
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Figure 5.13. Positive nanoESI-IM mass spectrum of a mixture of Tf and 2 in 100 mM NH4OAc, pH 7.2. A. 
Driftscope image. B. ESI mass spectrum corresponding to the driftscope image in A. Ions corresponding to 2 
or Tf are indicated. The ions present for each protein were: [Tf+19H]
19+
, [Tf+18H]
18+
 and [Tf+17H]
17+
; and 
[ 2+20H]
20+, [ 2+19H]
19+ and [ 2+18H]
18+. 
 
The final conditions for IM resolution of 2 and Tf are reported in section 2.2.5. The above mass 
spectrum shows ions corresponding to 2 and Tf. The driftscope image (Figure 5.13A) shows clear 
separation between the two proteins. The peaks at short drift times (~2.5 – 5 ms) correspond to 
Tf, while the longer drift times (~5 – 8 ms) correspond to 2. This is in agreement with the known 
B 
A 
19+ 
18+ 
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three-dimensional structures for the two proteins. The globular Tf structure is more compact and 
thus takes a shorter drift time to traverse the drift cell than the ring-shaped 2. 
These initial experiments demonstrate the ability of the Synapt™ HDMS™ instrument to separate 
proteins of similar mass (to within 1.8% in mass) but different shape. Different conformations of 
the same protein were also separated and analysed using this technique. 
 
5.2.2 TWIMS separation of unfolded and folded conformations of DnaB-N: 
The effect of protein conformation on charge state distribution 
The use of ESI-MS to study protein conformation was described briefly in section 1.7. Changes in 
the conformation of a protein are thought to result in changes in the CSD observed in ESI mass 
spectra.108-112 In positive ion mode, the CSD of a protein arises from protonation of the basic amino 
acid side chain residues and the N-terminus that are exposed to the surface of the electrospray 
droplet.192,193,305 Consequently, if a protein is in a more compact (folded) shape, there are fewer 
basic residues available to the surface of the droplet for protonation than the same protein when 
in an unfolded conformation. De la Mora306 investigated the maximum charge of electrosprayed 
ions carried by a number of folded proteins to determine the relationship between charge and 
molecular weight. The maximum charge (ZR) that can be carried by a folded protein can be 
calculated by considering the protein as spherical, with a size estimated from the molecular weight 
(mw), according to equation 1:306 
Equation 1 ZR = 0.0778√mw 
The effect of changes in protein conformation on CSD in positive ion ESI-MS has been the focus of 
several earlier studies. Lysozyme is a protein with a native structure held together by four disulfide 
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bonds.113 Loo et al. investigated the changes in the ESI mass spectrum of lysozyme as a result of 
treatment with dithiothreitol (DTT) to reduce the disulfide bonds and unfold the protein.113 A shift 
to higher charge states (lower m/z) was observed in the mass spectrum, consistent with the 
hypothesis that unfolding made a greater number of ionisable residues available to the surface of 
the droplet.113 Simmons and Konermann investigated the refolding of myoglobin from an unfolded 
form in the presence of free haem.307 The appearance of different CSDs in the mass spectra 
corresponded to several different conformations of myoglobin as the haem bound to the protein. 
The complicating factor in these studies is that the changes in protein conformation were induced 
by changing the solvent or addition of ligands and these factors may also affect the ionisation 
process, for example, by changing the surface tension of electrosprayed droplets.  
 
5.2.2.1 DnaB-N 
DnaB is the replicative helicase of E. coli. Its N-terminal is involved in oligomerisation to form a 
hexamer.43 The structure of the N-terminal domain (residues 24-136) of DnaB (DnaB-N) has been 
determined previously by NMR.308 It has been shown to be an all-helical single-domain protein, 
with the N- and C-termini in close proximity, extending out from the centre of the protein.308 In 
our laboratory, these structural features allowed the cyclisation of DnaB-N (cyc-DnaB-N) by 
introduction of an amide bond and a flexible, nine amino acid peptide linker between the N- and 
C-termini, with little alteration to its structure.124 In order to decrease its propensity for 
oligomerisation, the F102 residue was changed to glutamic acid.309 A DnaB-N derivative was also 
produced, containing the same amino acid linker, but without cyclisation, to give a linear version 
of the same protein (lin-DnaB-N). NMR studies have shown that the linear and cyclised forms have 
essentially the same structure, with only a mass difference of 18 Da corresponding to the loss of a 
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water molecule through peptide bond formation. A schematic representation of both the cyclised 
(cyc) and linear (lin) forms of DnaB-N (but with a five amino acid linker) is shown in Figure 5.14.   
 
Figure 5.14. The NMR-determined structures of: A. Cyclised (cyc) DnaB-N and B. Linear (lin) DnaB-N. The 
sequence of the five amino acid linker is also shown. The arrow indicates the location of the peptide bond 
between the N- and C-termini. Adapted from 310. Note the NMR structures were determined for the protein 
without a linker, but the five amino acid linker used in this work is drawn here. 
 
 
Previous investigation of these two proteins showed the cyc-DnaB-N with a nine amino acid linker 
to be more stable to unfolding than the linear form. Using differential scanning calorimetry, the 
melting temperature measured for the cyclised form was 14 °C higher than the linear.124 ESI-MS 
has also been used to follow the hydrogen/deuterium exchange kinetics of the amide protons of 
both proteins at neutral pH.309,311 The unfolding rate of cyc-DnaB-N was significantly slower than 
lin-DnaB-N. In this work, cyc- and lin-DnaB-N each with the five amino acid linker showed similar 
behaviour to the corresponding proteins with the nine amino acid linker.311 
Previously in our laboratory, the ESI mass spectra of the two forms of DnaB-N (nine amino acid 
linker) were compared under the same solution and instrument conditions.310 When the linear 
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DnaB-N was unfolded by decreasing the pH to 2, a second charge state distribution appeared at 
lower m/z consistent with the presence of a population of unfolded protein (Figure 5.15). Under 
the same conditions, the low m/z charge state distribution was not observed in the spectrum of 
the stable cyclised DnaB-N.310 These mass spectra confirmed that cyclisation of the protein 
stabilises it with respect to unfolding by decreasing pH. 
 
 
Figure 5.15. Positive ion ESI mass spectra of lin-DnaB-N and cyc-DnaB-N with the 9 amino acid linker in 10 
mM NH4OAc, pH 2.0. A. Lin-DnaB-N, with the appearance of ions at low m/z. B. Cyc-DnaB-N. Reproduced 
from Watt et al. 2007.310 
 
ESI mass spectra of the two DnaB-N forms were also compared under the same solution and 
instrument conditions, at neutral pH (i.e., pH 7.6). The resulting spectra are reproduced in Figure 
5.16. The spectra of linear and cyclised DnaB-N were very similar. Since the cyclised form is more 
stable to unfolding, this indicated that both forms of the protein retained their structure during 
the ionisation process. The most abundant ions for each protein were the [M+7H]7+ ions, at m/z 
1938.0 for the linear form and m/z 1935.4 for the cyclised form, consistent with the masses of 
13,559 and 13,541 Da, respectively. This is consistent with the maximum number of charges, ZR, 
which could be carried by a folded protein of these masses (9) according to equation 1. Ions of 
A 
B 
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very low abundance at lower m/z were observed in the spectrum of lin-DnaB-N, consistent with a 
small population of unfolded protein.310 
 
Figure 5.16. Positive ion ESI mass spectra of lin-DnaB-N and cyc-DnaB-N with the 9 amino acid linker in 10 
mM NH4OAc, pH 7.6. A. Lin-DnaB-N. B. Cyc-DnaB-N. A small amount of dimer, 2M, was observed. Adapted 
from Watt et al. 2007.310 
 
 
In the current study, the Synapt™ HDMS™ TWIMS mass spectrometer was used to investigate 
further the cyclised and linear forms of DnaB-N. This work was carried out to confirm that the 
different CSDs observed in the ESI mass spectra represent different conformational forms (more or 
less folded) and to determine whether different conformations of DnaB-N are resolvable by 
TWIMS MS. In the following experiments, the cyclised and linear DnaB-N incorporated the five 
amino acid linker shown in Figure 5.14 (5-cyc-DnaB-N and 5-lin-DnaB-N). The cyclised protein was 
previously shown in hydrogen/deuterium exchange experiments to unfold ~10 times more slowly 
than the linear form.311 The first experiments involved confirming that the 5-lin- and 5-cyc-DnaB-N 
analysed using the Synapt™ HDMS™ showed similar behaviour to that previously reported for 9-
lin- and 9-cyc-DnaB-N using a Waters ESI-QTOF2 mass spectrometer. 
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Figure 5.17. Positive ion ESI mass spectra of 5-lin- and 5-cyc-DnaB-N using the Synapt™ HDMS™ instrument. 
A. Linear DnaB-N in 10 mM NH4OAc, pH 7.6. B. Cyclised DnaB-N in 10 mM NH4OAc, pH 7.6. C. Linear DnaB-N 
in 10 mM NH4OAc, pH 2. D. Cyclised DnaB-N in 10 mM NH4OAc, pH 2. 
 
Samples were prepared under the same conditions as the previous work. The corresponding 
spectra for samples sprayed from 10 mM NH4OAc, pH 7.6 and adjusted to pH 2 using formic acid 
are shown in Figure 5.17. The spectra obtained using the Synapt™ HDMS™ instrument are quite 
similar to those previously obtained. Ions also appear at low m/z for 5-lin-DnaB-N at pH 7.6 
(compare Figure 5.17A and Figure 5.16A), but were of slightly higher abundance when analysed 
D 
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using the Synapt™ HDMS™ (Figure 5.17A). Comparison of the spectra of 5-lin- and 5-cyc-DnaB-N 
obtained at pH 2 (Figure 5.17C and 5.17D) show ions of high abundance to lower m/z consistent 
with a greater extent of unfolding, especially for 5-lin-DnaB-N (C). This is expected as the linear 
form is less stable to unfolding. The most abundant ion in all spectra corresponded to the 
[M+7H]7+ ion, with the ion [M+13H]13+ also abundant in the spectrum of the linear DnaB-N sample 
at pH 2, consistent with the previous work. 
Next, TWIMS data were obtained to determine the drift times of ions in the different CSDs of the 
ESI mass spectra. The ion mobility data for the 5-lin- and 5-cyc-DnaB-N were first compared at pH 
7.6 (Figure 5.18). The driftscope image (A) and ESI mass spectrum (B) of 5-cyc-DnaB-N (Figure 5.18, 
I), show a predominant CSD centered around the [M+7H]7+ ion at m/z 1869.6. This CSD is also 
present in the spectrum of 5-lin-DnaB-N (Figure 5.18, II). The linear version also shows ions in the 
mass spectrum (II, B) consistent with unfolded protein. This population is evident in the driftscope 
image (II, A) at a longer drift time. Other ions are present that correspond to a dimer of DnaB-N 
(e.g. [2M+11H]11+ at m/z 2379.7, corresponding to a mass of 26,176 Da). DnaB forms a hexamer 
that involves contacts between N-termini domains.312 In our laboratory, crystals of DnaB have 
been grown which reveal dimer and trimer. These ions were also present at lower abundance in 
our previous ESI-MS experiments (see Figure 5.16).  
It is likely that some of the ions, especially those carrying a greater number of charges (to lower 
m/z) than [M+7H]7+, represent a mixture of folded and unfolded forms.  
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Figure 5.18. Positive ESI-TWIMS of I, 5-cyc-DnaB-N (left) and II, 5-lin-DnaB-N (right). A. Driftscope images. B. Mass spectra. The drift time distributions 
corresponding to a folded and unfolded conformation are indicated. Some ions of 5-lin-DnaB-N represent both folded and unfolded conformations. Ions 
corresponding to monomer (M), dimer (2M) or trimer (3M) are indicated on the mass spectra (B).  
Folded Folded 
Unfolded 
A 
B 
I   5-cyc-DnaB-N II   5-lin-DnaB-N 
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The presence of folded and unfolded forms for a given m/z was investigated further by selecting a 
single charge state and closer examination of the drift plot for that value of m/z. The drift plots for 
the 8+ ion of the 5-lin- and 5-cyc-DnaB-N are shown in Figure 5.19 (I and II, B). 
 
  
Figure 5.19. Positive ESI-TWIMS of I, 5-cyc-DnaB-N (left) and II, 5-lin-DnaB-N (right), corresponding to the 
8+ ion (m/z 1636.4 for 5-cyc-DnaB-N and m/z 1638.6 for 5-lin-DnaB-N). A. Driftscope images.  B. Drift plots. 
C. Mass spectra. The drift plot for the 5-cyc-DnaB-N shows a drift time of 11.5 ms and the drift plot for the 5-
lin-DnaB-N shows two drift times at 11.9 and 14.2 ms.   
 
The drift time plot for the [M+8H]8+ ion of 5-cyc-DnaB-N shows one drift time at ~11.5 ms (Figure 
5.19IB). The [M+8H]8+ ion of the 5-lin-DnaB-N sample under the same solution and instrument 
conditions shows at least two distinct drift times at ~11.9 and ~14.2 ms (Figure 5.19IIB). This 
indicates that two conformations, a folded (drift time, 11.5-11.9 ms) and a more unfolded (drift 
time 14.2 ms) conformation, of the linear DnaB-N are present at the same m/z and this is 
resolvable using the Synapt™ HDMS™ instrument. The *M+13H]13+ ion at lower m/z (1008.7), 
expected to represent only the unfolded conformation since this ion was not present in the 
A 
B 
I   5-cyc-DnaB-N II   5-lin-DnaB-N 
C 
A 
B 
C 
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cyclised spectrum (Figure 5.18IB), exhibited only one drift time corresponding to a more unfolded 
conformation (not shown). This is consistent with the hypothesis that the appearance of CSDs at 
lower m/z is the result of DnaB-N unfolding. 
 
5.2.3 Comparison of drift times of negatively and positively charged 
calmodulin 
The final stages of ionisation of proteins in the electrospray process are thought to be best 
described by the charge residue model (CRM).306 In this model, the gas-phase protein ions are 
produced as evaporation of the solvent in the electrospray droplet is completed.122 In positive ion 
ESI, protons are transferred from solvent (usually from ammonium of ammonium acetate) to the 
side chains of basic amino acid residues.122 In negative ion ESI, protons are transferred from the 
side chains of acidic amino acid residues to the acetate from ammonium acetate.122,313 The 
accessibility of these side chains will determine the maximum number of charges acquired by 
these proteins.18,107,122 The conformation of a protein will affect the accessibility of the ionisable 
amino acids, and thus the observed charge state distribution in the ESI mass spectrum. The extent 
of ionisation can also be influenced by other factors such as the pH and ionic species that are in 
the solutions from which they are sprayed18,108,122 and the gas-phase basicities of the basic amino 
acid side chains (for positive ESI).122,314,315  
To maintain any noncovalent interactions that are important to the native structure of a 
biomolecular complex, sample mixtures are usually kept close to neutral pH.122 An acidic protein 
will have a net negative charge and a basic protein will have a net positive charge under neutral 
conditions, so this may affect the selection of either positive or negative ion mode when using ESI-
MS122 especially for small proteins. The effect that opposite polarity ionisation has on the ability of 
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ESI-MS to detect noncovalent complexes and indicate conformational changes in protein structure 
has been investigated previously in this laboratory using the well-characterised protein, 
calmodulin, as an example.122 
Calmodulin (CaM) is a small, acidic protein involved in the regulation of Ca2+ signalling in 
eukaryotic cells. CaM has been the subject of extensive study and its different conformational 
forms have been well characterised.316-318 The structure of apoCaM is shown in Figure 5.20A. CaM 
in its active form has bound calcium ions in its two EF-hand, Ca2+-binding domains, forming a 
dumbbell shape68 (Figure 5.20B). The conformational change induced by the binding of Ca2+ ions 
results in the exposure of hydrophobic regions of the protein.69 The hydrophobic regions of CaM 
are the point of interaction with a number of target proteins (or peptides) and ligands.319 This 
interaction induces a further conformational change, whereby the C- and N-terminal EF-hand 
domains bend toward each other and wrap around the peptide forming a binding tunnel320. CaM 
with bound Ca2+ can also bind a number of antagonists that inhibit its activity,321 such as the 
antipsychotic drug trifluoperazine (TFP). The crystal structure of Ca4CaM bound to TFP
318 is shown 
in Figure 5.20C). This structure illustrates the change in the Ca4CaM structure that results in 
inhibition of its activity. 
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Figure 5.20. Structures of conformational forms and complexes of calmodulin. A. ApoCaM (PDB 1CFC); B. Ca4CaM (PDB 1CLL) and C. Ca4CaM-TFP (PDB 
1CTR). Calcium ions shown as red spheres, and TFP shown in yellow. TFP is trifluoperazine; structure shown at top right. 
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The binding of metals and peptides to CaM has been investigated previously using ESI-MS. 
Negative ion ESI-MS was used to confirm the presence of up to four Ca2+ ions bound to CaM.70 
Negative ion ESI-MS has also been used to compare the charge state distribution (CSD) of apoCaM 
(CaM with no Ca2+ ions present) and CaM upon addition of calcium. When four Ca2+ ions were 
bound to CaM, ions carrying fewer negative charges were observed, consistent with a 
conformational change that decreased solvent accessibility to negatively charged residues.322 
Previously in our laboratory, negative and positive ion ESI mass spectra of CaM and complexes of 
CaM with Ca2+ and TFP were compared.122 While most proteins are analysed by positive ion ESI-
MS, CaM is a small, acidic protein (pI ~4) and can be analysed by ESI-MS as negative or positive 
ions. In negative ion mode ESI-MS, apoCaM was observed to have two distinct CSDs with the most 
abundant ions from each charge envelope at m/z 1048.4 and 2397.7, that corresponded to 
[apoCaM-16H]16-, and [apoCaM-7H]7-, respectively (Figure 5.21(a)).  
 
 
 
 
 
 
 
 
 
Figure 5.21. Negative and positive ESI mass spectra of apoCaM and Ca4CaM. (a) Negative mode apoCaM. (b) 
Positive mode apoCaM. (c) Negative mode Ca4CaM. (d) Positive mode Ca4CaM. Inserts show spectra 
transformed to mass scale. Reproduced from Watt et al. 2005.122  
 
(d) (c) 
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The presence of these CSDs suggests that there were at least two protein conformations: a more 
folded form (centred around the 7- ion) and an unfolded form (16-). The positive ion spectrum of 
apoCaM is shown in Figure 5.21(b). The most abundant ion in this spectrum was at m/z 2099.9 
corresponding to the [apoCaM+8H]8+ ion. In positive ion mode, the relative abundances of highly 
charged ions (low m/z) of apoCaM were significantly lower than in negative mode. It was thought 
that this result suggests negative ion spectra of apoCaM are a more sensitive indicator of unfolded 
apoCaM than positive ion mode. Apart from the polarity of ionisation, the ESI mass spectra were 
acquired under identical conditions. 
In this same study, the calcium-binding properties of CaM were also investigated using positive 
and negative ESI-MS. Figures 5.21(c) and (d) show the ESI mass spectra of Ca4CaM in negative and 
positive ion mode, respectively. A mass increase of 38 Da is observed for each calcium bound, 
corresponding to the binding of divalent calcium ions that have displaced two protons. In negative 
ion mode, the ion series observed for the Ca4CaM spectrum were quite different to apoCaM. 
When bound with calcium, only one charge envelope was observed with the most abundant ion 
being [Ca4CaM-8H]
8- (m/z 2117.2). This was consistent with a conformational change in CaM upon 
binding calcium to a more folded form. The binding of the antipsychotic drug, TFP, to Ca4CaM was 
also investigated using negative and positive ESI-MS.122 The crystal structure of Ca4CaM with TFP 
shows that the Ca4CaM undergoes a significant conformational change upon binding TFP (Figure 
5.20C). The resulting positive and negative ion ESI mass spectra are shown in Figure 5.22. 
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Figure 5.22. Positive and negative ESI mass spectra of Ca4CaM ± a 5-fold excess of TFP. (a) Positive mode 
Ca4CaM alone. (b) Positive mode Ca4CaM+TFP. (c) Negative mode Ca4CaM+TFP. Adapted from Watt et al. 
2005. 122 
 
Comparison of the positive ion ESI mass spectrum of Ca4CaM alone (spectrum A) and that with TFP 
added in a 5-fold excess (spectrum B) shows a shift in the charge state distribution. The addition of 
TFP resulted in a shift from the 8+ charge state to the 5+ charge state. In spectrum B, three species 
were observed, corresponding to Ca4CaM alone ([Ca4CaM+5H]
5+, m/z 3389.5), a complex with one 
TFP molecule ([Ca4CaM+1TFP+5H]
5+, m/z 3470.9) and two TFP molecules ([Ca4CaM+2TFP+5H]
5+, 
m/z 3552.3). The observed change in charge state distribution from 8+ to 5+ upon TFP binding was 
proposed to reflect changes in the accessibility of ionisable residues on the protein as a result of 
the conformational change.122 
The negative ion ESI mass spectrum of Ca4CaM with 5-fold excess of TFP added (spectrum (c)) 
showed no ions from the Ca4CaM-TFP complex. The observed spectrum is similar to that of 
226 
 
Ca4CaM alone (Figure 5.21(c)), with the most abundant ion as [Ca4CaM-8H]
8-. A possible 
explanation for this unexpected result was suggested by reference to the crystal structures of 
Ca4CaM and Ca4CaM-TFP shown in Figure 5.20. The binding of TFP brings some acidic residues 
(near the Ca2+ binding region) closer together. In particular, residues Glu7 and Glu11 are brought 
closer to Glu127 and Glu123, and Glu14 is brought closer to Glu114. The electrostatic repulsion 
will favour protonation of these residues, lowering the response factor for negative ion ESI mass 
spectra of this complex. Another possible explanation for this result may be that the gas-phase 
negative complex may be less stable than the positively charged complex in the mass 
spectrometer.122 
In the current work, the Synapt™ HDMS™ instrument was used to investigate the complexes of 
CaM, in particular the conformational changes that occur upon binding calcium in negative and 
positive ion mode ESI-MS. In order to comment on the stability with respect to unfolding of 
positively or negatively charged CaM and its complexes in the mass spectrometer, the drift times 
were compared under conditions that were identical other than the ionisation mode. In the 
previous work,122 a Waters ESI-QTOF2 instrument was used for this work. To ensure the spectra 
obtained using the Synapt™ instrument were similar to those obtained previously, the samples 
were analysed in TOF mode. The resulting spectra are shown in Figure 5.23. 
 
227 
 
 
Figure 5.23. Positive and negative ion mode ESI mass spectra of apoCaM and Ca4CaM obtained using the 
Synapt™ HDMS™ instrument. A. Positive mode apoCaM (cf. Figure 5.21(b)). B. Negative mode apoCaM (cf. 
Figure 5.21(a)). A small peak is present next to the apoCaM peak corresponding to three Ca2+ ions bound to 
CaM. C. Positive mode Ca4CaM (cf. Figure 5.21(d)). D. Negative mode Ca4CaM (cf. Figure 5.21(c)). 
 
 
The spectra of apoCaM and Ca4CaM in both positive and negative ESI ion mode are in reasonable 
agreement with those previously obtained. A greater relative abundance of ions to lower m/z 
(800-1800) was observed in the positive ion spectrum of apoCaM (Figure 5.23A). The ion of 
greatest abundance for the spectrum obtained using the Synapt™ HDMS™ instrument is the 7+ 
ion, whereas the 8+ ion was the most abundant previously (QTOF2). In the negative ion spectrum 
of apoCaM, two charge envelopes were observed as previously (cf. Figure 5.21(a)), but in addition, 
at values in the range of m/z >2000, there were ions to higher m/z of ions from apoCaM 
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corresponding to apoCaM+3Ca2+ suggesting that removal of Ca2+ by dialysis against EDTA was 
incomplete for this sample. With only 3 Ca2+ bound, it might be expected that the protein was not 
fully folded. The positive and negative ESI mass spectra of Ca4CaM were similar to those previously 
obtained using the QTOF2 (Figure 5.21(c) and (d), respectively) with the exception that the 7+ and 
7- ions (rather than the 8+ and 8-) were the most abundant.   
TWIMS data were obtained to investigate the differences between the mass spectra observed for 
the samples in positive and negative ion mode, in particular whether there were differences in 
drift time for positively and negatively charged ions. Initial work carried out by Bowers and 
coworkers323 used TWIMS to investigate the effect of calcium and peptide binding on the relative 
stabilities of the different CaM conformers. This work demonstrated that CaM complexes can be 
readily analysed using this instrument. TWIMS data for the same sample of apoCaM were acquired 
using the Synapt™ HDMS™ instrument in positive and negative ion mode but under otherwise 
identical conditions (Figure 5.24). The conditions are described in section 2.2.7. Under the 
conditions required to obtain ion mobility mass spectra, the mass spectra revealed that the major 
species in the apoCaM sample was from CaM with no Ca2+ bound with an ion of low abundance 
(~20%) from apoCaM+1Ca2+. The binding of one Ca2+ ion is not expected to induce the 
conformational change caused by the binding of four Ca2+ ions (Figure 5.20), but is a complicating 
factor in the interpretation of the ion mobility spectra. 
Figure 5.24 shows the driftscope images (A) and ESI mass spectra (B) of apoCaM in negative (I) and 
positive (II) mode. A cursory comparison of the driftscope images (IA and IIA) shows that the ion 
mobility spectra are different between the two ionisation modes and that the negative ions all 
occur at relatively shorter drift times, suggesting that negatively charged apoCaM has a more 
compact structure. 
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Figure 5.24. ESI-IM mass spectra of apoCaM under the same solution and instrument conditions. I, Negative ion mode spectrum and II, Positive ion 
mode spectrum A. Driftscope images B. Mass spectra. 
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The drift times for each charge state (negative vs. positive) can be compared by referring to the 
drift plots shown in Figure 5.25. In this figure the drift times observed for positive and negative 
ions with the same absolute value of z (charge) are compared. Figure 5.26 compares the drift 
times for ions of like polarity. The collisional cross section determined from the ion mobility 
depends on the absolute value of the charge (see Smith et al. 2009284 for a summary). 
When z = 6 or 7 for both positive and negative ions, the drift time distribution is relatively 
symmetrical suggesting one predominant conformational form. The negatively charged apoCaM 
has a shorter drift time suggesting it is more compact than positively charged apoCaM (Figure 
5.25). The drift times for different values of z for negative and positive ions are shown in Table 5.1. 
The different structures for negative and positive apoCaM suggested by the different drift times 
have implications for experimental design for analysis of noncovalent complexes of CaM. Since it is 
an acidic protein, it is often analysed in negative mode. It seems likely that positively charged 
apoCaM will have different properties from negatively charged apoCaM. 
When z = 14, the drift time distribution is also relatively symmetrical for both positive and 
negative ions, suggesting one (unfolded) form. The negatively charged “unfolded” form had a 
shorter drift time than the positively charged form. The positive ion TWIMS spectrum shows that 
there are two conformational forms for z = 8, and also when z = 9. 
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Figure 5.25. Comparison of positive and negative ion drift times for ions of apoCaM (from Figure 5.24 IA and 
IIA). 
z = 6 z = 7 
z = 8 z = 9 
z = 11 z = 14 
232 
 
To more closely inspect the different forms present especially when z = 8 or 9, the drift plots for 
each charge state are compared for both the positive and negative ion spectra in Figure 5.26. 
 
Figure 5.26. Comparison of the changes in drift time distribution with charge for positive and negative 
apoCaM. The dotted lines show the position of the ions with the longest and shortest drift times for 
negatively and positively charged apoCaM. Ions proposed to be from like conformational forms have the 
same labels; e.g. *, , , . These are the same data shown in Figure 5.25, but presented for a different 
perspective. 
z = 6 z = 6 
z = 7 z = 7 
z = 8 z = 8 
z = 9 z = 9 
z = 11 z = 11 
z = 14 z = 14 
* 
* 
* 
 
 
 
 
 
 
 
 
 
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Table 5.1. Drift times for main ions obtained in negative and positive ion mode for apoCaM. 
 
Negative ion mode Positive ion mode 
Charge state Drift time (ms) Charge state Drift time (ms) 
6- (m/z 2797) 7.05 6+ (m/z 2798) 11 
7- (m/z 2397) 5.13 7+ (m/z 2398) 8.21 
8- (m/z 2097) 3.9, 5.77 8+ (m/z 2099) 6.41, 9.8 
 
 
In TWIMS spectra, ions with lower values of z have longer drift times. Hence, taking the case of 
negative apoCaM, a shift from a drift time of 7.05 to 5.13 ms is observed for z = 6- to 7- (Table 5.1). 
When z = 8-, there are two drift time distributions: one at approximately the same drift time as the 
7- (cf. 5.13 and 5.71 ms) and one at 3.9 ms. The latter is most likely associated with the form 
corresponding to that observed for z = 6- and 7-. These proposed same folded forms are marked 
with an asterisk in Figure 5.26. Other proposed similar forms are also given the same labels. 
TWIMS data were also obtained for a sample of Ca4CaM using the Synapt™ HDMS™ instrument in 
positive and negative ion mode. The results are shown in Figure 5.27. 
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Figure 5.27. ESI-IM mass spectra of Ca4CaM under the same solution and instrument conditions. I, Negative ion mode spectrum and II, Positive ion 
mode spectrum A. Driftscope images B. Mass spectra.  
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The driftscope images for negative (Figure 5.27 IA) and positive (Figure 5.27 IIA) Ca4CaM appear to 
be more similar than was observed for positive and negative apoCaM. Figure 5.28 compares the 
drift time distribution for given positive and negative values of the same charge (z) and Figure 5.29 
compares the change in drift time distribution with charge for positive and negative Ca4CaM. In 
both positive and negative ions some heterogeneity of conformational forms is evident for z = 8 to 
z = 11 by the asymmetry of the drift time distributions. For the “folded” Ca4CaM (z = 6, 7), the 
negatively charged protein in this case has a slightly longer drift time than the positively charge 
protein (Figure 5.28). The negative and positive “unfolded” forms (z = 14) are difficult to 
distinguish based on drift time. The drift times for different values of z for negative and positive 
ions of Ca4CaM are shown in Table 5.2. 
The greater similarity observed for positive and negative Ca4CaM compared with apoCaM suggests 
that the structure provided by the binding of Ca2+ (see Figure 5.20) prevents, to some extent, the 
structural deformation caused by imposing opposite polarity on apoCaM. Nevertheless, the 
difference in collisional cross section for the folded form suggested by the slightly longer drift time 
for negatively charged Ca4CaM shows caution needs to be exercised when choosing the polarity 
for ESI-MS of small, acidic proteins.  
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Figure 5.28. Comparison of positive and negative ion drift time chromatograms of different charge states of 
Ca4CaM. 
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Figure 5.29. Comparison of the changes in drift time distribution with charge for positive and negative 
Ca4CaM. 
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Table 5.2. Drift times for main ions obtained in negative and positive ion mode for Ca4CaM. 
 
Negative ion mode Positive ion mode 
Charge state Drift time (ms) Charge state Drift time (ms) 
6- (m/z 2822) 7.18 6+ (m/z 2824) 6.7 
7- (m/z 2419) 5.3 7+ (m/z 2421) 4.87-5.1 
8- (m/z 2117) 4.5-5.2 8+ (m/z 2118) 3.85 
 
 
5.3 Summary and future directions 
The coupling of mobility separation of ions on the basis of shape and size with ESI-MS opens up a 
range of possibilities with regard to the study of structural biology, and investigations of large 
multi-protein complexes that are involved in cellular processes.  
The work in this chapter outlined the application of TWIMS to resolve protein conformers. A 
mixture of proteins of similar mass but different shape was successfully resolved using TWIMS. 
Solution and instrument conditions were optimised to allow differentiation of a sample of the 2 
sliding clamp of the bacterial replisome, and human transferrin.  The differences in CSD thought to 
be the result of protein unfolding were investigated using linear- and cyclised-DnaB-N. These 
proteins differ only by the mass of a water molecule and have essentially the same structures. The 
cyclised protein is more stable against unfolding than the linear protein. At low pH, a CSD at lower 
m/z arises in the mass spectrum of linear but not cyclised DnaB-N. Examination of drift times 
confirmed that this was most likely the result of protein unfolding as evidenced by an increase in 
drift time. At pH 7.6, the linear DnaB-N also showed some unfolding. Further investigation of this 
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resulted in the resolution by TWIMS of an unfolded and folded conformation at the same value of 
m/z.  
Previous work using ESI-MS alone revealed differences in the CSDs of complexes of CaM when 
analysed in positive or negative ion mode. TWIMS was used to investigate whether these 
differences were the result of a change in the conformation when analysed in these different ion 
modes. It was found that apoCaM exhibited a larger collisional cross section (inferred from longer 
drift time) in positive ion mode. The difference in drift times between positive and negative 
Ca4CaM was smaller suggesting the structure imposed by the binding of Ca
2+ prevented structural 
deformations arising as a result of polarity. Further investigation of this work will involve 
experiments to check the reproducibility of these results, in particular to ensure the complete 
removal of Ca2+ from Ca4CaM for investigations of apoCaM. The results of this work indicate that 
caution should be used when selecting a suitable ionisation mode when studying small acidic 
proteins.  
These preliminary studies using TWIMS demonstrate its ability to resolve conformational forms of 
proteins and protein complexes. This technique holds great promise for further applications to the 
study of protein conformation. 
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Chapter 6 
 
Concluding Remarks 
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The applications of MS have progressed to the point where the molecular interactions of 
biomolecular machines can be analysed. In the last ten to fifteen years, much of the work in this 
field involved validation of ESI-MS as a tool for structural biology. Now, new information is being 
obtained from ESI-MS data. 
In this work, a putative second nucleotide binding site has been observed on rubisco activase. This 
information would be difficult to gain by any other method. For example, treatment with 
radioactive nucleotides only provides an average of the number of nucleotide molecules bound to 
the protein. The ESI-MS results provided confirmation that M. burtonii rubisco assembled in the 
presence of substrates and cofactors to form a decamer. In studies such as these where only gel 
filtration or PAGE is available, it can sometimes be difficult to assign a final stoichiometry 
especially where a large number of small subunits associate. 
Biomolecular machines such as the ribosome and proteasome have been analysed by ESI-MS.98,102 
However, these complexes are relatively robust while the replisome is a relatively fragile 
biomolecular machine. The replisome has not been isolated intact in sufficient amounts for 
biophysical characterisation. Consequently, progress has been made by over-expression and 
structural studies of individual subunits and small subassemblies. ESI-MS presents a useful screen 
for analysis of relatively stable interactions. It has been demonstrated here and in other 
work23,58,276,278 that subassemblies of the replisome can be analysed by ESI-MS. The preparation of 
a more stable 2 complex by exploiting the consensus sequence for 2-binding in the t 2 
complex has formed the basis to build up larger components of the replisome. The stable 
subassemblies screened in this way provide clues to assemblies that might be amenable to 
crystallisation and X-ray analysis. While these small subassemblies are stable in the mass 
spectrometer, it is possible that larger assemblies will be stable when bound with appropriate DNA 
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structures or with other replisomal proteins. The results reported here have provided confidence 
for the further studies and based on this work, in part, a new interaction between 2 and  has 
been identified.280 
This process: identification of protein binding partners, overexpression and structural 
determination, biochemical and biophysical analysis, ESI-MS to characterise the interaction of 
assemblies will be amenable to other protein assemblies where much less is known. 
The commercial availability of the Synapt™ HDMS™ (TWIMS) presents new opportunities for 
analysis of protein conformers. At present, this technology is in its infancy for such applications. 
The magnitude of conformational change necessary to allow resolution of the protein conformers 
for resolution based on collisional cross section in the TWIMS cell is not readily predicted. This is 
because some substantial conformational changes may not significantly affect the collisional cross 
section. The TWIMS cell can readily separate the globular protein transferrin (Mr 79,674 Da) and 
the ring-shaped 2 sliding clamp (Mr 81,173 Da). In addition the unfolded form of DnaB-N was 
readily separated from the folded conformation.  
Small, acidic proteins can be analysed by ESI-MS as either positive or negative ions. TWIMS 
analysis showed that for calmodulin, the drift times for negatively charged and positively charged 
proteins (and therefore the collisional cross section) are different. This observation raises 
important experimental consideration for investigating such proteins when inferences are to be 
made about behaviour in solution. It remains to be seen whether TWIMS technology will be useful 
for resolution of ligand-induced conformational changes that may substantially alter distances 
between some protein residues and change the shape of a protein but may not necessarily affect 
the two-dimensional cross section along any axis. Since the structure of rubisco activase is 
unknown, TWIMS offers a suitable method for determining whether it occurs as a hexameric ring 
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as has been observed for other AAA+ proteins. The cross sections of ring-shaped proteins and 
globular proteins of the same mass are readily distinguished (e.g. transferrin and 2, Figure 5.13, 
and Ruotol et al. 2005292).  
The results reported here provide new information about tobacco rubisco activase and M. burtonii 
rubisco and have provided a starting point for future investigations of the assembly of the E. coli 
replisome. The application of TWIMS technology for understanding biomolecular machines will 
become clearer over the next decade. 
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